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Abstract
Nanoparticles continue to be studied for their properties as carriers for small molecules,
such as bio-imaging agents, biologically relevant targeting ligands, and therapeutic drugs as tethering
these small molecules to a larger particle provides stability to the molecule and lessens the probability
that the system is cleared prematurely from the body. However, the body suffers from intense
auto-fluorescence, so one way to improve imaging agents to combat the auto-fluorescence issue is
to create a system that is fluorescence activatable; the activation must occur when the system is
only in the intended environment. Additionally, intense light scattering occurs at the blue end of
the visible spectrum; one approach to overcome this issue in various nano-photonic applications is
to generate scintillating (i.e. a material that converts ionizing energy, such as x-rays, to visible
light) nanoparticles: 1) nanoparticles can be doped with various blue emitting organic scintillators,
which emit even as single molecules, making the system x-ray active and 2) utilize a blue-emitting
inorganic polycrystalline ceramic nano-scintillator. X-rays also more effectively penetrate the body
when compared to visible light so x-ray excitable materials may have more advantageous imaging
and therapeutic properties when compared to traditional light based theranostics. To address these
issues three main approaches were taken:
(1) Fluorophore functionalized bovine serum coated polymeric nanoparticles with far red
activated fluorescence
Activated fluorescence was achieved for a poly(propargyl acrylate) (PA) nanoparticle system.
In this work, the system consisted of an azide modified bovine serum albumin (azBSA) that had
been covalently attached to a newly synthesized alkyne modified silicon phthalocyanine (alSiPc)
derivative through a copper catalyzed azide alkyne Huisgen cycloaddition, (“click chemistry”). The
azBSA/alSiPc was then covalently attached, via click chemistry, to the PA particle sized at ca. 67 nm
(PA/BSA/alSiPc). The native system had no emission. However, when the system was incubated at
ii

37 o C for 30 min with the digestive enzyme, trypsin, it was seen that the system became fluorescent.
This phenomenon is due to the trypsin digesting the “weak link” BSA, which releases free alSiPc,
a highly fluorescent dye. The PA/BSA/alSiPc system was confirmed to be biocompatible, and, to
investigate activated fluorescence in cancer cells, human non-small cell lung cancer cells (A549 cell
line) were used. The PA/BSA/alSiPc system was incubated with the cells at varying time points in
an effort to observe a fluorescence increase over time as the cells uptake the system. The particle is
taken to the lysosomes and endosomes of the cancer cell. This is where the digestive enzymes are
located, and the BSA is digested via endocytosis, resulting in the release of free alSiPc in the cell.
It was seen, through live cell scanning confocal microscopy, that the fluorescence was activated in
the cell. Additionally, the system was evaluated in an in vitro photodynamic therapy set-up and
compared to the free fluorophore as well as the particulate system without the BSA linker.
(2) Fully organic x-ray active colloidal crystalline arrays exhibiting color control via sequential Förster Resonance Energy Transfer (FRET) and photonic band gap control
In an effort to overcome the inherent scattering in optical bio-imaging, x-rays excited optical
luminescence and x-ray fluorescence computed tomography (XFCT) are attractive alternates to
traditional optical imaging techniques. To avoid potential toxicity issues that come with imaging
agents containing heavy metals, especially gadolinium, we propose a fully organic system that can
be tuned across the entire visible through judicious choices of donor/acceptor Förster Resonance
Energy Transfer (FRET) pairs. In the current system, polystyrene sub-100nm nanoparticles were
synthesized with a variety of organic dyes encapsulated inside the particle. Three emitter series
were synthesized, with anthracene (Anth), Anth and an azide modified naphthalimide derivative
(Napth), and Anth, Napth, and a rhodamine B derivative (RhB) (emitter series no 1, no 2, and
no 3, respectively). Anthracene, a widely used organic blue-emitting scintillator, is used as the
x-ray “pump” source to then transfer energy to Napth (green emitter) followed by transfer from
Napth to RhB (red emitter), where applicable. Additionally, the nanoparticles self-assembled into
electrostatically stabilized crystalline colloidal arrays. By tuning the stop band of the crystal through
the emission of the Anth, Napth, and RhB for emitter series no 1, no 2, and no 3, respectively, the
color could be greatly influenced by the change in the local density of optical states. Additionally, all
emitter series could be combined to produce a variety of colors including white. In this way, a fully
tunable organic x-ray active colloidal crystal could emit a wide variety of colors all while mitigating
the toxic effects observed from x-ray active heavy metal-containing imaging compounds.
iii

(3) Organic fluorophore coated polycrystalline ceramic LSO:Ce scintillators for x-ray bioimaging
Lutetium oxyorthosilicate doped with 1-10% cerium (Lu2 SiO5 :Ce, LSO:Ce) radioluminescent particles are coated with a single dye or multiple dyes to generate an effective energy transfer between the core and dye or between two dyes when excited via x-rays. LSO:Ce particles
were surface modified with an alkyne modified naphthalimide (6-piperidin-1-yl-2-prop-2-yn-1-yl-1H benzo[de]isoquinoline-1,3-(2H )-dione, AlNap) and/or alkyne modified rhodamine B (N -(6-diethylamino)9-{2-[(prop-2-yn-1-yloxy)carbonyl]phenyl}-3H -xanthen-3-ylidene)-N -ethylethanaminium, AlRhod) derivatives to tune the x-ray excited optical luminescence from blue to green to red using Förster Resonance
Energy Transfer (FRET). As x-rays penetrate tissue much more effectively than UV/visible light,
the fluorophore modified phosphors may have applications as bio-imaging agents. To that end, the
phosphors were incubated with rat cortical neurons and imaged after 24 hours. The LSO:Ce surface
modified with AlNap were able to be successfully imaged in vitro with a low power x-ray tube. To
use the LSO:Ce fluorophore modified particles as imaging agents, they must not induce cytotoxicity.
Neither LSO:Ce nor LSO:Ce modified with AlNap showed any cytotoxicity toward normal human
dermal fibroblast cells or mouse cortical neurons, respectively.

iv
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in a bright blue color under x-ray irradiation (right). X-ray radioluminescence (blue) and reflection
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Chapter 1

Introduction
Nanoparticles have long been utilized in a variety of applications, including optical materials, coatings and paints, carriers for drugs, fluorescent dyes, radionuclides and contrast agents
for MRIs, and receptor-ligand complexes. This work serves to expand the current nanoparticle
technology in several fields: 1) nanoparticulate bioimaging utilizing activated fluorescence, 2) exploring biological applications of radioluminescent particles, and 3) developing organic scintillating
nanoparticles as colloidal crystalline arrays and bioimaging agents. The following chapter focuses
on utilizing a nanoparticle platform with surface attachable or encapsulated moieties to enable better cancer theranostics, create particulate-based x-ray sensitive systems for bioimaging, and exploit
photonic crystals that can be excited and manipulated via x-rays. More specifically, fluorophore development for enhanced bioimaging, fluorescence activation and targeting for greater bioimaging and
better diagnostics will be addressed. Further, radioluminescent particles for bioimaging, theranostic, and photonic crystals will be discussed along with the scintillation mechanism for both organic
and inorganic scintillating materials. These results have been published as (1) M.K. Burdette,
R. Jenkins, Y. Bandera, R.R. Powell, T.F. Bruce, X. Yang, Y.Z. Wei, and S.H. Foulger. “Bovine
serum albumin coated nanoparticles for in vitro activated fluorescence.” Nanoscale, 8(48):2006620073, 2016. (2) Y. Bandera, M.K. Burdette, J.A. Shetzline, R. Jenkins, S.E. Creager, and S.H.
Foulger. “Synthesis of water soluble axially disubstituted silicon (IV) phthalocyanines with alkyne
& azide functionality.” Dyes and Pigments, 125:72-79, 2016. (3) R. Jenkins, M.K. Burdette, and
S.H. Foulger. “Mini-review: fluorescence imaging in cancer cells using dye-doped nanoparticles.”
RSC Advances, 6(70):65459-65474, 2016. (4) M.K. Burdette, Y. Bandera, G.M. Gray, and S.H.
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Foulger. Advanced Optical Materials, in press, 2018. (5) M.K. Burdette, H.W. Jones, Y. Bandera, and S.H. Foulger. “X-ray radioluminescent hydrogel stabilized crystalline colloidal arrays.”
Optics Express, in review, 2018. (6) M.K. Burdette, Y. Bandera, E. Zhang, A. Trofimov, A. Dickey,
I. Foulger, J. Kolis, K.E. Cannon, A.F. Bartley, L.E. Dobrunz, M.S. Bolding, L. McMahon, and
S.H. Foulger. “Organic fluorophore coated polycrystalline ceramic LSO:Ce scintillators for x-ray
bioimaging.” Langmuir, in review, 2018. Additionally, several side projects have resulted in the
following publications: (1) C.F. Huebner, C. Tonkin, T.M. McFarlane, M.K. Burdette, Y. Bandera,
and S.H. Foulger. “Asymmetric electrically conducting element printed from aqueously dispersed
pentacene nanoparticles.” Colloid and Polymer Science, 294(12):2013-2019, 2016. (2) C.F Huebner, V. Tsyalkovsky, Y. Bandera, M.K. Burdette, J.A. Shetzline, C. Tonkin, S.E. Creager, and
S.H. Foulger. “Nonvolatile optically-erased colloidal memristors.” Nanoscale, 7(4):1270-1279, 2015.
(3) Y. Bandera, T.M. McFarlane, M.K. Burdette, M. Jurca, O. Klep, and S.H. Foulger. “Synthesis of n-alkyl methacrylate polymers with pendant carbazole moieties and their derivatives.”
Journal of Polymer Science Part A, in press, 2018.

1.1

Advances in fluorophore development, activation, and
targeting for cancer theranostics
The following section will discuss the advances in fluorophore development, fluorescence acti-

vation, and cellular targeting for bioimaging and cancer theranostics. Chapter 2 explores fluorophoreprotein functionalized nanoparticles for in vitro activated fluorescence and passive targeting. Some
of the reported information in this chapter has been published as R. Jenkins, M.K. Burdette, and
S.H. Foulger. “Mini-review: fluorescence imaging in cancer cells using dye-doped nanoparticles.”
RSC Advances, 6(70):65459-65474, 2016., and is reproduced by permission of The Royal Society of
Chemistry.

1.1.1

Phthalocyanine & porphryin fluorophore development for enhanced
bioimaging and cancer theranostics
Since the Federal Drug Administration’s (FDA) approval of indocyanine green (ICG) as a

molecule used for bioimaging, there has been a drastic increase in research devoted to developing

2

and improving fluorophores for bioimaging. For fluorophores to be considered for bioimaging and
possible cancer theranostics (i.e. imaging and treating cancer all in one sitting) the fluorophores
need to be somewhat water soluble, have either increased in vivo circulation time or be able to be
attached to a platform, such as a nanoparticle, that will increase the in vivo circulation time, have
a good quantum yield, and exhibit a high contrast when placed in the body[1]. Toward this goal,
many fluorophore classes are being explored and modified to accommodate all of these features with
phthalocyanine and porphyrins being some of the more popular dyes studied due to their red/near
infrared emission and their ability via triplet state intersystem crossing to excited ground state
oxygen to its excited singlet state, which is highly toxic and can be exploited to kill cancer cells[2].
Porphyrin dyes are tetrapyrroles which are derivatized from blood, namely hemoglobin and
myoglobin[1]. The first investigation of a porphyrin dye as a diagnostic or therapeutic agent was
performed by Meyer-Betz in 1913 where he injected himself with hematoporphyrin (cf. Figure 1.1).
Hematoporphyrin (Hp) had been discovered approximately 72 years earlier when Scherer, investigating properties of blood, discovered that dried blood, when subjected to concentrated sulfuric
acid, a heating profile, and the removal of iron followed by an alcohol treatment, produced the Hp
molecule[3]. Meyer-Betz experienced no side effects from the dye until he went into the sunlight where
he then experienced extreme swelling; he remained photosensitive for several months[4]. However, a
later investigation by Schwartz uncovered that the photosensitivity was due to the oligomerization of
the hematoporphyrin rather than the monomeric form of hematoporphyrin, which is quickly cleared
by the body[4]. These investigations sparked a new area of research into porphyrin dyes, their second
generation counterparts, phthalocyanines, and their subsequent use in photodynamic therapy.
The first porphyrin dye approved by the FDA for the treatment of cancer and other abnormal cell growth conditions was Photofrin, which was approved for the treatment of advanced
esophageal, early lung, microinvasive endobronchial, gastric and papillary bladder cancer and cervical dysplasia (a non-cancerous condition where abnormal cells begin to grow on the cervix)[5].
Photofrin is a purified derivative of oligomeric hematoporphyrin[6] and is used as a fluorophore in a
cancer treatement known as photodynamic therapy (cf. Figure 1.2). Photodynamic therapy (PDT)
is a light therapy that relies on the generation of cytotoxic singlet oxygen as the main mechanism of
cell death.[7] In essence, red/near infrared light (at the absorbance wavelength of the fluorophore)
excites the fluorophore from its ground state to its excited singlet state. From the excited singlet
state, a forbidden transition from the singlet state to the triplet state of the fluorophore occurs.
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Figure 1.1: Structure of hematoporphyrin.

The fluorophore in its excited triplet state undergoes an intersystem crossing and excites molecular oxygen, generating oxygen in its excited singlet state[8, 9] (cf. Figure 1.3). Singlet oxygen is
highly cytotoxic, but has a short half life, which causes it to traverse only very short distances, so
targeted photodynamic therapy is effective at killing cancer cells while leaving healthy cells mostly
unharmed[8]. A similar study involving 11 patients with inoperable non-small cell lung cancer produced a 91% complete cancer cure rate when treated with Photofrin II and PDT[10]. A clinical
trial involving patients with a variety of bladder cancers resulted in tumor shrinkage for 75-84%
of patients after PDT treatment with Photofrin as the photosensitizer. Additionally, at 50 months
from treatment, 59% of patients were still living with 50% of the initial patient population remaining
cancer free[11].
While Photofrin has therapeutic effects against many types of cancer and other diseases, it
has quite a few drawbacks including prolonged skin photosensitivity, low molar extinction coefficient
resulting in high doses of Photofrin being needed to induce a therapeutic effect, and insufficient subdermal light penetration[12]. To address some of the issues associated with Photofrin, phthalocyanine
dyes, which are structurally similar to porphyrins, have been investigated. A phthalocyanine dye,
termed Pc 4, has been perhaps the most successful alternative to Photofrin.
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Figure 1.2: Structures of the mix of small molecules and oligomers that compose the drug Photofrin.
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Figure 1.3:

Jablonski diagram depicting the processes that occur during photodynamic therapy (PDT). i) Absorbance of light by the photosensitizer (PS) promoting electrons from the ground state (0 PS) to the excited state
(1 PS), ii) thermalization to the lowest vibrational energy possible within the given electronic band, (iii) fluorescence
of the photosensitizer, (iv) intersystem crossing from the excited singlet state (1 PS) to the excited triplet state (3 PS)
of the photosensitizer, (v) phosphorescence of the photosensitizer, (vi) energy transfer from the photosensitizer in its
triplet state (3 PS) to molecular oxygen in its ground state (3 O2 ), and (vii) absorbance of the transferred energy by
molecular oxygen which becomes a reactive oxygen species.

Due to their having a central metal atom, phthalocyanines tend to have longer lived triplet
states which generate more singlet oxygen that traditional porphyrins[13, 14]. Pc 4, a silicon phthalocyanine dye with structure HOSiPcOSi[CH3 ]2 [CH2 ]3 N[CH3 ]2 , has a higher molar extinction coefficient, causes less skin photosensitivity, and has a greater light penetration in tissue than Photofrin[15]
(cf. Figure 1.4).Pc 4 has a redshifted excitation wavelength when compared to Photofrin with the
excitation maximum being 635 nm and 675 nm for Photofrin and Pc 4, respectively[15]. Pc 4 has
shown remarkable therapeutic effects against a variety of cancers in vivo and has been successful in
phase 1 clinical trials. In one in vivo study involving U87 human glioma immunocomprimised rats
exposure to Pc 4 resulted in a 3.89:1 tumor tissue to normal brain tissue accumulation ratio. Upon
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irradiation, cell death was cancer cell specific[16]. Furthermore, Pc 4, and other phthalocyanines,
bind to serum albumin proteins present in the body, which can be exploited as a drug delivery
method.[17] Phase 1 clinical trials investigated the effect of Pc 4 in conjunction with photodynamic
therapy on cutaneous neoplasms. The results of the clinical trials showed that Pc 4 was well tolerated
with no adverse effects. In fact, upon one PDT treatment with Pc 4, 37% of patients experienced a
50% reduction in tumor area or thickness.[18] In another clinical study, 12 out of 13 patients with
operable non-small cell lung cancer responded to PDT treatment with Pc 4 in one treatment. Out
of 13 patients, 10 saw their tumors completely disappear in one treatment while 2 patients had to
receive and additional PDT treatment for complete tumor death.[5] These clinical trials are encouraging and has spawned additional research into second and third generation photosensitizers based
on porphyrins and phthalocyanines.
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Figure 1.4: Structure of silicon (IV) phthalocyanine Pc 4.

However, one of the main drawbacks of Pc 4 is that it is not water soluble and is prone to
aggregation in aqueous environments, so much research has focused on increasing water solubility
and decreasing aggregation of porphyrins and phthalocyanine dyes. For example, a water soluble
porphyrin (THPP), with zinc metal as the central atom, was developed, which showed an increase
in in vitro photodynamic therapy activity by 2-3 times when compared to Photofrin[19]. To try to
increase the water solubility of zinc phthalocyanines (ZnPcs), substituents can be introduced on the
macrocycle and can be subsequently quaternized to increase water solubility. In one such study,
imidazole groups (ZnPc1) or pyridiloxy groups (ZnPc2) were introduced on the macrocycle and
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were subsequently quaternized. Quaternization resulted in increased water solubility and proved to
have a positive effect on singlet oxygen quantum yield and in vitro photodynamic therapy when
compared to unsubstituted ZnPc in an aqueous environment. Between the two derivatives, ZnPc1
showed an increased fluorescence quantum yield and lifetime, while ZnPc2 showed a higher triplet
state and singlet oxygen quantum yield. When introduced to human breast adenocarcinoma cells
(MCF-7), ZnPc1 decreased cell viability to 40% while ZnPc2 decreased cell viability to 55% after
one irradiation treatment at a concentration of 40 µM and 80 µM[20], respectively.
Other synthetic routes to disrupt π-π stacking and increase water solubility include employing copper (I) catalyzed azide/alkyne cycloaddition reactions (also known as CuCAAC reactions) to
create phthalocyanines with different architectures; 4-arm star polymers utilizing either polystyrene
or poly(tert-butyl acrylate) were synthesized with symmetrically tetra terminal alkynyl-substituted
phthalocyanines as the core with the central metal atom being either copper or zinc[21]. This type
of architecture improves water solubility and prevents aggregation of the phthalocyanines due to the
extension of the polymeric arms which disrupts the π stacking of the phthalocyanine. When the π-π
orbitals stack, the phthalocyanine molecule, upon excitation, de-excites non-radiatively due to photoinduced electron transfer where an excited molecule (i.e. has an electron in the singlet electronic
state) transfers its energy to a molecule in the ground state through a redox reaction[22]. In this
process, a photon is never emitted.
Another way to prevent π-π stacking of the planar phthalocyanine molecule is to synthesize
the dye to have oxygenated alkyl chains or long polymeric chains which are directly attached to the
central metal atom. One set of dyes that were synthesized in this manor contained azide or alkyne
functionality making them ideal candidates for use in click reactions, which allows the dyes to be
used in a nanodevice for cancer theranostics.[23] Such phthalocyanine dyes were synthesized and
will be discussed further in Chapter 2.

1.1.2

Activation
Currently, there is an interest in developing “smart” NIR nanoparticles for cancer ther-

anostics. For example, the well known fluorescence quenching effects of gold nanoparticles were
employed by the Mirkin group[24] to develop “nanoflares” which are designed to provide an intracellular emission signal that directly correlates with the concentration of a specific nucleic acid or
other molecular target. These particles are oligonucleotide-functionalized gold nanoparticles that are
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tagged (i.e. hybridized) to short, fluorophore-labeled probes. Without a target, the fluorophore is
close to the surface of the gold particle and the fluorescence is quenched; upon binding to the target
the flurophore is released, resulting in an emission signal. Similarly, activation was achieved for a
BODIPY probe covalently conjugated to N-benzyl-4-hydroxyaniline. N-benzyl-4-hydroxyaniline is
sensitive to nitric oxide, which is responsible for regulating a wide variety of physiological processes;
however, when the amount of nitric oxide becomes in-balanced, it can be a cause or indicator of
cancer, making the detection of irregular levels of nitric oxide desirable. Originally, the BODIPY/Nbenzyl-4-hydroxyaniline conjugate is nonfluorescent due to N-benzyl-4-hydroxyaniline quenching the
fluorescence of BODIPY. However, upon interaction with nitric oxide, the N-benzyl-4-hydroxyaniline
undergoes a nitrosation reaction, which effectively activates the fluorescence of BODIPY and serves
as a visual indicator of nitric oxide. Further, the amount of nitric oxide can be detected by monitoring
the emission level observed from the BODIPY flourophore[25]. Yuan and colleagues created a novel
nanoprobe with a derivatized tetraphenylethylene covalently attached to 2,4-dinitrobenzenesulfonyl.
It should be noted that tetraphenylethylene is a commonly used fluorophore exhibiting aggregation
induced emission. However, this absorbance of the fluorophore is in the ultraviolet range, which decreases the effectiveness of the fluorophore in fluorescence imaging. Therefore, tetraphenylethylene
was modified to have a dicyanovinyl group and methoxy group, which act as a donor/acceptor pair,
which redshifts the absorbance of the fluorophore. Upon reaction with 2,4-dinitrobenzenesulfonyl,
the fluorescence of tetraphenylethylene is quenched. However, upon cellular uptake and interaction
with biothiols, the quencher is cleaved from the fluorophore, which activates the fluorescence of
tetraphenylethylene and a high signal to noise ratio was observed. Additionally, tetraphenylethylene
is a singlet oxygen generator and, with MDA-MB-231 cells, cell death was observed after excitation
of the fluorophore. The nanoprobe was further functionalized with a cyclic RGD probe, providing active targeting for cells overexpressing αv β 3 integrin[26]. Another study on activation focused
on nanoparticles made from curcumin (Cur), a chemotherapy drug, with encapsulated perylene
and 5,10,15,20-tetro(4-pyridyl) porphyrin (H2 TPyP) (a donor-acceptor pair). The intact system,
upon initial cellular internalization, has no therapeutic effect; the system has a red emission due to
Förster Resonance Energy Transfer (FRET) occuring between the fluorophores. After some time,
Cur nanoparticles begin to dissociate, treating cancer via chemotherapy, while the fluorescence of
the system shifts from red to green. Cur emits green, and, due to the disintegration of the Cur
particles, FRET is no longer achievable between perylene and H2 TPyP. However, any part of the
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intact Cur particles will continue to emit red; therefore, this system can be used to estimate real
time drug dosage[27].

1.1.3

Targeting
There are two main routes of targeting bioimaging or therapeutic agents to the desired

site: passive or active targeting. Passive targeting relies on normal cellular processes that have
the ability to bring certain molecules, proteins, or nanoparticles into the cell. One of the most
exploited techniques for passive targeting is the Enhanced Permeation and Retention (EPR) effect:
nanoparticles or other agglomerated systems of over 30 nm stay in circulation longer than systems
below 30 nm because sub-30 nm systems are quickly cleared through the excretory system. The
excretory system does not as easily secrete systems overs 30 nm, which allow them to remain in
the body longer and is proportional to their therapeutic efficacy. While passive targeting has its
merits, active targeting, which generally uses a ligand to bind to a receptor on the cell surface, has
advantages because it can exactly target cells of interest.
In ligand-based targeting, the ligand binds specifically to a receptor that is overexpressed by
tumor cells. The ligands used vary based on the receptor expressed and can include peptides, small
molecules, and nucleic acids[28, 29, 30, 31]. Commonly targeted surface cell receptors are transferrin,
folate, epidermal growth factor receptors (EGFRs), and glycoproteins[29, 32, 33, 34, 35, 36, 37].
Various systems have been developed to exploit active targeting. One particularly interesting study
revolved around a nitroredutase (NTR)-targeted Cy7 dye (a cyanine dye) functionalized with paranitro benzoate, as the targeting moiety, to identify tumors with hypoxia. The nitro-benzoate linker
binds to the NTR through hydrogen bonding, which causes a change in the electron withdrawing
strength of the molecule, which causes a shift in fluorescence. The change in fluorescence serves as a
visual cue that a cell exhibiting NTR has been located. Hypoxia occurs when cells are deoxgenitated;
deoxygenitated cells are indicative of cancer as tumors have a much lower oxygen content than normal
cells. This technology could aid in the early identification of cancers that can be more difficult to
detect[38]. A commonly used route to bioconjugation relies on streptavidin-biotin binding chemistry.
For example, a phthalocyanine derivative was funtionalized to have an αvβ6 integrin targeting ligand.
It was found through in vitro, in vivo, ex vivo fluorescence, optical imaging, and ex vivo PET scans
that the targeted phthalocyanine system did successfully bind to αvβ6 integrin, which is widely
upregulated in cancers, so targeting this receptor may prove beneficial in treating such cancers as
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pancreatic cancer[39].

1.2

Colloidal Crystalline Arrays
Colloidal crystalline arrays (CCAs) are dielectric materials made from highly monodispersed,

highly stable sub-200 nm nanoparticles and a matrix (i.e. water, air, etc.) where there is a refractive
index mismatch between the matrix and the nanoparticles, which causes interesting light propagating
properties[40, 41]. The mismatch in the refractive indexes causes light to only be able to propagate along certain directions of the crystal and are described by Bragg diffraction theory[42, 43].
Nanoparticles are considered to be colloidally stable when the absolute value of the zeta potential,
which is a measure of surface charge, is 30 mV or greater[44]. The following subsections will describe
the materials science behind CCAs as well as CCAs as sensors. Chapter 3 and 4 explores traditional
colloidal crystalline array technologies with a new component: x-ray active dyes; the emission of the
CCA is manipulated not only by the photonic band gap but also by the FRET pairs associated with
the x-ray active dye. While much research has focused on CCAs with photoluminescent dyes, to the
best of the author’s knowledge, there has never been a report of CCAs with x-ray active components
presented outside of the work presented in the following chapters.

1.2.1

Fabrication of colloidal crystalline arrays
There are traditionally two ways to create CCAs: 1) steric packing of the spheres, also called

“hard-sphere” packing[45, 46], and 2) electrostatic packing where the charge on the surface of the
particles imposes long-range repulsion between the particles[47, 48, 49]. Both of these systems will
arrange themselves in a body-centered cubic (BCC) or face-centered cubic (FCC) minimum energy
configuration[50, 51, 52]. While “hard-sphere” packing is easy and versatile to a variety of materials,
electrostatically packed arrays are more easily manipulated to reach the desired properties of the
dielectric device, and will be the focus of this discussion.
CCAs self-order at the nanometer length scale which results in a spacial periodicity of 102 103 nm, causing the stop band (i.e. the range in which energy is forbidden to propagate) to be in
the optical regime[53]. Electrostatically packed CCAs can be utilized in liquid form where the stop
band can be moved by diluting or concentrating the sample with deionized water.
However, liquid CCAs suffer from being easily destroyed by ionic contamination and me10

chanical stress. To overcome this disadvantage, CCAs can be encapsulated in hydrogel form.[54]
To create the hydrogel, the liquid CCAs is mixed with a monomer, a cross-linker, and an initiator,
often a photo-initiator. The hydrogel transforms the liquid CCA into a crystalline gel that is not
sensitive to ionic contamination but where the stop band can still be manipulated by a variety of
means including, mechanical perturbations and a dehydration/hydration process with a variety of
chemicals[54]. For example, compressing the hydrogel will cause a blue shift in the rejection wavelength while holding the hydrogel in tension will induce a red shift in the stop band. On the other
hand, adding a solvent that will dehydrate the hydrogel, such as acetone, will cause the hydrogel to
shrink resulting in a blue shift in the rejection wavelength; however, a solvent that super-hydrates the
hydrogel, such as methanol, ethanol, or isopropanol, will result in a red shifted rejection wavelength
in the hydrogel.
Colloidal crystals follow the dynamic Bragg diffraction theory, which states that radiation on the order of atomic spacing (or in the case of colloidal crystalline arrays, the interparticle
spacing) is scattered from the atom (or particle) in a normal mirror-like fashion with constructive
interference[55]. In the specific case of CCAs, the radiation waves are scattered from the particles.
The path distance between two constructive waves is given by the Bragg theory equation (cf. Eqn.
1.1), where λ◦ is the rejection wavelength, dhkl is the interplanar spacing, n is the refractive index
of the composite, and θ is the Bragg angle (cf. Figure 1.5)[56]. The described parameters are in
terms of colloidal crystalline arrays. The dhkl spacing is based on the [111] plane when the rejection
wavelength is measured normal to the CCA due to its face center cubic (FCC) or body center cubic
(BCC) crystal structure yielding a θ of 90◦ C[57, 58]. From the calculated d111 , the lattice constant,
ac can be calculated (cf. Eqn. 1.2), which can then be used to calculate the nearest neighbor spacing,
a, of the particles (cf. Eqn. 1.3). With these calculations, the rejection wavelength for a given nearest
neighbor particle spacing can be predicted.

λ◦

=

ac =

√

2ndhkl sin θ

(1.1)

3d111

(1.2)
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Figure 1.5: Schematic representation of Bragg diffraction theory where λ0 is reflection wavelength, θ is diffraction
angle which is 90o for the [111] plane, and dhkl is particle distance.
√
a = ac / 2

(1.3)

Hydrogels are relevant for medical applications or where the crystal needs to be in a moisturerich environment. However, hydrogels are fragile as they are upwards of 80 % water, but they can
be transformed into a robust polymer composite band gap material by dehydrating the hydrogel
and re-swelling it with a polymer[53]. The polymerization of the polymer-swollen gel results in a
robust film of the colloidal crystal that can be utilized in a variety of sensing applications where the
material needs to be more durable than a hydrogel.
Photoluminescent dyes can be encapsulated in the interstitial spaces of the hydrogel (or
photonic band gap composite) or can be electrostatically or covalently attached directly to the
particles in the hydrogel. When the stop band overlaps with the emission of the fluorophore, the
emission of the fluorophore is either suppressed or enhanced[59]. The stop band decreases the
local density of optical states and causes a decrease in the emission; if the material has enough
gain and the material has an optical resonator(s) such as a mirror on one side of the device and
the colloidal crystals on the other, the decrease in the local density of optical states results in a
stimulated emission. The gain material is generally a laser photoluminescent dye such as Rhodamine
B. However, the gain material can be changed such that the photoluminescence of the gain material
can be tuned from purple to red in the visible spectra. In this way, organic, tunable lasers can be
made and utilized[60].
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Figure 1.6: a) Liquid colloidal crystalline array in a BCC formation where dilution of the liquid with additional
deionized water causes the rejection wavelength to red shift while the removal of deionized water causes the rejection
wavelength to blue shift. b) Colloidal crystalline array in hydrogel form where pulling the hydrogel in tension causes
a red shift in the rejection wavelength while compressing the hydrogel causes the rejection wavelength to blue shift.
All blue shifts are caused by a decrease in the inter-particle spacing, while all red shifts are the result of an increase
in the inter-particle spacing.

1.2.2

Colloidal crystalline arrays as sensors
Because colloidal crystals, in liquid, polymer encapsulated hydrogel, or polymer composite

form, change their stop band properties based on minute volume changes, CCAs can be used a efficient and low-cost sensors. Monodispersed polystyrene nanoparticles encased in poly(hydroxyethyl
acrylate) hydrogels were utilized as a glucose monitoring system. In hydrogel form, the polystyrene
nanoparticles were functionalized with boronic acid. The crystals remained stable even after functionalization. In the presence of compounds that contain vicinal cis diols, such as glucose, the
boronic acid binds to glucose causing the boronic acid or boronic acid derivative to be deprotonated
to the boronate ion. Upon formation of the boronate ion, Donnan potential causes the hydrogel
to swell, which red shifts to stop band. Donnan potential occurs when ions can flow through a
selectively permeable membrane, which causes a sustained electric potential difference and keeps the
system from reaching equilibrium[61, 62]. The glucose concentration can be monitored by reading
the change in color of the hydrogel and comparing it to a calibrated color chart. These glucose
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monitoring devices can be fabricated into contact lenses that can read the glucose concentration in
tear fluid. Devices that can quickly and non-invasively monitor glucose concentration are important
for individuals afflicted with diabetes, where constant glucose monitoring is ideal, but impractical
with today’s standards for monitoring. By closely monitoring glucose concentrations non-invasively,
the quality of life for those living with diabetes could be increased[63]. The device described above
monitors low glucose concentration (0.1 mM to 100 mM) in low ionic strength liquids, such as tear
fluid; the same device can be slightly modified to detect high glucose concentrations in high ionic
strength liquids, such as blood[64].
Similar CCA devices have been fabricated to monitor creatinine levels. Creatinine is a small
molecule whose presence indicates kidney failure. The polystyrene nanoparticles were functionalized
with the enzyme creatinine deiminase and 2-nitrophenol and embedded in an polyacrylamide based
hydrogel. In the presence of creatinine, the enzyme binds, which results in deprotonating the 2nitrophenol, creating a phenolate species. The phenolate species is more soluble in the hydrogel
than 2-nitrophenol, which results in a swelling of the hydrogel, causing the rejection wavelength,
and thus the color observed, to change. This sensor can detect creatinine in human blood at
concentrations up to 6 µM quickly and efficiently detect creatinine without any interference from
sugars, ureas and uric acid, dopamine, or pyruvate, which interfere with creatinine detection in
current screening methods[65]. This method can easily be translated to other molecules of interest
as the volume change of the hydrogel only relies on an enzyme that releases H+ or OH− upon binding
to its conjugate. Similar sensing methods have been employed for detecting ammonia in the blood.
Excess ammonia in the blood can be indicative of liver malfunction and urea cycle disorders[66].
CCA hydrogels can be used not only as biological sensors, but also as metal ion sensors. Polyacrylamide/polystyrene nanoparticle based hydrogels can be functionalized to have 8hydroxyquinoline molecules covalently attached to the polystyrene nanoparticles. 8-hydroxyquinoline
complexes with Cu2+ , Co2+ , Ni2+ , and Zn2+ ; at low concentrations of these ions, 8-hydroxyquinoline
complexes two metal ions, while at high concentrations, 8-hydroxyquinoline complexes only one
metal ion. When 8-hydroxyquinoline complexes two metal ions, it forms a cross-link between two 8hydroxyquinoline molecules, causing the gel to shrink and blue shift. Conversely, when the molecule
complexes one ion in an environment of high concentration of the ions, the cross-links that were
formed when the metal ions were at low concentrations break, causing the hydrogel to swell and
red shift. These shifts can be monitored by eye or, it a more specific measurement is needed, by
14

a spectrometer. The binding at high concentrations is reversible (log(Kf )=10.70), but is only partially reversible at the low concentrations because the association constant of bisliganded complexes
is roughly two times that of the monoliganded complex. Thus, the hydrogel works as a dosimeter at
concentrations lower than 1 µM, and a reversible sensor for metal ions at concentrations higher than 1
µM. These sensors have applications in monitoring drinking water purity cheaply and efficiently[67].
While the polyacrylamide/polystyrene/8-hydroxyquinoline hydrogels were good at detecting Cu2+ ,
Co2+ , Ni2+ , and Zn2+ , they could not detect lead ions (Pb2+ ). However, 8-hydroxyquinoline could
be replaced with a crown ether. Instead of functionalizing the nanoparticle, the crown ether is polymerized into the polyacrylamide hydrogel matrix. Upon exposure to Pb2+ , the crown ether traps
the ion, which immobilizes the counterion of Pb2+ , causing the hydrogel to swell due to an increase
in osmotic pressure since the ions are trapped and not allowed to flow freely[68].

1.3

Radioluminescent particles
Radioluminescent materials, or scintillators, have long been utilized for detectors in positron

emission tomography (PET) and computer tomography (CT) scans[69, 70] and are employed in medical therapies and diagnostics[71, 72], dosimetry[73, 74], and homeland security[75] as scintillators
transform ionizing radiation into visible light. The following sections will describe the scintillation
mechanism as well as current efforts in radioluminescent particles for bioimaging, drug delivery and
cancer therapy, and optogenetics. Chapter 5 focuses on inorganic scintillating particles surface functionalized with organic fluorophore(s), and explores the photophysics and biocompatibility of such
systems.

1.3.1

Scintillation mechanism
Scintillators can take the form of inorganic crystals, organic small molecules (both as solids

and in solutions), and plastic films. The scintillation mechanism for inorganic materials is different
from that of organic materials. Organic materials rely on the electronic and vibrational states of the
molecule, rather than a crystal lattice, which is why they can be used in solid and liquid form unlike
inorganic scintillators. Most organic scintillators have multiple aromatic rings, and they scintillate
due to the π-conjugation of the aromatic rings. The scintillation mechanism of organic materials is
similar to that of the photoluminescence mechanism with scintillation causing ionization; electrons
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are promoted not just to the lowest unoccupied molecular orbital (LUMO) but to the ionization
level of the molecule[76]. As the electrons lose their energy, light is emitted as the electrons return
to their ground state orbitals (cf. Figure 1.7). While organic scintillators scintillate in a variety of
forms, they produce much lower light outputs and are more prone to radiation damage, which limits
their lifetime, when compared to inorganic scintillators[77].
ionization level

ii

1

S

iii

2
1
0

iv

i

0

S

2
1
0
iii

Figure 1.7: Scintillation mechanism of organic materials. i) Absorbance of ionizing radiation (i.e. ionization), ii)
recombination of ions causing the de-excitation of the molecule to the singlet electronic excited state, iii) relaxation of
electrons to lowest vibration band of the electronic state, and iv) x-ray excited optical luminescence as the electrons
relax to the ground electronic state of the molecule.[76]

Inorganic scintillators rely on the crystal structure of the material; therefore, they only work
in single crystal or polycrystalline form. There are two main classifications of inorganic scintillators:
intrinsic and extrinsic scintillators. Intrinsic scintillators have inherent scintillation properties without the need of any additive. One of the most used intrinsic scintillators is bismuth germanium oxide
(BGO), which is often used as a reference for other scintillation materials because it has been very
well characterized[78, 79, 80]. On the other hand, extrinsic scintillators are more abundant; these
materials require the addition of active or luminescent centers for the scintillator to emit visible light
upon X-ray irradiation. The band gap of extrinsic scintillators is too wide for visible light to emit
upon absorbance of ionizing radiation; therefore active centers, or dopants, are introduced to create
intermediate band gap levels in the main band gap structure[81]. There are three stages in the
scintillation process for both types of inorganic scintillators. Once the scintillator is irradiated with
high energy photons (such as those that come from x-ray or γ-ray radiation), electrons are promoted
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from the valence band to the conduction band, which leave behind holes in the valence band. The
electron-hole pairs either travel through the conduction band until they reach the luminescent center
or they get trapped in the conduction band by defects in the material. Trapped electron-hole pairs
are omitted from the scintillation process and do not generate any light. The electron-hole pairs
that reach the luminescent centers recombine and transfer their energy to the active center, which
then emits visible light[82, 83, 84, 85, 86] (cf. Figure 1.8).

Figure 1.8: Scintillation of inorganic materials. 1) Absorbance of x-rays or gamma rays, which generate electronhole pairs, 2) thermalization of the electron-hole pair causing it to go to the lowest vibrational state in the electronic
state, 3.1) electron-hole migration through the conduction band toward active or luminescent centers, 3.2) electronic
traps in the conduction band which will capture an electron hole pair (eliminating it from the scintillation process);
given enough additional energy, the electron hole pair can escape the trap and emit light, 4) excitation of the active
center from the energy transfer between the center and the electron-hole pair, 5) luminescence from the active center
as the electron hole pair relaxes to the ground state of the active center[87].

1.3.2

Radioluminescent particles for bioimaging
Scintillating particles are attractive candidates for bioimaging as x-rays can penetrate the

body[88]. Once the scintillator is excited, visible light is emitted, which can easily be detected
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through traditional detection methods. One such study focused on zinc gallate doped with chromium
(ZnGa2 O4 :Cr) nanoparticles that were able to be imaged through at least 20 mm of tissue. These
particular nanoparticles were used for near-infrared long lasting luminescence probes and could be
imaged not only through 20 mm of tissue but could also be imaged and re-imaged over several
irradiation cycles[89]. These types of nanoparticles could be important when monitoring a patient
over time.
Radioluminescent particles are also used heavily in research focusing on multimodal imaging
agents. Multimodal imaging agents can combine any combination of agents for magnetic resonance
imaging (MRI), CT, and traditional x-ray/optical imaging. MRI is an imaging technique that
applies a strong magnetic field to a patient which causes the spin of hydrogens in water contained in
biological tissues to align parallel or anti-parallel to the magnetic field. While under the magnetic
field, the patient or object being studied, is pulsed with a current in the radio-wave range of the
electromagnetic spectrum. This current causes the spins of the hydrogen atoms to strain against
the applied magnetic field. When the current is removed, the hydrogen atoms realign with the
magnetic field, which yields electromagnetic radiation. This radiation is detected and configured
into an image[90]. To yield a better image, contrast agents are used, which regulate the speed at
which the spin of the hydrogen atom realigns with the applied magnetic field. In this way, tissues
that could not normally be distinguished from one another are now easily discernable. While CT is
similar to MRI, CT relies on applying x-rays to a cross section of the body. The x-rays are collected
by detectors made of scintillators, and the optical signal is transformed into a 3D picture[91]. MRI
imaging is better for detecting nerves, obtaining images where bone may interfere with the image,
and generating a detailed image of cancer and various neurological diseases, while CT scans are better
for imaging bone fractures, blood flow, organ injury, and lung tissue. Multimodal imaging agents
are useful for diagnostics when both tests may need to be performed as the patient does not have to
take multiple contrast agents. These multimodial imaging systems generally consist of a gadolinium
component and such scintillating systems such as core/shell gadolinium orthoaluminate doped with
manganese or germanium/gold(GdAlO3 :Mn, Ge/Au) where the Gd component is the MRI contrast
agent and the Au regulates optical emission[92]. Other multimodal imaging scintillators include
iron oxide (FeO3 ) core particles coated with gadolinium oxide doped with europium (Gd2 O3 :Eu)[93]
and, more biologically friendly, poly(ethylene glycol) coated sodium gadolinium tungstate doped
with europium (PEG-NaGd(WO4 )2 :Eu[94].
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1.3.3

Radioluminescent particles for theranostic applications
While scintillating nanoparticles are promising for purely imaging applications, they are also

useful for theranostic applications. As stated previously, the term theranostics refers to imaging and
treating a diseases all at once. One of the more interesting theranostic applications include x-ray
induced photodynamic therapy[95]. In x-ray PDT, x-rays are used to stimulate a scintillator that
emits light that is then absorbed by a photosensitizer (a molecule that generates singlet oxygen
upon its excitation)[9, 8]. Currently, the main limitations of PDT are that it can only be used
topically or just below the skin because the light needed to excite the photosensitizer is ineffective
in penetrating the body[96]. While work has been done on utilizing near-infrared light, which
penetrates the body better than UV light (but worse than x-rays) to excite the photosensitizer, the
amount of singlet oxygen generated is not optimal because the quantum yield of these fluorophores
when excited through near-infrared light is quite low[97]. While theoretical studies have been done
on the possibility of using x-ray as an excitation means for PDT, few experimental studies have
been performed even though the theoretical studies suggest that x-ray PDT is possible[98]. This
theoretical study showed that x-ray PDT was possible in extremely ideal situations; however, as
with all models, there are many assumptions that need to be experimentally determined to validate
the model. One such experimental study of the efficacy of x-ray PDT focuses on lanthanum fluoride,
europium (LaF3 :Eu) doped nanoparticles that have been conjugated to Rose Bengal dye[99]. Upon
x-ray excitation of the LaF3 :Eu nanoparticles, FRET occurs between the nanoparticles and the
Rose Bengal dye. This energy transfer causes the Rose Bengal dye to emit, but some of the energy
is transferred to a triplet state through an intersystem crossing. In an oxygen rich environment,
the energy associated with the triplet state of the dye is transferred to a triplet state of oxygen
which quickly relaxes to the singlet energy state, generating a reactive oxygen species, commonly
known as singlet oxygen; this singlet oxygen is highly toxic but has a short half life, so the singlet
oxygen is toxic only in its immediate environment, which makes this technique an attractive for a
variety of therapies[9, 8]. The LaF3 :Eu/Rose Bengal dye conjugate proved to be quite effective at
generating singlet oxygen[99]. Additional studies utilizing radioluminescent particles conjugated to
photosensitizers include SrAl2 O4 :Eu (SAO) with a mesoporous silica shell that allows for electrostatic
loading of the photosensitizer, merocyanine 540 (MC540), where the x-ray induced energy transfer
between SAO and MC540 generates singlet oxygen for cell death which was shown both in vitro
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and in vivo[100]; another study utilized the clinically relevant photosensitizer, Photophyrin, which
was covalently attached to terbium oxide doped (Tb2 O3 ) nanoparticles with a silica shell through
standard NHS chemistry and was shown to effectively generate singlet oxygen[101].
While x-ray PDT is a promising theranostic technique, there are other x-ray drug therapies
that may be just as relevant. Gadolinium oxysulfide doped with europium (Gd2 O2 S:Eu) nanoparticles that have been modified to have a hydrophilic shell were loaded with the cancer, drug protoporphyrin IX. Protoporphyrin IX is a photoactive drug, which is activated in this construction upon
the X-ray induced emission of Gd2 O2 S:Eu. The drug dosage can then be monitored by the intensity
of the x-ray stimulated emission, which can be correlated back to an exact concentration of released
protoporphyrin IX. As more protoporphyrin IX is released, the X-ray induced emission is enhanced,
which also allows for imaging of the site where the drug is being administered[102]. Gd2 O2 S:Eu
nanoparticles have also been utilized in yolk-in-shell particle morphologies where Gd2 O2 S:Eu is
the yolk and gadolinium oxysulfide doped with ytterbium and thulium (Gd2 O2 S:Yb, Tm) is the
shell.The construct is then encapsulated in a biocompatible hyaluronic acid sodium salt and chitosan layer. The hyaluronic acid sodium salt and chitosan layer is pH responsive, which triggers
the release of mitoxantrone, an FDA approved chemotherapy drug, while the level of emission of
Gd2 O2 S:Eu/Gd2 O2 S:Yb, Tm serves to monitor drug release under x-ray stimulation[103].

1.3.4

Radioluminescent particles for optogenetic technologies
Optogenetics was first proposed in the 1970s when Francis Crick hypothesized that light

could be utilized to manipulate specific regions in the brain without causing any influence over other
regions[104]. Since its proposal, a variety of light sensitive proteins, all termed opsins, have been
identified[105, 106]. These opsin proteins serve to open or close ion channels in neurons to either
cause a neuron to fire or cease firing upon light stimulation. Traditional optogenetic therapies require
the implantation of an optical fiber into the brain, which can cause tissue damage especially due to
the insertion of the fiber[107]. Generally, the optical fiber operates at 470 nm, which is the peak
absorbance of a widely used opsin, channelrhodopsin-2[108]. Blue light (i.e. 470 nm) scatters heavily
in tissue causing an attenuation of the light at a 1/r2 dependence, which limits the utility of using
blue light as a means of exciting these opsins[88]. With the limitations of traditional optogenetic
techniques in mind, a non-invasive x-ray excited optogenetic technique has been proposed[109]. In
this technique, the emission of radioluminescent nanoparticles upon x-ray irradation is coupled into
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the absorbance of the opsin in question. The opsin absorbs this energy, which causes the opsin to
open or close an ion channel resulting in a change in the chemical potential causing a neuron to fire
or cease firing. X-rays have the ability to penetrate through the skull to the brain without the need
for an invasive surgery to insert a fiber.
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Chapter 2

Bovine serum albumin coated
nanoparticles for in vitro activated
fluorescence and photodynamic
therapy applications
2.1

Attributions
Synthesis of silicon phthalocyanine derivatives and small molecule azide modified NHS as

well as quantum yield calculations and NMR were performed by Dr. Yura Bandera. Confocal
imaging performed under the guidance of Dr. Terri Bruce and Mrs. Rhonda Powell by Mary Kathryn
Burdette. Cell plating was performed by Dr. Xi Yang in Dr. Charlie Wei’s lab. NanoDSC curves were
obtained by Dr. Ragini Jenkins. Photodynamic therapy results were obtained under the guidance of
Dr. Ragini Jenkins and Dr. Anna-Liisa Nieminen at the Medical University of South Carolina. All
ideas presented were the result of discussions with Dr. Stephen Foulger. The results in this chapter
have been published as (1) M.K. Burdette, R. Jenkins, Y. Bandera, R.R. Powell, T.F. Bruce, X.
Yang, Y.Z. Wei, and S.H. Foulger. “Bovine serum albumin coated nanoparticles for in vitro activated
fluorescence.” Nanoscale, 8(48):20066-20073, 2016. (2) Y. Bandera, M.K. Burdette, J.A. Shetzline,
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R. Jenkins, S.E. Creager, and S.H. Foulger. “Synthesis of water soluble axially disubstituted silicon
(IV) phthalocyanines with alkyne & azide functionality.” Dyes and Pigments, 125:72-79, 2016. (3)
R. Jenkins, M.K. Burdette, and S.H. Foulger. “Mini-review: fluorescence imaging in cancer cells
using dye-doped nanoparticles.” RSC Advances, 6(70):65459-65474, 2016, and is reproduced by the
permission of The Royal Society of Chemistry.

2.2

Introduction
A promising new approach to treating cancer is emerging with theranostic nanomedicine[95,

110, 111]. This approach takes advantage of colloidal particles that are modified with various cargo
functionalities that allow them to act both in an imaging and therapeutic role. Specifically, these
“nanocarriers” are capable of diagnosis, drug delivery, and therapeutic response monitoring and
are expected to play a significant role in the emerging field of personalized medicine[112]. Typical
imaging agents include organic fluorophores, such as silicon phthalocyanine. Silicon phthalocyanines
(SiPc) are an emerging class of fluorescent dyes employed in cancer theranostics[113]. Unlike their
first generation counterpart, Photofrin[114], SiPcs are desirable because they absorb far red and
near infrared (NIR) light, have a low dark toxicity, and are chemically stable[115]. Photosensitizers
(PS) for photodynamic therapy that absorb in the NIR or far red region of the visible spectrum,
such as SiPc, are ideal for use in combating cancer because their excitation wavelength coincides
with the transparency window of the body allowing for deeper tissue imaging[116, 117]. However,
photosensitizers that absorb in this wavelength regime tend to have poor light output and are prone
to aggregation in physiological conditions[118, 119]. Furthermore, most of these fluorophores are
used in a static fluorescence system, i.e. the fluorophore is emissive when excited and its propensity
to emit once excited is not regulated by its environment. It would be desirable to have a system
with an “activated” fluorescence to act as an event signaler and to reduce background emission
noise. Fluorescence, initially in a “turned off” state, is only achieved after interaction with a specific
environmental parameter[120]. Other techniques, such as the use of quantum dots or gold particles, utilized for fluorescence imaging or detection using fluorescence signaling have recently been
explored[121, 122].
The focus of the current effort is creating nanocarriers that can carry an emissive dye into
a cell and only within the cell does the fluorphore become emissive. Toward this effort, increasing
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the emissivity of the fluorophore is of importance. Therefore, silicon phthalocyanines (a highly
emissive dye known to generate singlet oxygen) were derivatized to be more water soluble, nonaggregated, and have increased quantum yields when compared to native silicon phthalocyanine. At
first, various silicon phthalocyanines were attached to a polymeric nanoparticle, but the fluorescence
of the fluorophores remained no matter the environment. Therefore, fluorescence activated systems
were achieved with sub-100 nm colloidal particles, which have had derivatives of highly emissive,
non-aggregated SiPc dyes attached to the particle surface through a digestible linking protein. The
linking protein is a modified bovine serum albumin (BSA) that can be degraded by a proteolytic
enzyme to release the quenched fluorophores from the particles, rendering them emissive once excited.

2.3
2.3.1

Results & Discussion
Synthesis and characterization of SiPc derivatives
Novel axially disubstituted SiPc complexes 4a, b and 5a, b were synthesized starting from

commercially available silicon phthalocyanine dichloride (SiCl2 Pc), as presented in Figure 2.1. SiCl2 Pc
reacts with modified triethylene glycols of variable molecular weights in the presence of sodium hydride with toluene as the reaction solvent. The reaction requires high temperatures and leads to the
nucleophilic substitution of the two chlorine atoms with good yields of the final product after purification. For this method, the nucleophilic substituent ligands can vary[123]. As key intermediates,
triethylene glycol derivatives (1a or 3a) with azide or alkyne terminal groups and the corresponding
PEG 600 derivatives were used (1b or 3b). The synthetic pathway to compounds 1a, b and 3a, b
is described in Figure 2.2.
Compounds 1a, b were synthesized in one step from triethylene glycol or PEG600 by the
nucleophilic substitution of one hydrogen in the hydroxyl group to the propargyl group. The reaction was performed in tetrahydrofuran in the presence of sodium hydride and propargyl bromide.
Compounds 3a, b were synthesized in two steps from the same starting material used for the synthesis of 1a, b. The first intermediates are mesylates (2a, b). The reaction of triethylene glycol with
a small excess of methanesulfonyl chloride in dichloromethane yields 2a. The obtained compound
2a contains a small amount of the bismesylated derivative, but the product can be used in the next
step without additional purification because disubstituted impurities will not react with SiPcCl2
in the final stage of the synthesis of compound 5a. Compound 2b was synthesized similarly to
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Figure 2.1: Synthetic route to compounds 4a,b and 5a,b; (i) Reaction conditions: NaH, toluene, reflux.

2a. Treatment of 2a, b with sodium azide in refluxed acetonitrile yields mono-azide derivatives of
triethylene glycol and PEG 600 (3a, b) with high yields.
All synthesized axially disubstituted SiPcs were verified by 1 H,

13

C NMR, and ESI Mass

analyses. The presence of azide groups in PEGylated SiPc (4b) was also confirmed by FTIR analysis.
The azide groups on 4b have a strong absorption at 2098 cm−1 . The 1 H NMR spectra of 4a, b and
5a, b shows the shielding of the axial substituent protons by the electron cloud of the SiPc ring. Wellseparated, upfield shifted triplets, starting from -1.92 ppm, show methylene protons (cf. Figure 2.3).
The closer the atoms of the axial substituents are to the point of attachment to the SiPc ring yields a
proportional larger upfield shift of the methylene groups in the proton spectrum. The obtained NMR
spectrum corresponds to previous reports for similar compounds[124, 125, 123]. Alkyne protons in
modified triethylene glycols 1a, b and PEGylated SiPcs 5b show a triplet at 2.43 ppm, while, for
the shorter analog 5a, the signal is shifted to 2.34 ppm. The same behavior is observed for CH2
protons attached to the azide group; the triplet from 3.37 ppm (3a, b and 4b) is shifted to 2.93 ppm
in compound 4a. Aromatic protons in the final SiPcs show two, well-separated downfield shifted
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Figure 2.2: Synthetic route to compounds 1a, b, 2a, b, and 3a, b; (i) Propargyl bromide, NaH, THF, r.t.; (ii)
MeSO2 Cl, Et3 N, CH2 Cl2 , r.t.; (iii) NaN3 ,m acetonitrile, reflux.

multiplets. Figure 2.4 shows the ESI mass analysis of SiPc 5b. Multiple peaks are separated by 44
mass units [OCH2 CH2 ]+ starting from molecular ion M+ . Compound 4b shows similar results (cf.
Appendix A).

Figure 2.3:

1H

NMR spectrum of 5b in CDCl3 . Methylene groups closest to the SiPc ring have the highest upfield

shift.

SiPcs 4a, b and 5a, b are soluble in alcohols, acetone, dichloromethane and other common,
polar, organic solvents excluding diethyl ether. PEGylated SiPcs 4b and 5b have good solubility in
water. Crude products were easily purified by flash column chromatography on silica.

26

Figure 2.4: ESI Mass analysis of 5b, positive ionization.

2.3.2

Photophysical properties of SiPc derivatives
The UV-Vis absorbance spectra of 4a, b and 5a, b, in methanol, are displayed in Figure 2.5.

The relevant spectroscopic parameters are summarized in Table 2.1. All synthesized SiPcs showed
a sharp, intense, well-defined absorbance peak (Q-band) at 671-676 nm along with two vibrational
bands at 604 and 645 nm, and a Soret band at 330-360 nm, depending on the particular SiPc. The
Q band is a result of electrons moving from the ground state to the first singlet state, while the Soret
band is a result of electrons moving from the ground state to the second singlet excited state[126].
Thus, the Soret band is representative of the high energy band, while the Q band represents the lower
energy band. Generally, phthalocyanines without a metal complex will have multiple Q bands due
to the asymmetric vibrational splitting of the orbitals; however, the presence of the metal complex
causes these vibrational bands to become symmetric yielding one large Q band. These absorbance
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bands are indicative of a non-aggregated SiPc for all newly synthesized SiPcs. The same results
were obtained in THF and DMSO; all compounds in all solvents tested showed no aggregation. The
maximum fluorescence emission for compounds 4a, b and 5a, b, in methanol, occurred at 680 nm
when excited at 630 nm.

Figure 2.5: Absorbance of 4a, b and 5a, b in methanol at a concentration of 5 µg/mL.

compound

4a
4b
5a
5b

λabs (nm)
352, 606, 671
358, 607, 676
354, 604, 672
355, 604, 672

λem (nm)
683
680
681
680

Table 2.1: Absorption and emission of 4a, b and 5a, b in methanol at a concentration of 5 µg/mL. Excitation at
630 nm.

The absorbance spectra for SiPcs 4b and 5b, in water, is provided in Figure 2.6. PEGylated
SiPc, 4b, was dissolved in water at a concentration of 5 µg/mL where it showed a strong absorbance
peak at 676 nm, which is characteristic of non-aggregated SiPc. The water solubility of 4b is 3
mg/mL. Compound 5b shows a strong Q band in water at 720 nm, which suggests that the dye
molecules are self-associating. The water solubility of 5b is 0.2 mg/mL. The aggregation behavior
of 5b can be explained by the presence of lipophilic alkyne groups at the end of the PEG chains; it
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decreases solubility in water and makes aggregation easier. Increasing the length of the PEG chains
in SiPcs could allow for new dyes with even greater solubility in water. The emission spectra of
both 4b and 5b show J-aggregates at 761 nm and 757 nm, respectively. This red-shifted peak does
suggest that there are aggregates of 4b and 5b forming, but these peaks are much less pronounced
than in the spectra of similar SiPcs, which indicates that there is minimal aggregation in this
system. It should also be noted that 4b has a slight J-aggregate peak, with 5b having quite a large
J-aggregate peak, which agrees with the absorbance spectra obtained for both of these molecules.
J-aggregates occur when the dye has self associated with itself and are characterized by a longer
emission wavelength than the “isolated” dye molecule. J-aggregates are undesirable in this case
because they represent a path of non-radiative energy transfer, which will decrease singlet oxygen
generation when the dye is utilized in PDT[127]. The molar extinction coefficient (ε) and fluorescence

Figure 2.6: Absorbance (pink) and emission (green) of (a) 4b and (b) 5b in water at a concentration of 5 µg/mL.
Excitation at 630 nm.

quantum yield (φF ) for all synthesized phthalocyanines were calculated. The data is summarized
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in Table 2.2. ZnPc (φF = 0.3), dissolved in toluene containing 1% pyridine by volume, was used
as a standard for fluorescence quantum yield calculations[128]. All silicon phthalocyanine derivates
had a greater fluorescence quantum yield than the standard ZnPc, which indicates that the SiPc
derivatives produce more photons that participate in fluorescence, rather than a variety of quenching
mechanisms, than ZnPc, which can be an indicator of a good photosensitizer for use in PDT. The
generation of more photons may indicate that the SiPc derivatives will generate more singlet oxygen
than ZnPc. To further support this claim, the molar extinction coeffiecent was calculated for all
derivatives. It was found that all derivatives had molar extinction coefficients between 200,000 and
260,000 M−1 cm−1 with methanol as the solvent. These values are in good agreement with the
value found for zinc phthalocyanine (ε=281,800) when dissolved in pyridine[129]. Unfortunately,
zinc phthalocyanine is only soluble in pyridine so an exact comparison between the standard and
the silicon phthalocyanine derivatives could not be made.
compound

4a
4b
5a
5b

εa (M−1 cm−1 )
259900
209200
208600
218500

φbF
0.50
0.51
0.52
0.51

Table 2.2: Molar extinction coefficient and fluorescence quantum yield of all four silicon phthalocyanine derivatives.
a Solvent

is methanol. b Solvent is toluene with 1% pyridine. Excitation at 665 nm.

To further their usefulness, the SiPc derivatives were modified by copper (I) catalyzed
azide/alkyne cycloaddition (CuCAAC) reactions with appropriate small molecules, polymers, nano
or microparticles, or proteins (cf. Figure 2.7). An example of such a system is presented in Figure
2.8, where the photoluminescence spectra of 67 nm poly(propargyl acrylate) (PA) particles, surface
modified with 4a,b (PA/SiPcs) through CuCAAC, is presented. Clearly, the attachment of the
fluorophores to the particles has not significantly altered their spectral profile since both exhibit an
emission peak at ca. 680 nm.

2.3.3

invitro Photodynamic therapy of SiPcs and PA/SiPcs
Photodynamic therapy occurs when a photosensitive element, generally a fluorophore, goes

from a singlet ground state to a singlet excited state via excitation from a specific monochromatic
wavelength of light. Upon reaching its excited singlet state, the photosensitizer undergoes an in-
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Figure 2.7:

Possible routes, which employ SiPcs (4a, b and 5a, b), to construct complex systems via “click”
reactions. See Figure 2.8 for a specific example.

tersystem crossing to an excited triplet state, which then transfers energy to oxygen in the body
promoting the oxygen from its unexcited triplet ground state to an excited singlet energy state,
generating a reactive oxygen species known as singlet oxygen (1 O2 ). This singlet oxygen is very
toxic, and can easily kill cancer cells via necrosis and/or apoptosis, effectively killing a tumor[130].
At first, the photosensitizing abilities of 4a and 4b, analogous to 5a and 5a, respectively,
were tested and compared to the efficiency of the standard Pc4, a standard silicon phthalocyanine
used in PDT. UMSCC22A cells were cultured for 24 hours and then incubated with concentrations
ranging from 25 to 400 nM of the SiPcs for 18 hours in media. At the conclusion of 18 hours,
the cells were irradiated with a 670 nm laser approved for PDT and cell death was assessed with
propidium iodide exclusion over time. The 200 nM treatment of 4a revealed that it is an effective
photosensitizer. When compared to Pc4, 100 % cell death took approximately 2.5 hrs longer, but the
result clearly shows that 4a is a very promising photosensitizer (cf. Figure 2.9a). All concentrations
surveyed showed 100 % cell death but varied in the amount of time it took for complete cell death
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Figure 2.8:

Photoluminescence spectra of 67 nm poly(propargyl acrylate) (PA) particles surface modified with
4a,b through copper(I)-catalyzed azide alkyne cycloaddition (CuCAAC). Particles dispersed in DMSO. Excitation
wavelength was 630 nm.

to be reached. However, there was less than 10% cell death for the cells subjected to 400 nM of
4b. It should be noted that, at the concentrations used in these PDT studies, the fluorophore itself
possessed no detectable dark toxicity.
To understand how the fluorophores would behave when attached to a nanoparticle under
PDT conditions, PDT studies were performed using first the PA/4a and PA/4b system since the
fluorescence of the intact particulate systems was never quenched. However, under the same experimental PDT conditions as the free fluorophore, both systems showed no cell death with the number
of cells comparable to that of the control cells that had not been exposed to the particulate system
(cf. Figure 2.9a,b). It is thought that this lack of therapuetic effect is due to the dye actually being
tethered to the particle which may allow for easier, non-radiative energy transfers rather than intersystem crossing. In the case of PA/5b, it may be possible that the long PEG600 arms are having an
effect on the central silicon atom causing it to be less effective at singlet oxygen generation. Axial
substitution has been shown to affect singlet oxygen production because the central metal atom is
important in the singlet oxygen quantum yield[131].
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Therefore, it seemed that a stimuli responsive element was needed to “untether” the dye
from the particle in a specific environment to allow the dye to fluoresce and generate singlet oxygen upon being irradiated. Toward this effort, poly(propargyl) acrylate nanoparticles were surface
functionalized bovine serum albumin (BSA) tagged with 5a.
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Figure 2.9: Cell viability after exposure to (a) 4a at concentration of 200 nM (4) or Pc 4 (200 nM, •) with cells
not exposed to any sensitizer (◦) as a control, (b) PA/4a or (c) PA/4b conjugate at a dye concentration of 50 nM
(◦), 100 nM (H), 200 nm (4), 400 nM (), and 800 nM () with cells not exposed to any sensitizer (•) as a control,
(inset) compound 4b at a concentration of 400 nM (•) or Pc 4 (400 nM, ◦) with cells not exposed to sensitizer (H)
as a control. All cells were irradiated with a laser approved for PDT studies at a wavelength of 670 nm and a power
of 200-400 mJ after various incubation times.

2.3.4

Fluorescent activation of PA particles modified with azBSA/5a.
Figure 2.10 presents a schematic for the synthesis and fluorescence activation of SiPc mod-

ified colloidal particles. Initially, bovine serum albumin (BSA) is modified through standard Nhydroxysuccinimide (NHS) chemistry to decorate the protein with azide functionality (cf. Experimental section for details). The resulting proteins (azBSA) then undergo a CuCAAC reaction
to attach alkyne modified SiPc (5a) to them (cf. Figure 2.10a). Finally, this dye labeled protein
assembly (azBSA/5a) is covalently attached to 67 nm poly(propargyl acrylate (PA)) nanoparticles through another CuCAAC reaction, resulting in a dye-labeled protein coated colloidal particle
(PA/azBSA/5a).
As discussed previously, 5a has an emission peak centered at ca. 680 nm when dispersed
in a good solvent for the dye, such as methanol. In this methanol, the maximum absorbance of 5a
is 672 nm and the maximum emission is 680 nm, yielding a Stoke’s shift of 8 nm. In contrast, the
emission spectrum for 5a in phosphate buffered saline (PBS), a physiological relevant buffer and
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Figure 2.10: (a) Schematic of the procedure for modifying azide labeled bovine serum albumin (azBSA) with
alkyne modified silicon phthalocyanine (5a) and its attachment to poly(propargyl acrylate) (PA) nanoparticles. (b)
Schematic of the procedure for the fluorescence activation of PA/azBSA/5a particles. PA/azBSA/5a particles with
nonfluorescent 5a are incubated with trypsin resulting in the digestion of the azBSA and release of 5a, rendering the
“freed” dyes fluorescent. Protein remnants, “freed” 5a, and particles are separated through centrifugation (cf. Figure
2.12).

poor solvent for 5a, exhibits a red shift greater than 100 nm resulting in one broad peak centered
at 813 nm, suggesting that the fluorophore exists in an aggregated state in an aqueous environment
relative to MeOH (cf. Figure 2.11). Additionally, the quantum yield of phthalocyanine fluorphores
is significantly reduced in a poor solvent (e.g. PBS) relative to methanol[132, 118, 119]. As stated
earlier, 5a had a quantum yield of 0.51 in toluene with 1% pyridine[23], but this value is reduced to
0.01 when the dye is dispersed in PBS. Additionally, upon attachment to the particle, the emission is
completely quenched in an aqueous environment. Therefore, there must be a release of fluorophore
and a fluorescence activation.
Figure 2.12a presents the photoluminescence of PA/azBSA/5a particles when dispersed in
PBS and excited at a wavelength of 630 nm. In this solvent, the luminescence of the particles
is severely reduced and only a small bump is evident above the emission baseline. Surprisingly,
previous researchers have often utilized BSA to enhance the fluorescence of hydrophobic dyes in
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Figure 2.11: Absorbance (green) and emission (red) of 5a in methanol. Photoluminescence of 5a (blue, dashed
line) in PBS, a poor solvent for 5a. All solutions had a concentration of 5 µg/mL and all emission spectra were
excited with a wavelength of 630 nm. Inset presents the structure of 5a.

aqueous environments by the presumed ability of BSA to sequester individual fluorophores into the
hydrophobic pockets of the protein[133]. Additionally, numerous drugs or fluorophores have been
complexed with serum albumin (either bovine or human), which resulted in greater bioactivity and
photoluminescence with respect to the isolated fluorophore[134, 135, 136, 137, 138, 118, 139, 140].
Within these BSA/fluorphore studies, this enhancement is largely dependent on the relative ratio
of BSA to the dye (i.e. indocyanine green (ICG)) with greater fluorescence activation observed in
higher protein to dye molar ratios (BSA:ICG)[141]. In the current system, physically mixing 5a
with azBSA in a molar ratio of 1:1, while dispersed in PBS, results in no emission “turn on” relative
to the dye alone in the solvent, though there is a slight baseline shift in the protein/dye solution due
to scattering of the azBSA (cf. Figure 2.13). Nonetheless, as presented in Figure 2.13, increasing
the ratio of azBSA to 5a to 200:1 does result in an emission “turn on” of the dye. The threshold
for initiating the fluorescence was determined to be ca. 12:1 BSA:5a.
Fluorophore systems with covalently attached BSA have been less studied[142, 143]. In the
current system, approximately every azBSA was decorated by 14 fluorophore molecules as deter-
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Figure 2.12:

(a) Photoluminescence of PA/azBSA/5a particles when initially dispersed in PBS (•) and 30 min
after the addition of trypsin (◦). Concentration of the particulate system was 0.320 mg/mL while trypsin was added
to the particle solution at a concentration of 8.7 mg/mL. (b) Photoluminescence of sediment (•) and supernatant (◦)
after PA/azBSA/5a particles were incubated for 30 min at 37 ◦ C with trypsin and separated through centrifugation.
Emission spectra were excited with a wavelength of 630 nm.

mined by absorbance studies. In the physically mixed 1:1 azBSA:5a system presented in Figure
2.13, the emission is quenched and, as expected, the covalently attached dye to the protein at a 1:14
azBSA:5a ratio also results in a quenched system (data not presented). With 14 dyes attached to one
azBSA protein it could be speculated that the dyes are able to aggregate together and quench their
emission. It should be noted that 14 dyes per 1 protein was the optimal amount of dye loading (cf.
Experimental Section). Not surprisingly, attaching, on average, 12 of these dye/protein assemblies
to a 67 nm PA particle does not alter the emission characteristics of the dye/protein assemblies,
and the fluorescence of the decorated particles is quenched (cf. Figure 2.12). In this construction,
one particle has 12 azBSA proteins, and each protein has 14 dyes attached to it; therefore, each
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particle has 12 proteins and 168 dyes attached. The covalent attachment of the dye to the protein
and this protein-dye assembly attachment to particle results in the opposite response to what has
been reported with other BSA/dye complexations[120], namely the emission of the fluorophore is
quenched in this construction.
Though there are no published reports on the BSA/SiPc ratio for fluorescence quenching, the
current ratio of 1:14 azBSA:5a is significantly higher in dye content relative to the protein than the
previously reported quenched in a 1:1 BSA:ICG system. Additionally, no difference in luminescence
output was observed with the dye-decorated protein alone (azBSA/5a) or when attached to the PA
particles (PA/azBSA/5a). Nonetheless, when the non-fluorescent PA/azBSA/5a particles in Figure
2.12 were incubated with trypsin at 37 ◦ C for 30 min there was a significant increase in the observed
photoluminescence with an emission maximum at ca. 687 nm, which was attributed to the silicon
phthalocyanine derivative.












































 







 

 

 

 

 

 

 















     
Figure 2.13: Emission of a physical mixture of azBSA and 5a in a molar ratio of 0:1, 1:1, 12:1, and 200:1 azBSA:5a.
Concentration of 5a remained the same for all samples. Curves shifted for clarity. Excitation at a wavelength of 630
nm.

In order to establish the source of the enhanced photoluminescence, the digested sample
was centrifuged at 27,216 g for 15 min to separate the supernatant from the sediment. Figure 2.12b
presents the photoluminescence of these two components. The sediment is largely composed of
the particles and is clearly nonfluorescent when redispered in PBS, while the supernatant, which
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contains the remnants of the azBSA and 5a after the trypsin digestion, exhibits the signature
emission of the parent silicon phthalocyanine with a peak at ca. 687 nm. The supernatant exhibited
a slightly decreased photoluminescence when compared to the photoluminescence of the sample
directly after trypsin digestion, which was speculated to be due to the hydrophobic dye precipitating
from solution. Trypsin digestion of BSA has been shown to result in a broad spectrum of molecular
weight components at the protein to trypsin ratios employed in the effort [144, 145]. We speculate
that the disassembly of azBSA with trypsin results in a number of dyes being attached to longer
protein sections that afford the dyes some level of hydrophilicity. These dye/peptide complexes are
solubilized by PBS, which results in their emission spectrum being similar to the small molecule 5a
when dispersed in a good solvent (cf. Figure 2.11). Furthermore, it should be noted that tryptic
digestion takes place only at the C-terminal to arginine and lysine residues[146]. To establish that
the protein was still able to be digested post modifications, nanoDSC curves were obtained from
native protein, modified protein, and their digested counterparts (digested via trypsin). Native,
undigested BSA showed a single endotherm at ca. 69o C with azide modified, undigested BSA showing
a single endotherm at 66o C[147]. This 3o C difference may indicate a slight conformation change,
but overall, the azBSA remains similar to native BSA. Both native and modified digested proteins
showed multiple endotherms with two main differences 1) denaturing of the native protein had a
much quicker onset at 44o C instead of the 62o C onset for azBSA and 2) both digested proteins
showed peaks at ca. 62o C and 68o C, but the digested native BSA also showed several peaks between
ca. 44o C and 60o C[148] (cf. Figure 2.14). The presence of several peaks indicates that the digestion
and denaturization of BSA occurs when several distinct parts of the protein are cleaved or denatured
(i.e. unfolded from its lowest energy configuration) from the main body of the protein. Regardless
of the exact mechanism, it is evident that azBSA is able to be digested.

2.3.5

in vitro fluorescence activation.
The onset for florescence has been indicated to occur with the trypsin digestion of the azBSA

on the PA/azBSA/5a particles. Recent in vitro studies have shown that altered BSA is taken into
the lysosomal and endosomal compartments of the cell[149, 143, 120] and, in the J774 cell line,
BSA conjugates are readily degraded[142]. Further, previous co-localization studies with surfaced
modified PA particles in UMSCC22A cells indicated that the particles were internalized by the cells
through endocytosis and accumulated in the lysosomes[120]. Based on these results, its speculated
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Figure 2.14: NanoDSC curves of (a) native BSA and (b) azide modified BSA (azBSA). Undigested proteins
presented in pink while digested proteins are presented in green.

that these PA/azBSA/5a particles may be internalized by living cells and, through further processing
of the cells through their endocytotic pathways, fluorescence could be activated. To this end, live
cell laser scanning confocal imaging was performed on A549 human alveolar adenocarcinoma cells
(human non-small cell lung cancer) treated with 1 µM PA/azBSA/5a particles. To demonstrate
that the cells were alive during imaging, Hoechst stain was employed to co-stain the cells. A549 cells
were chosen as the model cell line because they are common epithelial lung cancer cells that have
been studied since 1972[150, 151]. Furthermore, lung cancer is the leading cause of cancer-related
deaths among adults. Therefore, the results found using A549 cells are expected to be similar for
other cancer cell lines[152].
Figure 2.15 presents images of the A549 cells after incubation with 1 µM of PA/azBSA/5a
particles for 1 hr, 17 hr, and 24 hr. A cytotoxicity assay (MTS assay) was performed using A549
cells and the PA/azBSA/5a particles at concentrations that overlapped the range utilized in the
confocal study; these studies indicated that the particles were not cytotoxic to the cells.
After 1 hr of incubation, minimal fluorescence was observed in cells that had internalized the
PA/azBSA/5a particles; in these images the cells were illuminated by 635 nm light to excite 5a (cf.
Figure 2.15, right panel). By 17 hr, the cells exhibited an overall increase in fluorescence compared
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Figure 2.15:

Laser scanning confocal images of A549 cells after incubation with 1 µM PA/azBSA/5a particles
for 1 hr, 17 hr, and 24 hr. Differential interference contrast (DIC) images of cells are presented in the left column.
Corresponding images of cells stained with Hoescht dye (middle column, cyan (405 nm excitation)) and PA/azBSA/5a
particles (right column, red (635 nm excitation)) are also presented. The right panel presents the activated fluorescence
of the particles in the cells as a function of time. At early time points, (1 hour of incubation), cells incubated with
PA/azBSA/5a exhibited minimal fluorescence. Over time, (17 and 24 hours of incubation), cells incubated with
PA/azBSA/5a demonstrated an overall increase in fluorescence intensity. All cells were imaged in Live Cell Imaging
Solution, and all microscope settings were kept constant throughout the experimental time course.

to images collected after 1 hour of particle incubation. This increase in fluorescence over time could
be attributed to cellular uptake of the particles, and the digestion of the BSA coating resulting in
the release of the dye. Many cancerous cells recognize BSA and readily incorporate the protein
into the cell[153]. It has also been found that incorporating proteins into a nanoparticle system
increases the bioactivity of the system along with exhibiting a greater enhanced permeability and
retention effect[154, 155]. Previous studies with sub-100 nm PA particles surface modified with short
chained chromophores indicated a quicker cellular uptake and fluorescence activation than in the
current system[120]. In the current system, the dyes are attached to azBSA, which is then attached
to the particle, resulting in a much larger assembly, possibly on the order of ca. 100 nm with the
azBSA affording a “fuzzy” mobile outer surface. Though covalently attaching the azBSA to the PA
particle is speculated to provide some level of “stealth” to the nanoparticle system resulting in a
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greater cellular uptake than the bare particle, the time for fluorescence activation may be longer since
the particles must undergo digestion before 5a fluoresces[120]. The cells were imaged after 24 hr of
incubation and exhibited slightly more fluorescence in the 635 channel (far right column) than the 17
hr image (cf. Figure 2.15). The confocal images and the cytotoxicity assay offer compelling evidence
that the particles are being internalized by the cell and that the fluorescence is only activated by the
digestion of the azBSA present on the PA/azBSA/5a particles once the particles are in the cell. An
attractive part of this particle-protein-contrast agent is that the fluorescence is not activated until
the digestion of the azBSA, which increases the targeting efficiency of the contrast agent (5a).

2.4

Conclusion
It was shown that activated fluorescence can be achieved with a particle mediated pro-

tein/dye system. The system employed in this study was based on a PA particle scaffold with a
silicon phthalocyanine tagged shell of BSA around the nanoparticle. It was shown that, through
tryptic proteolytic digestion, the system went from being nonfluorescent to fluorescent. As a model,
A549 cells were used to study the activated fluorescence in vitro. Once internalized, the confocal
images of the cells showed that there was activated fluorescence as fluorescence intensity increased
with time of particle incubation. This system is attractive for photodynamic therapy (PDT) because 5a is nonfluorescent when the system is intact, meaning that the system can be delivered to
a specific site in the body without fear of damaging any unintended tissue. Once internalized and
digested by cancer cells, 5a regains it propensity to fluoresce, and the tumor may then be irradiated
to induce cell death.

2.5
2.5.1

Experimental
Reagents and solvents
Silicon phthalocyanine dichloride (SiPcCl2 ), triethylene glycol, and polyethylene glycol 600

(PEG 600) were purchased from Sigma-Aldrich. Other reagents were purchased from Alfa Aesar.
All commercial reagents were used without further purification. All solvents were dried according to
standard methods. Triethylene glycol and PEG 600 were dried in THF solutions over A4 molecular
sieves. 1 H and 13 C NMR spectra were recorded on a JEOL ECX300 spectrometer (300MHz for pro41

ton and 76MHz for carbon). Chemical shifts for protons are reported in parts per million downfield
from tetramethylsilane and are referenced to residual protium in the NMR solvent (CDCl3: δ 7.26
ppm, DMSO-d6: δ 2.50 ppm). Electrospray (ESI) mass spectra were obtained using Finnigan LCQ
spectrometer and HP 1100 (HPLC). All commercial reagents were used without further purification. All solvents were dried according to standard methods. Deionized water was obtained from a
Nanopure System and exhibited a resistivity of ca. 1018 Ohm−1 cm−1 .

2.5.2

Infrared spectroscopy
Fourier transform infrared (FTIR) spectra were obtained with a Nicolet 6700 by Thermo

Scientific FT-IR spectrometer and all spectra were measured with FTIR-ATR with a diamond head.

2.5.3

Optical characterization methods
Absorbance spectra were obtained using a Perkin-Elmer Lambda 950 UV/VIS/NIR spec-

trophotometer. Photoluminescence (PL) spectra were collected using a Thermo Oriel xenon arc
lamp (Thermo Oriel 66902) mated with a Thermo Oriel Cornerstone 7400 1/8m monochromator
(Thermo Oriel 7400).

2.5.4

Synthesis and characterization data

2.5.4.1

Synthesis of compound 1a
Compound 1a was synthesized according to literature[156]. Sodium hydride (0.32 g, 13.32

mmol) was added to the solution of triethylene glycol (2 g, 13.32 mmol) in tetrahydrofuran (30 ml).
The obtained mixture was stirred at room temperature for 30 min; then propargyl bromide solution
(80%) in toluene (2 g, 13.45 mmol) was added. The mixture was stirred for 6 h at room temperature and filtered. The filtrate was evaporated; the residue was extracted with dichloromethane and
washed with water. The organic solution was dried with Na2 SO4 , filtered, and evaporated under
reduced pressure to yield a brown oil. The crude product was purified by flash column chromatography on silica. The first eluent was dichloromethane, which serves to remove a majority of the
impurities. A second eluent, acetone, was used to collect the product (cf. Figure 2.16). Yield: 1.63
g (65%), pale yellow oil.

1

H NMR (CDCl3 ) δ 2.43 (t, 1H, J=2.4 Hz, CCH), 3.61 (m, 2H, OCH2 ),

3.67-3.74 (m, 10H, OCH2 ), 4.21 (d, 2H, J=2.4 Hz, CH2 CC).
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2.5.4.2

Synthesis of compound 1b
Compound 1b was synthesized according to the above procedure. The crude product was

washed with hexanes twice, decanted, dried, and used in the next step without further purification
(cf. Figure 2.16). Yield: 83%, clear oil.

1

H NMR (CDCl3 ) δ 1.83 (s, 1H, OH), 2.43 (t, 1H, J=2.4

Hz, CCH), 3.60-3.71 (m, 56H, OCH2 ), 4.20 (d, 2H, J=2.4 Hz, CH2 CC).
2.5.4.3

Synthesis of compound 2a
Methanesulfonyl chloride (3.2 g, 27.94 mmol) was added to the solution of triethylene glycol

(4 g, 26.64 mmol) in dichloromethane (50 ml). The reaction was cooled with ice. Triethylamine
(2.97 g, 29.3 mmol) was added dropwise to the stirred solution. The ice bath was removed, and the
obtained mixture was stirred at room temperature for 6h. The reaction mixture was then washed
with water twice. The organic solution was dried with Na2 SO4 , filtered, and evaporated under
reduced pressure. The obtained product contains approximately 10% of bis-methylsulfonylated
triethylene glycol and was used in the next step without additional purification (cf. Figure 2.16).
Yield: 3.6 g (59%), clear oil. 1 H NMR (CDCl3 ) δ 3.07 (s, 3H), 3.61 (m, 2H, CH2 OH), 3.67 (m, 4H),
3.76 (m, 4H), 4.37 (m, 2H, CH2 OSO2 ).
2.5.4.4

Synthesis of compound 2b
Compound 2b was synthesized according to the above procedure and was used in the next

step without additional purification (cf. Figure 2.16). Yield: 87%, clear oil.

1

H NMR (CDCl3 ) δ

3.07 (s, 3H), 3.58-372 (m, 40H), 3.75 (m, 2H), 4.37 (m, 2H, CH2 OSO2 ).
2.5.4.5

Synthesis of compound 3a
Compound 2a (3.6 g, 15.77 mmol) was dissolved in acetonitrile (20ml), and sodium azide

(2.56 g, 39.38 mmol) was added to the solution. The obtained mixture was stirred and refluxed for
16h. After cooling, the mixture was extracted with dichloromethane and was washed with water.
The organic solution was dried with Na2 SO4 , filtered, and evaporated under reduced pressure. The
obtained product contains about 10% of bis-azido-derivative, but it was used in the next step without
additional purification (cf. Figure 2.16). Yield: 2.47 g (89%), clear oil. 1 H NMR (CDCl3 ) δ 3.38 (t,
2H, J=4.8 Hz, CH2 N3 ), 3.59-3.79 (m, 10H).
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2.5.4.6

Synthesis of compound 4a
Silicon phthalocyanine dichloride (0.2 g, 0.33 mmol) was mixed with dry toluene (4ml),

and the solution of compound 3a (0.17 g, 0.97 mmol) in toluene (2 ml) was added to the reaction
mixture. The mixture was stirred under a nitrogen atmosphere for 5 minutes and sodium hydride
(0.023 g, 0.96 mmol) was added. The mixture was refluxed for 20 h. After cooling, the solution
was extracted with ethyl acetate and was washed with water. The organic solution was dried with
Na2 SO4 , filtered, and evaporated under reduced pressure. The residue was washed with hexanes.
The organic solution was decanted away from the insoluble product, and the product was purified by
flash column chromatography on silica with an eluent of a solution of dichloromethane:acetone (10:1),
Rf =0.3 (cf. Figure 2.17). The dry product was dissolved in a minimum of dichloromethane and was
added dropwise to hexane solution. The precipitates from this solution were filtered, collected, and
dried. Yield: 0.13 g (45%), blue crystals, mp 169-170 o C with destruction. 1 H NMR (CDCl3 ) δ -1.91
(t, 4H, J=5.5 Hz, CH2 OSi), 0.42 (t, 4H, J=5.5 Hz, CH2 ), 1.66 (t, 4H, J=4.8 Hz, CH2 ), 2.45 (t, 4H,
J=4.8 Hz, CH2 ), 2.92 (m, 8H, CH2 CH2 N3 ), 8.34 (dd, 8H, J=3.1 Hz, ArH), 9.63 (dd, 8H, J=3.1 Hz,
ArH).

13

C NMR (CDCl3 ) δ 50.36, 54.92, 68.83, 69.24, 69.54, 69.58, 123.78, 131.03, 136.13, 149.38

(CN). ESI+ Mass (m/z): calculated for C44 H40 N14 O6 Si [M+Na]+ 911.29, found 911.0
2.5.4.7

Synthesis of compound 4b
Compound 4b was synthesized according to the procedure of 4a with the substitution of

compound 3b for compound 3a. Compound 4b was purified by flash column chromatography on
silica with an eluent of a solution of dichloromethane:methanol (10:1). Rf =0.4 (cf. Figure 2.17).
Yield: 66%, dark blue oil. 1 H NMR (CDCl3 ) δ -1.92 (t, 4H, J=5.5 Hz, CH2 OSi), 0.37 (t, 4H, J=5.5
Hz, CH2 ), 1.66 (t, 4H, J=4.8 Hz, CH2 ), 2.44 (t, 4H, J=5.2 Hz, CH2 ), 2.96 (t, 4H, J=4.8 Hz, CH2 ),
3.21 (t, 4H, J=5.2 Hz, CH2 ), 3.37 (m, 8H, CH2 ), 3.44 (m, 4H, CH2 ), 3.51-3.69 (m, 70H, CH2 ),
8.33 (dd, 8H, J=3.1 Hz, ArH), 9.62 (dd, 8H, J=3.1 Hz, ArH).

13

C NMR (CDCl3 ) δ 50.79, 54.80,

68.68, 69.46, 69.90, 70.16, 70.20, 70.39, 70.48, 70.54, 70.69-70.81 (m), 123.77, 130.98, 136.10, 149.34
(CN). ESI+ Mass (m/z): calculated for compound 4b avg. C86 H12 4N14 O26 Si [M+H]+ 1797.87, found
multiple peaks starting from 1963 (See Supplementary Information).
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2.5.4.8

Synthesis of compound 5a
Silicon phthalocyanine dichloride (0.2 g, 0.33 mmol) was mixed with dry toluene (4ml) and

the solution of compound 1a (0.19 g, 1.0 mmol) in toluene (2 ml) was added to the reaction vessel.
The obtained mixture was stirred under a nitrogen atmosphere for 5 minutes and sodium hydride
(0.023 g, 0.96 mmol) was added. The mixture was stirred and refluxed for 20h. After cooling, the
mixture was extracted with ethyl acetate and was washed with water. The organic solution was
collected, dried with Na2 SO4 , filtered, and evaporated under reduced pressure. Compound 5a was
purified by flash column chromatography on silica with an eluent of a 3:1 dichloromethane:acetone
solution, Rf =0.2 (cf. Figure 2.17). The dry product was dissolved in a minimum of dichloromethane
and added dropwise to hexanes solution. The precipitates from this solution were filtered, collected,
and dried. Yield: 53%, blue crystals, mp 172-173 o C. 1 H NMR (CDCl3 ) δ -1.90 (t, 4H, J=5.5 Hz,
CH2 OSi), 0.40 (t, 4H, J=5.5 Hz, CH2 ), 1.67 (t, 4H, J=4.8 Hz, CH2 ), 2.34 (t, 2H, J=2.4 Hz, CCH),
2.46 (t, 4H, J=4.8 Hz, CH2 ), 2.98 (t, 4H, J=4.8 Hz, CH2 ), 3.29 (t, 4H, J=4.8 Hz, CH2 ), 3.95 (d,
4H, J=2.4 Hz, CH2 CC), 8.34 (dd, 8H, J=3.1 Hz, ArH), 9.63 (dd, 8H, J=3.1 Hz, ArH).

13

C NMR

(CDCl3 ) δ 54.85, 58.29, 68.72, 68.84, 69.48, 69.53, 69.75, 74.47, 79.76, 123.79, 131.0, 136.13, 149.37
(CN). ESI+ Mass (m/z): calculated for C50 H46 N8 O8 Si [M+Na]+ 937.31, found 937.13.
2.5.4.9

Synthesis of compound 5b
Compound 5b was synthesized according to the procedure of 5a with the substitution of

compound 1b for compound 1a. Compound 5b was purified by flash column chromatography on
silica. Two eluents were employed. The first eluent was ethyl acetate and was used to remove the
majority of impurities. The second eluent was a 3:1 solution of dichloromethane:methanol and was
used to remove the remaining impurities and to wash the product from the silica. Rf =0.2 (cf. Figure
2.17). Yield: 64%, dark blue oil.

1

H NMR (CDCl3 ) δ -1.92 (t, 4H, J=5.5 Hz, CH2 OSi), 0.37 (t,

4H, J=5.5 Hz, CH2 ), 1.64 (t, 4H, J=4.8 Hz, CH2 ), 2.44 (m, 6H, J=4.8 Hz, CH2 and CCH), 2.96
(m, 4H, CH2 ), 3.20 (m, 4H, CH2 ), 3.36 (m, 4H, CH2 ), 3.44 (m, 4H, CH2 ), 3.49-3.71 (m, 80H, CH2 ),
4.21 (d, 4H, J=2.4 Hz, CH2 CC), 8.34 (dd, 8H, J=2.8 Hz, ArH), 9.62 (dd, 8H, J=2.8 Hz, ArH).

13

C

NMR (CDCl3 ) δ 54.80, 58.53, 68.68, 69.21, 69.43, 69.46, 69.89, 70.20, 70.38, 70.47, 70.52, 70.68 (m),
74.69, 79.77, 123.77, 130.99, 136.10, 149.35(CN). ESI+ Mass (m/z): calculated for compound 5b
avg. (n=10-11) C90 H126 N8 O28 Si [M+K]+ 1817.83, found 1818.40.
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Figure 2.16:

Precursor compounds for the modification of silicon phthalocyanine dichloride to yield silicon phthalocyanine derivatives. i) Propargyl bromide, sodium hydride (NaH) as the base, tetrahydrofuran (THF), stirring
at room temperature; ii) methanesulfonyl chloride (MeSO2 Cl), triethyl amine (Et3 N), stirring in methylene chloride
at room temperature; iii) sodium azide (NaN3 refluxing in acetonitrile.

Synthesis of poly(propargyl acrylate) (PA) particles. Poly(propargyl acrylate) (PA) particles were prepared according to a published method[97] using a standard aqueous emulsion polymerization technique with propargyl acrylate as the monomer, sodium dodecyl sulfate as the surfactant,
potassium persulfate as the initiator, and divinylbenzene as the crosslinker, resulting in spheres with
a diameter of ca. 67.1 ± 0.12 nm measured with a Coulter N4Plus DLS and a concentration of 18
mg/mL after dialysis.

Preparation of azide labeled bovine serum albumin (azBSA). Standard BSA was tagged
with azide groups (azBSA) using standard N-hydroxysuccinimide (NHS) coupling chemistry.[157,
158] Briefly, 1 mM of BSA was reacted with excess 3-azidopropanoate-N-hydroxysuccinimide ester
(azNHS, 23 mM) in PBS with 2% THF. The two were allowed to react for eight hours via a wrist
action shaker in the dark. The reaction was purified from small molecule azNHS by dialysis in a
12,000-14,000 molecular weight cut off bag for two days with frequent changes of the dialysis water.
(cf. Figure 2.18)

Synthesis of PA/azBSA/5a modified nanoparticles. In order to synthesize the particle system incorporating both BSA and 5a, subsequent click reactions were performed. A solution of
azBSA (32 mg, 0.0048 mmol) in 1x PBS (1 mL) was mixed with a solution of 5a (4.406 mg, 0.0048
mmol) in THF along with solutions of CuSO4 (2.40 mg, 0.0096 mmol) and sodium ascorbate (9.52
mg, 0.048 mmol) in PBS to afford a final solvent ratio of 5.5:1 PBS:THF. This mixture was allowed
to react for 1 hour. Then, PA particles (1.03 × 1014 , .908 mL) were entered into the reaction flask
along with more catalysts, CuSO4 (2.40 mg, 0.0096 mmol) and sodium ascorbate (9.52 mg, 0.048
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Figure 2.17: Synthetic scheme to afford azide or alkyne derivatized silicon phthalocyanine. i) Reaction refluxed in
toluene with sodium hydride (NaH) as the base.

mmol), resulting in an 11:1 ratio of PBS to THF. The reaction mixture was allowed to react for
approximately 48 hours. After 48 hours, the reaction was stopped with the removal of the catalysts
and unattached fluorophore through a series of washes via centrifugation with a solution of 60%
PBS and 40% THF. The removal of free fluorophore was monitored by UV/Vis spectroscopy of the
supernatant. When the maximum absorbance peak of the free fluorophore had disappeared, the
reaction was said to be free from unattached fluorophore. The resulting system consisted of PA
particles surrounded by a shell of azBSA with attached fluorophore on the surface of the azBSA. It
should be noted that twenty of the possible forty binding sites were used in calculations for binding
of dye to protein. The other half were used for protein binding to particle to ensure that there was
no BSA that was not bound to a particle. As such, the 14:1 dye:protein dye loading was found to
be the optimal amount of dye loading possible.

Calculation of grafting densities.

All grafting densities were calculated based on optical density

measurements where molar extinction coefficients of BSA and 5a had to be calculated (in THF) as
well as a calibration curve of particles (in THF). Based on these calculations, there were 14 dyes per
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Figure 2.18: Reaction scheme to yield azide labeled BSA.

protein and 12 proteins per particle, yielding 168 dyes per particles.

Molar extinction coefficient of azBSA.

Molar extinction coefficient for BSA was calculated

in THF to be 4,511,036 M−1 cm−1 at 290 nm using multiple solutions of concentrations 1µg/mL,
2µg/mL, and 5µg/mL.

Molar extinction coefficient of 5a Molar extinction coefficient for 5a was calculated in THF
to be 226,368 M−1 cm−1 at 688 nm using multiple solutions of concentrations 1µg/mL, 2µg/mL,
and 5µg/mL.

PA particles calibration curve.

To interpret the number of PA particles in a sample, a calibra-

tion curve was generated by preparing several, known concentrations of PA nanoparticles in THF
and obtaining the absorbance spectrum for each concentration. Then the mass of PA particles was
graphed against their absorbance at 400 nm and a linear line of best fit was obtained, which was
extrapolated to determine the number of particles in a given sample. It should be noted that 400
nm was chosen because it coincided with where the particles just began scattering light.

5a to azBSA. It was found that there were 14 5a molecules per protein. This was calculated based
on a click reaction that involved only azBSA and 5a with the same molecular ratios as if particles
had been present. After the click reaction, the product was washed multiple times with THF and was
centrifuged at 22,716 g for 15 min to remove any unattached dye. UV/vis spectroscopy performed
on the supernatant of the last wash did not show a characteristic peak of 5a, so the reaction was
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said to be clean of unattached dye. The azBSA/5a system was redispersed in THF and UV/vis was
obtained. Based on the calculated molar extinction coefficients of azBSA in THF and 5a in THF,
the number of molecules of each azBSA and 5a were found.
azBSA to particle.

It was found that there were 12 azBSAs per particle. This was calculated

based on the click reaction between PA particles, azBSA, and 5a as described earlier. Based on
the calculated molar extinction coefficients of azBSA in THF and the calibration curve generated
from various, known concentrations of PA particles in THF, the number of molecules of azBSA and
number of PA particles were found. The 14 dyes per azBSA and 12 azBSA per particle yield 168
5a molecules per particle.
Cell analysis.

Human A549 cell line was obtained from ATCC (Rockville, MD) and was cultured

in F-12K media (Kaighn’s Modification of Ham’s F-12 medium) containing 10 % fetal bovine serum
(FBS) and 1 % Penicillin-Streptomycin. Cells were cultured at 37 o C in a humidified atmosphere of
95 % air 5 % CO2 .
Cytotoxicity assay.

A549 cells were cultured on 96 well plates for 24 hr at a cell density of 20,000

cells per well. After culture, the cells were incubated with varying concentrations of particles, namely
2 × 109 , 2 × 1011 , and 2 × 1013 particles/mL for 48 hr. At the conclusion of 48 hr, cell death was
measured with a MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)2H-tetrazolium salt) assay according to the manufacturer’s instructions (Promega, Madison, WI).
The absorbance spectra were gathered using a BioTek Eon Microplate spectrophotometer using
Gen5 20 All-in-One Microplate Reader software. At the concentrations used in the laser scanning
confocal studies, the particles were not toxic to the A549 cells (cf. Figure 2.19).

2.5.5

Laser scanning confocal imaging.
A549 cells were plated (15,000 cells/well) and stained in an 8-well coverglass bottom chamber

slide (Lab-Tek) and observed using a Leica SPE inverted confocal microscope (Leica Microsystems),
equipped with a 40X oil-immersion objective (N.A.= 1.15), and an acousto-optical tunable filter
(AOTF) for emission wavelengths. The cell density of 15,000 cells per well was chosen in an effort
to prevent any contact mediated inhibition at the 24 hr time point. At 24 hr, we wanted to insure
that all cells were still viable and able to actively process the particles. Cells were incubated with 1
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Figure 2.19: Cytotoxicity of particulate system at 2×109 , 2×1011 , and 2×1013 .

µM of PA/azBSA/5a for varying time periods, namely 1hr, 17 hr, and 24 hr. After each time point,
the treatment was removed, by aspirating the media, and the cells were washed with 500 µL of 1x
PBS. Then, 2 µM Hoechst (AnaSpec, San Jose, CA) diluted in Live Cell Imaging Solution (Life
Technologies, Grand Island, NY) was added, and the cells were incubated at 37◦ C for 30 minutes.
After 30 min, the stain was removed, and the cells were washed with 500 µL of 1x PBS; then Live
Cell Imaging Solution was placed into the wells. To observe Hoechst staining (cyan), a 405 nm
laser was used for excitation and emission wavelengths of 415-480 nm were collected using an AOTF
tunable PMT. To observe PA/azBSA/5a fluorescence (red), cells were observed using a 635 nm
laser for excitation and PMT emission settings of 650-749 nm. Image collection and processing was
performed using Leica LAS X software. In order to make observations about fluorescence intensity,
all microscope settings, including laser power, gain, offset, frame averaging and/or accumulation
were constant throughout the imaging time course experiment.

Photodynamic therapy. UMSCC22A cell cultures were incubated with 50 - 400 nm of the sample
for 18 hours before exposure to 200 - 400 mJ/cm2 red light (670 nm) from an Intense-HPD 7404
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diode laser (North Brunswick, NJ). After exposure to the 670 nm monochromatic laser light, cells
were incubated for various periods of time prior to analysis. Cell death was assessed by propidium
iodide (PI) fluorometry using a multi-well fluorescence plate reader, as previously described[159].
Before exposure to light, the cells were washed and fresh media supplemented with PI (30 µM) and
Insulin-Transferrin-Selenium-X (ITX) reagent [insulin (10 µg/ml), transferrin (5.5 µg/ml), selenium
(6.7 ng/ml), ethanolamine (0.2 mg/ml)] (Gibco) but no FBS was added to the cells. PI fluorescence
was measured at frequent intervals using 530 nm excitation (25 nm band pass) and 620 nm emission
(40 nm band pass) filters. Between measurements, plates were placed in a 37 o C, 5 % CO2 incubator.
At the end of the experiment, digitonin (200 µM) was added to each well to permeabilize all cells
and label all nuclei with PI. Cell viability determined by PI fluorometry is, in essence, the same as
cell viability determined by trypan blue exclusion[159].
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Chapter 3

Dynamic Emission Tuning of
X-Ray Radioluminescent
Dye-Doped Crystalline Colloidal
Arrays: Coupling the Optical stop
band with Sequential Förster
Resonance Energy Transfers
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in press, 2018.

3.2

Introduction
Due to the tissue penetration depths afforded to x-ray radiation relative to the visible spec-

trum, imaging techniques that exploit x-ray sensitive agents have been a focus of growing research
interest[160] both as negative[161] and positive contrast agents[89, 162, 163, 164], while the coupling of diagnostic and therapeutic roles for scintillating probes which convert x-ray energy into
visible/NIR light have also been recently explored[165, 166]. For example, in the theranostic role,
the poor efficiency of 1 O2 generation by organic photodynamic therapy (PDT) photosensitizers has
been mitigated by coupling the photosensitizers with scintillating particles to stimulate the PDT
photosensitizers[167]. The scintillation mechanism of inorganic systems are inherently tied to the
electronic bandstructure of the crystal, while for organics scintillators the molecular electronic structure dictates the radioluminescence properties[168]. This latter feature allows the organic systems
to be used as scintillators in a solid, liquid, or gas phase.
Though x-ray projection imaging and computed tomography (CT)[169] are established imaging techniques which detect x-ray attenuation in a sample, x-ray fluorescence (XRF)[170] is an alternative imaging approach which focuses on a positive contrast and can be coupled with CT in X-ray
fluorescence computed tomography (XRCT)[171] to produce three-dimensional elemental maps in a
sample. Probes that exhibit x-ray radioluminescence are employed in x-ray excited optical luminescence (XEOL) and x-ray luminescence computed tomography (XLCT) with XLCT being proposed
as a dual molecular/anatomical imaging modality that utilizes the selective excitation and optical detection of x-ray radioluminescent nanoparticles[172, 173]. Color tuning of radioluminescent
perovskite nanocrystals has also recently been reported where counter-ion type and concentration
influenced the emission wavelength[174].
X-ray attenuation, x-ray fluorescence, and optical luminescence performance is enhanced
with nanoparticle probes composed of materials with increasing atomic number. For example,
successful nanoparticle x-ray imaging agents include gadolinium oxide[175], gadolinium or lanthanum
oxysulfides doped with europium or terbium[176], sodium gadolinium tungstate[177], and alkali metal
gadolinium fluorides doped with europium[163] as well as alkali metal yttrium fluorides doped with
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ytterbium/erbium[178] or gadolinium[179]. However, the majority of these nanoparticle systems
may pose varying levels of toxicity when employed in vivo[180, 181, 182, 183] and require chelating
agents or a passivation overcoat, for example, biocompatible polymers[184, 185], to deter leaching
into tissue[186] which can be particularly damaging for patients experiencing renal failure[187], as
kidney inflammation is a serious, common side effect of their use[188].
In order to mitigate the toxicity effects of current scintillating nanoparticles, we present
a fully organic x-ray radioluminescent colloidal platform that can be tailored to emit anywhere
in the visible spectrum through judicious choice in donor/acceptor pairing and multiple sequential
Förster resonance energy transfers (FRET). The approach is demonstrated with three unique classes
of ca. 100 nm polystyrene particles doped with (1) a molecular scintillator with a blue emission,
(2) a molecular scintillator and a donor/acceptor pair with a green emission, and (3) a molecular
scintillator and two donor/acceptor pairs with a red emission. In addition, the particles are assembled
into a colloidal crystal to demonstrate emission tuning through a coupling of rejection wavelength
(i.e. the stopband of the optical bandstructure) with emission.

3.3

Results & Discussion
Figure 3.1a presents the three series of particles that are the focus of this study. In brief, a

standard emulsion polymerization procedure was followed (cf. Experimental Section) to synthesize
polystyrene particles that were ca. 100 nm. During the polymerization, various dyes were mixed with
the styrene monomer and slowly dropped in the reaction vessel, doping the resulting particles with
the emitters. Three groupings of dyes were utilized to create emitter series n◦ 1 - n◦ 3 and included
anthracene (Anth), Anth and 2-(3-Azidopropyl)-6-piperidino-2-aza-2H-phenalene-1,3-dione (Napth),
and Anth, Napth, and Rhodamine B (RhB), respectively; Figure 3.1b presents their absorbance
spectra and x-ray induced radioluminescence (XRL) when excited by ionizing radiation from an
Amptek Mini-X x-ray unit equipped with a silver target operating at 50 kV and 79 µA. While a
variety of highly fluorescent probes[189] could have been chosen, Napth was chosen because if forms
a good FRET pair with Anth, while Napth forms a good FRET pair with RhB.
For emitter series n◦ 1, the only organic dye encapsulated in the particles is anthracene. Anthracene was chosen as the molecular scintillator because it is the brightest known organic scintillator
with scintillation efficiency similar to the commonly used inorganic scintillator bismuth germanium
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Figure 3.1: (a) X-ray induced radioluminescent polystyrene particles were doped with anthracene
(Anth) (emitter series n◦ 1), Anth and 2-(3-Azidopropyl)-6-piperidino-2-aza-2H-phenalene-1,3-dione
(Napth) (emitter series n◦ 2), or Anth, Napth, and rhodamine B dye (RhB) (emitter series n◦ 3).
(b) Optical absorbance (blue curve) and x-ray radioluminescence (red curve) for emitter series n◦ 1
- n◦ 3. Optical absorbance of particles measured in aniline (ca. 1011 particles/cm3 ) while x-ray
radioluminescence measured with particles dispersed in deionized water (ca. 1014 particles/cm3 ).

oxide (BGO).[190] BGO is often used as a standard among inorganic scintillators.[191] The absorbance of anthracene spectrum has three strong peaks at 345 nm, 363 nm, and 382 nm, while a
shoulder is present at 394 nm. This spectrum is characteristic of anthracene which exhibits a number
of sharp absorbance peaks when dispersed in solution or as a single crystal[192]. Anthracene is a well
know x-ray radioluminescent material that has been utilized in x-ray detectors for over six decades,
though its fluorescence efficiency is significantly less when excited by ionizing radiation relative to
photoexcitation[193, 194]. In Figure 3.1b, emitter series n◦ 1 exhibits a XRL peak spanning from
394 nm to 500 nm with a maximum at 424 nm when excited by x-ray radiation, giving the particles
a blue emission color when optically observed.
Emitter series n◦ 2 is composed of particles that encapsulate both the Anth and Napth
emitters. In the design of these particles, Anth serves as the pump source to the Napth emitters by
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converting ionization radiation to the energy transferred to the Napth emitters to achieve their green
emission color, while the Förster distance between the Anth donor and the Napth acceptor is 3.03
nm. In the absorbance spectrum of the particles, the signature of the Anth dye is still evident, but the
broad low peak centered at 444 nm is attributed to the Napth dye. The radioluminescence spectrum
of the dye doped particles (cf. Figure 3.1b, emitter series n◦ 2) exhibits a dominant emission peak
centered at 520 nm attributed to the Napth emitters, with a small shoulder at 425 nm attributed to
the Anth emission. This spectral profile indicates a significant level of energy transfer from the Anth
(donor) to the Napth dye (acceptor), though we would expect that within the ca. 95 nm particle
that there would be donor and acceptor dyes spaced farther away from each other than the Förster
distance, resulting in the appearance of the Anth emission.
Similarly, emitter series n◦ 3 is composed of particles that encapsulate all three dyes: Anth,
Napth, and RhB. The absorbance spectrum clearly indicates that all three dyes are encapsulated in
the particles by the appearance of peaks indicative of the Anth and Napth dyes, as well as a broad
peak centered at 554 nm (cf. Figure 3.1b, emitter series n◦ 3) attributed to the RhB dye. The XRL
spectrum of emitter series n◦ 3 (cf. Figure 3.1b) exhibits a peak located at 622 nm (red emission
color), and this emission is attributed to the RhB dye. Small emission peaks were observed from
the Anth and Napth dye, indicating incomplete energy transfer from the Anth emitter to the Napth
dye and from the Napth emitter to the RhB fluorophore, though clearly a majority of the energy
is being transferred by virtue of the large RhB emission. The Förster distance between the Napth
donor and the RhB acceptor is 2.98 nm. The repetitive FRET occurring in emitter series n◦ 3 allows
for a 198 nm red-shift in the emission of the particles relative to the Anth. To verify the absorbance
and emission characteristics of the dyes, all three dyes (Anth, Napth, and RhB) were dispersed in
aniline as isolated dyes and their optical absorbance and photoluminescence spectra were obtained
(cf. Appendix B). The radioluminescence characteristics of the dyes were also studied, but only Anth
exhibited emission; no appreciable emission was observed for either Napth or RhB fluorophores under
ionizing radiation.
The effectiveness of the energy transfer across the various dyes in the particles is evident
when they are observed optically while being exposed to x-rays. Figure 3.2a-c presents optical images
of the three emitter series under x-ray illumination and indicates that their emission colors appear
a vibrant blue, green, and red for emitters series n◦ 1, n◦ 2, and n◦ 3, respectively. The color can
be quantified by utilizing the 1931 International Commission on Illumination (CIE) chromaticity
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(a)

(b)

(c)

(d)

(e)

Figure 3.2: Optical image of ca. 100 µl liquid drop of (a) emitter series n◦ 1, (b) emitter series n◦ 2,
and (c) emitter series n◦ 3 under x-ray illumination. Radioluminescence was generated by an Amptek
Mini-X x-ray unit equipped with a tungsten target operating at 50 kV and 79 µA. Particles were
dispersed in deionized water at a concentration of ca. 1013 particles/cm3 . (d) 1931 International
Commission on Illumination (CIE) chromaticity diagram with the x-ray induced radioluminescence
derived color coordinates of emitter series n◦ 1-3 presented in Figure 3.1. The CIE coordinates
of emitter series n◦ 1-3 define a triangle (labeled) that delimitates the color region accessible with
the current emitter series. The mixture composed of equal contributions of each emitter series
resulted in CIE (x, y)-coordinates of (0.346, 0.391) while “white” is defined at ( 31 , 31 ). (e) X-ray
radioluminescence of mixture containing emitter series n◦ 1-3 of Figure 3.1. Measurements performed
with particles dispersed in deionized water.
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diagram. Figure 3.2d presents the 1931 CIE chromaticity diagram with the color characteristics of
the emitter series presented in Figure 3.1 plotted at their specific CIE (x,y) color coordinates. All
the colors that can be formed by mixing three color sources together are found inside the triangle
formed by the source points on the chromaticity diagram, while white appears approximately at
the point (1/3, 1/3). Table 3.1 presents the dominant wavelength (λp ) and color purity (p) of the
colloids presented in Figure 3.1. The dominant wavelength for a color is defined as the wavelength
on the edge of the diagram that lies on a line joining the white point and the (x,y) position of any
color, while the color purity is defined as the ratio of distances between (1) the color point and the
white point and (2) the dominant wavelength and the white point. The primary colors will define
the region of the chromaticity figure accessible by the additive color approach. Monochromic or
saturated colors have p values that approach 1, while a color will have a p value that approaches
zero as the color becomes less vibrant or more “washed out”.
emitter series

n◦ 1
n◦ 2
n◦ 3
mixture of n◦ 1-3

CIE coordinates
(x,y)
(0.193, 0.109)
(0.293, 0.515)
(0.546, 0.338)
(0.346, 0.391)

disordered particles
dominant
wavelength (nm)
460 nm
542 nm
608 nm
563 nm

color
purity
0.737
0.446
0.655
0.212

CIE coordinates
(x,y)
(0.239, 0.172)
(0.321, 0.460)
(0.402, 0.337)
-

ordered particles
dominant
wavelength (nm)
455 nm
550 nm
606 nm
-

color
purity
0.520
0.353
0.214
-

1931 CIE coordinates, dominant wavelength, and color purity calculated for emitter series n◦ 1-3 as
isolated particles (disordered assembly) and for particles assembled into a crystalline colloidal array. For ordered
particles, CIE coordinates represent the maximum change with rejection wavelength tuning; see text for details.

Table 3.1:

Emitter series n◦ 1 has the most saturated emission with a color purity of 0.737 (cf. Table
3.1) and dominant wavelength of 460 nm. This is expected since these particles have only one emitter
relative to the other emitter series. Both emitter series n◦ 2 and n◦ 3 have color purities less than
the n◦ 1 particles largely due to the incomplete energy transfer across the FRET pairs. Surprisingly,
emitter series n◦ 3 has a more monochromatic color purity (0.655) relative to the particles of series
n◦ 2 (0.446), even though the n◦ 3 particles have two donor/acceptor pairs and should exhibit a
broader emission. In the design of the particles, the mixing of dyes at molecular lengths scales in the
individual particles results in the transfer of energy from shorter wavelength to longer wavelength
emissions as indicated in Figure 3.1b, while the sequestering of the dyes in individual particles allows
for mixing of different emitter series with the retention of their individual emission characteristics
due to a lack of energy transfer between particles. This additivity in their XRL profile is clearly
evident in Figure 3.2e where the three emitter series were mixed together at approximately equal
concentrations. The resulting emission had 1931 CIE coordinates of (0.346, 0.391) and color purity
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(a)

(b)

Figure 3.3: Optical image of a liquid drop containing a crystalline colloidal array composed of emitter
series n◦ 2 under (a) white light and (b) x-ray illumination. Particles were dispersed in deionized
water at a concentration of ca. 1013 particles/cm3 .

of 0.212, indicative of a broad emission and approaching a white color emission.
The XRL color characteristics of the “randomized” particles can be significantly altered
when the particles are assembled into a crystalline colloidal array (CCA) that exhibits a pseudogap in its optical band structure. Figure 3.3 presents an optical image of a CCA composed of
emitter series n◦ 2 under white light and when being excited by x-ray radiation. The variation in
the crystalline mosaic of the drop when it is illuminated with white light is clearly evident when the
drop is exposed to x-ray radiation. Under x-ray illumination, the color of emission varies through
different shades of green across the drop. To quantify the influence of the stop band on the emission
characteristics of the three different emitter series, the emission spectra of the ordered particles
were taken as the stop band was tuned through the respective emission profile of the particles.
For example, the XRL spectrum of a CCA composed of emitter series n◦ 3 was collected where the
rejection wavelength of the CCA was tuned from 412 nm to 720 nm by the addition of deionized
water to the liquid array. The dilution resulted in an expansion of the colloidal array and a shift of
the observed stop band to longer wavelengths. Figure 3.4 presents the XRL spectra of the ordered
particles (emitter series n◦ 3; cf. Figure 3.1) where the rejection wavelength was tuned to 514 nm
(cf. Figure 3.4a) and 630 nm (cf. Figure 3.4b), as well as the corresponding reflection spectra. The

59

collection of both the emission and reflection spectra was performed on the (111) face of the ordered
array. In addition, the XRL spectrum of the particles in a disordered state but at the same solid
content as its corresponding CCA is presented in Figure 3.4.
In Figure 3.4a, the stop band of the CCA is at 514 nm and the XRL spectrum of the ordered
particles closely mimics the emission spectrum of the particles in the disordered state (cf. Figure
3.1). Shifting the stop band to 630 nm results in a significant change in the XRL spectrum of the
ordered array with a diminution of the emission attributed to the RhB dye, specifically the emission
peak centered around 615 nm. There is a clear coupling of the RhB emission with the low density
of states of the CCA in the [111] direction. Further shifts of the stop band to longer wavelengths
result in a modification of the emission attributed to the RhB dye, until the rejection wavelength
was outside the emission range (ca. 720 nm) of the fluorophore.
Quantifying the variability in the XRL spectra of the ordered array when the rejection
wavelength was within the emission range of the fluorophores can be presented by inspecting the
bounded integrated emission intensities. Figure 3.5 presents the integrated XRL spectrum between
300 - 560 nm (I1 ; blue-green regime) and 560 nm - 800 nm (I2 ; red-NIR regime) for a range of
CCAs with various stop bands, as well as their corresponding “disordered” crystals. The 300 - 560
nm range includes the emission of the isolated Anth and the majority of the Napth emission, while
the 560 nm - 800 nm regime covers the RhB emission. The “disordered” crystals were achieved
by introducing a small quantity of NaCl to the CCA dispersion to destroy the long-range order of
the particles. The shorter wavelength integrated intensities (I1 ) for the ordered arrays and their
corresponding disordered systems exhibit a reduction in total integrated emission for both systems
with dilution. The decrease in integrated fluorescence intensities is due to an increase in interparticle
distances as the ordered arrays are diluted to achieve a shift in the observed stop band. Since the
disordered systems are matched to their corresponding CCA through particle density, the average
interparticle distance would increase as well for these particles with dilution. Since the area being
optically sampled during the emission measurements is an invariant, the expansion would result
in a net decrease in the number of particles, as well as dye molecules, in the sampled region and
ultimately reduce the observed XRL intensity. For emitter series n◦ 3, the integrated intensities in the
300 - 560 nm regime (I1 ) did not exhibit significant differences between the ordered and disordered
systems when the rejection wavelength of the CCA was within the 300 - 560 nm regime, though the
disorder particles always had slightly higher total integrated intensities.
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Figure 3.4: Comparison of x-ray induced radioluminescence of emitter series n◦ 3 in a crystalline
colloidal array (CCA) (blue curve) with a rejection wavelength at (a) 514 nm and (b) 630 nm and
disordered crystal (grey curve). Reflection spectra of the CCA is also presented (red curve).
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Figure 3.5: Comparison of integrated x-ray induced radioluminescence of emitter series n◦ 3 in a
crystalline colloidal array (CCA) and disordered particles with dilution. Integrated emission between
300 nm and 560 nm (I1 ) is labeled as blue circle (CCA) and blue diamond (disordered particles).
Integrated emission between 560 nm and 800 nm (I2 ) is labeled as red circle (CCA) and red diamond
(disordered particles). Particle density in deionized water were the same in the ordered particles
and corresponding disordered particles.
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When the rejection wavelength of the CCA was between 600 nm and 700 nm, the integrated
emission of the RhB dye (I2 ) is significantly reduced relative to the disordered system (cf. Figure
3.5) indicating a coupling between the light emitted from the RhB dye and the low density of
photonic states imposed by the ordered structure[195, 196]. It is well known that the local density
of optical states (LDOS) and the dynamics of spontaneous emission can be manipulated when in the
presence of engineered environments[197]. A number of researchers have shown theoretically and
observed experimentally that the spontaneous emission of an emitter can be inhibited or enhanced
when the emission is inside or outside, respectively, the band gap of a photonic crystal[198, 199].
In the current system, because of the low dielectric contrast between the polystyrene particles and
water, the stop band is not omni-directional and hence the fluorescence emission is not inhibited
completely in all directions in this range of frequencies; there is a fluorescence emission decrease
from the RhB dye in the [111] direction when the particles are in an array as compared to their
disordered state. Additionally, the LDOS influence on the FRET of two emitters remains a debated
question[200, 201, 202, 203, 204]. Recent efforts with sterically-packed colloidal crystals where
donor/acceptor dyes have been infiltrated into the array have demonstrated that a placement of the
pseudo-gap in the emission regime of the donor decreases the emission of the donor and increases
the emission of the acceptor[205]. The suppression of the donor emission and enhancement of the
energy transfer is attributed to a reduction of available modes for radiative decay of the donor in
the photonic crystal relative to the effective homogeneous medium. In the current system, tuning
the stop band within the Napth’s emission spectral region of emitter series n◦ 3 did not result in
any observable enhancements in the emission of RhB, even though there was an emission inhibition
when the stop band coincides with the RhB peak.
The d111 spacing can be estimated from the observed rejection wavelengths with λ◦ =
2nc dhkl sin θ, where λ◦ is the wavelength of the diffracted light in air, dhkl is the interplanar spacing,
nc is the refractive index of the composite, and θ is the Bragg angle. Assuming that nc = 1.368[206],
the observed stop band positions result in a predicted d111 interplanar distance ranging from 152
nm to 262 nm, values similar to previously published results[206]. The nearest neighbor distance
(i.e. primitive lattice parameter and spacing between particles at fractional coordinates 0,0,0 and
p
1/2,0,1/2 of the cubic unit cell) is a = 3/2d111 and ranges from 1.6 to 2.7 times larger than the
nearest neighbor distance based solely on intimate contact of the particles of emitter series n◦ 3.
The surface-to-surface distance of the nearest neighbor particles ranges from 70 nm to 204 nm,
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Figure 3.6: 1931 International Commission on Illumination (CIE) chromaticity diagram with the
x-ray radioluminescence-derived color coordinates of emitter series n◦ 1-3 presented in Figure 3.1.
The CIE coordinates of emitter series n◦ 1-3 define an outer triangle when the particles are disordered
and an inner triangle when they are in an ordered array; see text for details.

significantly larger than the Förster distance between either of the donor/acceptor pairs (ca. 3 nm)
and would obviate any interparticle FRET.
In a similar manner to emitter series n◦ 3, emitter series n◦ 1-2 exhibited a coupling between
the particle’s emission and their observed rejection wavelength. The altered emission spectra with
stop band tuning resulted in a modification of the emissive color characteristics, specifically an
inhibition of the spontaneous emission of the acceptor, Napth in emitter series n◦ 2 and Anth in
emitter series n◦ 1. The variation in the emission for all the emitter series is succinctly presented by
Figure 3.6. In this figure, the 1931 CIE chromaticity diagram with the emissive color characteristics
of the emitter series as disordered particles are presented as well the particles assembled into a CCA.
For the ordered particles, the plotted point represents the maximum change in CIE coordinates when
the rejection wavelength was tuned through the emission spectra of the particles. The coordinates
for the ordered particles inscribes a triangle within the triangle defined by the disordered particles
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and indicates that for all the emitter series, stop band tuning results in a less vibrant emissive color.
For emitter series n◦ 3, the color purity decreased from 0.655 for the disordered particles to 0.214,
indicating that the stop band tuning results in a more washed out emissive color, and this change was
the greatest relative to the other emitter series (cf. Table 3.1). In general, the n◦ 3 particles exhibited
the largest variation in the CIE metrics; the magnitude of the vector joining the CIE coordinates of
the disordered to ordered point on Figure 3.6 for emitter series n◦ 3 was 0.144, approximately twice
the magnitude for emitter series n◦ 2 which was 0.062, as well as emitter series n◦ 1 which was 0.078.
However, the decrease in spontaneous emission in the radioluminescence spectra attributed to the
stop band can be observed when compared to the disordered particles at the same solids content for
both emitter series n◦ 1-2 (cf. Figure 3.7 and 3.8). The stop band could be tuned from 425 nm to
597 nm and from 470 nm to 658 nm for emitter series n◦ 1 and n◦ 2, respectively.
There is also a remarkable difference in color between the CCA versus the randomized
particles when observed at the same solids content. An observable color difference is considered to
be 2 or above. Presented in Figure 3.9) is the color difference (∆ E) plotted against both volume and
rejection wavelength. For all emitter series, ∆ E was the largest when the rejection wavelength was
inside the emission of the Anth, Napth, and RhB for emitter series n◦ 1, n◦ 2, and n◦ 3, respectively,
which lends additional credibility to the claim that the stop band changes the emission characteristics
of the emitter series.

3.3.1

Hydrogel fabrication
While the stop band, and thus XRL and chromaticity, of liquid CCAs are easily manipulated

and tuned to desired properties, they suffer from being quite sensitive to ionic contamination, chemical, and mechanical deformation. Therefore, it is desirable to generate hydrogel stabilized CCAs.
Hydrogel CCAs offer advantages of liquid CCAs as they are more durable, while still maintaining the
ability to manipulate the stop band and color observed. Additionally, hydrogels have applications
as biological devices, such as sensors (cf. Introduction), tissue scaffolds[207, 208, 209, 210], and drug
delivery vehicles[211, 212], as they are upwards of 80 % water and are generally biocompatible.
Emitter series n◦ 3 was transformed into a hydrogel stabilized CCA via photopolymerization of poly(ethylene glycol) methacrylate (cf. Experimental Section). When compared to a non
crystalline hydrogel of the same particle content and polymerization technique, the crystalline hydrogel formed from emitter series n◦ 3 exhibits a decrease in spontaneous emission at the rejection
65

a

ordered crystal with
rejection wavelength
at 638 nm

rejection wavelength
at 638 nm

6000
600

4000
400

3000

reﬂection (a.u.)

disordered crystal

5000

2000
200

1000
0
300

10000

radioluminescence (a.u.)

800

400

500

600

700

wavelength (nm)

b

800

1000
disordered crystal

8000

rejection wavelength
at 538 nm

800

6000
600
4000

ordered crystal with
rejection wavelength
at 538 nm

2000

0
300

400

reﬂection (a.u.)

radioluminescence (a.u)

7000

200

400

500

600

wavelength (nm)

700

800

Figure 3.7: X-ray radioluminescence spectra of isolated emitter series n◦ 2 (gray) and crystalline
emitter series n◦ 2 (blue) with a rejection wavelength of (a) 660 nm or (b) 538 nm; the corresponding
reflection spectrum is also presented (red).
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Figure 3.10: X-ray radioluminescence spectra of a non-crystalline (red) and crystalline (blue) hydrogel made from emitter series n◦ 3. Also noted by the black arrow is the position of the rejection
wavelength of the crystalline hydrogel.

wavelength (ca. 575 nm) exhibited by the hydrogel (cf. Figure 4.3). It can be noted that the peak
at ca. 520 nm is attributed to Napth, 590 nm is RhB, and ca. 410 nm is Anth. The FRET does
not seem to be as complete as in the fully liquid form by virtue of the comparable peak heights and
size of the Napth to the RhB; nevertheless, FRET does occur with the hydrogel under direct x-ray
stimulation, and the rejection wavelength does decrease the spontaneous emission of the dye at the
stop band.

3.4

Conclusion
In summary, the current effort presents a general strategy for the preparation of a fully

organic x-ray radioluminescent colloidal platform that can be tailored to emit anywhere in the visible
spectrum through a judicious choice in donor/acceptor pairing and multiple sequential FRETs. This
is demonstrated with three different types of ca. 100 nm particles that are doped with anthracene as
the scintillating molecule to “pump” subsequent FRET dye pairs that result in emissions from ca.
400 nm out past 700 nm. The particles could be self-assembled in crystalline colloidal arrays and the
radioluminescence of the particles could be dynamically tuned by coupling the observed rejection
wavelength with the dyes’ emission. Due to the particles low potential for toxicity issues in vivo
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relative to other metal-based scintillating nanoparticles, these particles may find applications in the
growing field of x-ray luminescence-based medical imaging.

3.5

Experimental

Materials.

Particle synthesis. Monodisperse cross-linked polystyrene (PS) particles were prepared

using a modified emulsion polymerization procedure[213]. Styrene (TCI America, 99%) was purified
by extraction with an aqueous KOH solution(10% by mass, 3x100mL) followed by washing with
deionized water (DI-water, 18.2 MΩ cm) and drying over sodium sulfate. The washed styrene was
then distilled under vacuum. Where appropriate, anthracene (Anth) (1.5 g, 99%, Alfa Aesar),
2-(3-Azidopropyl)-6-piperidino-2-aza-2H-phenalene-1,3-dione (Napth) (25 mg), and Rhodamine B
(RhB) (25 mg, 99%, Acros Organics) were mixed with purified styrene (30 mL) under heating and
sonication. A standard emulsion apparatus was utilized where DI-water (123 mL) was charged to
the reaction vessel followed by purified styrene (10mL). The mixture was stirred at 370 rpm under a
nitrogen atmosphere. Ten minutes after the initial purge, sodium dodecyl sulfate (0.45 mL, SDS 29%
in water, The Chemistry Store) was added dropwise to the reaction. Divinylbenzene (DVB, 80%
Aldrich, purified by passing through alumina, 0.25 mL) was added dropwise to the flask; then the
temperature was raised to 65 ◦ C. Upon reaching 65 ◦ C, sodium hydrogen phosphate (99%, Fischer,
0.35 g in 2 mL DI-water) and potassium persulfate (99%, Fischer, 0.35 g in 8 mL DI-water) were
added to the reaction vessel dropwise. The temperature was then raised to 70 ◦ C. Upon reaching
70 ◦ C, the dye/styrene mixture (15mL) was added to the flask dropwise followed by the addition of
purified DVB (0.6 mL) dropwise. The rest of the dye/styrene mixture (15 mL) was added dropwise
to the reaction vessel. The reaction was allowed to proceed for 2.5 hours upon which the reaction
was allowed to cool to 37◦ C. The product was filtered via gravity, and the filtrate was purified by
dialysis until conductivity of the bath remained constant. After purification, the product was stored
in Nalgene containers over an excess of mixed bed ion exchange resin Bio-Rad AG-501-X8(D). After
the cleaning procedures, emitter series n◦ 1, n◦ 2, and n◦ 3 particle diameter was measured to be 94.9
nm ± 13.1 nm, 119.7 nm ± 15.6 nm, and 116.4 nm ± 18.0 nm, respectively, (average and standard
deviation) with a Coulter N4Plus dynamic light scatter (DLS). The zeta potential of the particles
was measured with a ZetaPlus zeta potential analyzer (Brookhaven Instruments Corp.) and were
-87.9 mV, -80.3 mV, and -64.8 mV for emitter series n◦ 1, n◦ 2, and n◦ 3, respectively.
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Figure 3.11: Synthetic scheme of azide modified naphthalimide.
	
  
	
  

2-(3-Azidopropyl)-6-piperidino-2-aza-2H-phenalene-1,3-dione synthesis.
	
  

2-(3-Azidopropyl)-

6-piperidino-2-aza-2H-phenalene-1,3-dione
(Napth) was prepared according to a procedure described
	
  
elsewhere[214] (cf. Figure 3.11). Napth was employed in this effort due to its moderately enhanced
water solubility[215] relative to naphthalimide.

Optical imaging.

Optical images were captured using a Canon EOS Rebel T6 camera remotely

triggered. X-ray images were collected at 50 kV and 79 µA using an Amptek Mini-X x-ray unit
equipped with a tungsten target.

Optical and X-ray characterization. X-ray radioluminescence spectra were obtained using a
fiber optic bundle (Oriel) connected to a fiber coupled grating spectrometer (Jobin Yvon MicroHR)
equipped with a CCD detector (Synapse). Reflection spectra were obtained using a bifurcated fiber
optic bundle (Ocean Optics) connected to a fiber coupled spectrometer (Ocean Optics USB2000)
with the output arm attached to the spectrometer and the input arm attached to a white light
source (Ocean Optics LS-1-CAL) with the incident light normal to the sample surface. Absorbance
spectra were obtained using a Perkin-Elmer Lambda 950 UV/VIS/NIR spectrophotometer.

3.5.0.1

Soxhlet extractions
Soxhlet extractions were performed using boiling benzene on emitter series no 1 and no 2 (500

µL each) and boiling toluene on emitter series no 3. The duration of each Soxhlet extraction was 24
hr. After the first flush of the Soxhlet extraction, 1 mL aliquots of the boiling solvent were taken
from the round bottom flask at 1 min, 5 min, 10 min, 15 min, 20 min, 25 min, 30 min, 1 hr, 2 hr,
and 24 hr. After each aliquot was taken, 1 mL of near boiling solvent was added back to the round
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bottom flask. Soxhlet extractions were performed to ensure that the dyes were located inside the
particle. Since all solvents for anthracene and/or the dyes will swell polystyrene, the extractions
were performed over 24 hours to show that it took 24 hours for appreciable amounts of the dyes to
be washed from the particles. This seems to indicate that the dyes are inside the particles until they
are sufficiently swollen to allow for the dyes to diffuse from the swollen particle (cf. Figure 3.12).

3.5.1

Hydrogel preparation
Spacers were made from Parafilm by placing two pieces of parafilm together (1.5 in x 0.5

in) and cutting them with a die (die size: 1.2 cm x 2.0 cm). Total thickness of spacer was 250 µm.
All spacers were stored in deionized water with excess mixed bed ion exchange resin until ready for
use.
Glass slides (Corning, 3 inch x 1 inch x 0.039 mm) were cut in half, washed with soap
and water, and dried with nitrogen. Cut glass slides were placed into piranha solution (made with
96% H2 SO4 and 30% H2 O2 in a 3:1 ratio by volume, respectively) for at least 18 hours. After 18
hours, the glass slides were removed from the piranha solution, washed with water, and dried with
nitrogen. A solution of octadecyltrichlorosilane (OTS) in toluene (30 % by volume) was prepared in
the nitrogen glove box. The prepared solution was then removed from the glove box. The cleaned,
dried glass slides were coated with the OTS solution to transform the surface of the glass from
hydrophilic to hydrophobic. After coating, the glass slides were allowed to dry in air; the OTS
coating was completely dry when the coating went from clear to white. After the OTS coating was
dry, the white film was removed by rubbing it with Kimwipes. Nitrogen was used to remove any
residual Kimwipe fibers to ensure a clean surface. All remaining manipulations were performed in a
laminar flow hood.
Emitter series n◦ 3 (100 µL) was mixed with poly(ethylene glycol) methacrylate (60 µL, MW
360 g/mol), poly(ethylene glycol) dimethacrylate (6 µL, MW 550 g/mol), and 2,2-diethoxyacetophenone
(2 µL). The mixture was mixed via a shaker table at ca. 116 motions/min for approximately 10 hours
or until opalescence was observed. After 10 hours, one spacer was removed from the deionized water
and dried under nitrogen. Then the spacer was placed onto a cleaned, cut glass slide and pressed
firmly to make sure the spacer adhered to the glass slide. The mixture of monomers, initiator,
and CCA (100 µL) was placed in the center of the glass slide with the spacer as one large droplet.
The droplet was left undisturbed for 30-60 seconds. Another glass slide was then placed onto the
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Figure 3.12: Absorbance of a)emitter series n◦
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series n◦ 1 and emitter series n◦ 2) or toluene (emitter series n◦ 3). Photoluminescence was also
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◦
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droplet. Binder clips were applied to either end of the glass cell to seal the cell. The binder clips
were then removed and the cell was placed inside the UV chamber with a rotating dial (Electro-Lite
Corporation ELC-500 Light Exposure System). The cell was irradiated for 2 minutes on each side.
After irradiation, the cell was submerged in DI-water and the flat end of a spatula was inserted
between the glass slide and the top glass slide was removed. The hydrogel was removed from the
glass slide with a razor blade. All hydrogels were stored in deionized water with ion exchange resin.
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Chapter 4

X-ray radioluminescent hydrogel
stabilized crystalline colloidal
arrays
4.1

Attributions
Dr. Yuriy Bandera synthesized and analyzed, via NMR, all fluorophores described in the

following chapter. Haley Jones synthesized the hydrogels from colloids made by Mary Kathryn
Burdette and helped obtain the presented data. All other syntheses and analyses were performed
by Mary Kathryn Burdette with input and advice from Dr. Stephen Foulger. Additionally, the
ideas presented in this chapter are the result of discussions between Mary Kathryn Burdette and
Dr. Stephen Foulger. The results presented in the chapter are reported in the following publication:
M.K. Burdette, H.W. Jones, Y. Bandera, and S.H. Foulger. “X-ray radioluminescent hydrogel
stabilized crystalline colloidal arrays.” Optics Express, in review, 2018, and is reproduced under the
OSA Open Access Publishing Agreement.
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4.2

Introduction
To improve medical diagnostics and therapies, researchers have begun to turn to x-ray

radiation as the primary excitation source over traditional ultraviolet (UV) and visible light as x-ray
radiation has the ability to pass through tissue at much greater penetration depths than UV or
visible light[160, 167]. While traditional x-ray radiography and computed tomography (CT), where
CT requires the use of heavy metal contrast agents to interact with the bombarding x-ray radiation
to generate an image, have been used for decades clinically[161, 169], more sensitive techniques
are needed for early detection, treatment, and prevention of diseases. Currently, x-ray fluorescence
arising from molecules that can absorb ionizing radiation are being used as positive contrast agents
in x-ray luminescence computed tomography (XRCT) to enhance images and generate an elemental
map of the sample upon optical detection[165, 166, 171, 172, 173]. While enhanced imaging based on
x-ray radiation is promising, current contrast agents contain heavy metals (due to their high density
and ability to stop and absorb x-ray radiation), which can be toxic and require chelating agents or
passivation layers to separate the probe from the body[188, 186]. Molecules containing gadolinium,
such as gadolinium oxide[175], gadolinium oxysulfide with various dopants[176], sodium gadolinium
tungstate[177], and alkali metal gadolinium fluorides[163] are especially promising though there
are studies that have shown successful imaging of lanthanum oxysulfide doped with europium or
terbium[176], and doped alkali metal yttrium fluorides[178, 179], but their use is limited due to the
potential for toxicity.
However, fully organic, potentially less toxic[120, 97], x-ray imaging probes that incorporate
organic scintillators have been less studied. This group recently reported fully organic colloids made
from polystyrene that self assembled into crystalline colloidal arrays (CCAs) whose x-ray stimulated
emission ranged the entire visible spectrum utilizing an x-ray active “pump” source and various
Förster Resonance Energy Transfer (FRET) pairs. The luminescence of these crystals could not only
be tuned through FRET pair choice, but also through purely photonic means. The reported organic
colloids were highly luminescent, but only weak polycrystalline hydrogels were achieved. The current
approach focuses on a more versatile system with stilbene as the organic scintillator encapsulated
inside polystyrene-co-poly(propargyl acrylate) (PS-pPA) nanoparticles that formed electrostatically
stabilized CCAs that could be photopolymerized into stable, monolithic crystalline hydrogels, which
are more biologically applicable and mechanically robust than liquid CCAs. The hydrogels could then
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be post-processed through copper(I) catalyzed azide/alkyne cycloaddition (CuCAAC) reactions in
the hydrogel with a variety of azide modified fluorophores to achieve versatile hydrogels with various
emission characteristics.

4.3

Results & Discussion
Stilbene, an organic scintillator, was encapsulated inside polystyrene-co-poly(propargyl acry-

late) (PS-pPA) colloidal particles of size 131.1 nm ± 9.90 nm through a doped emulsion co-polymerization.
The polymerized stilbene/PS-pPA particles were electrostatically self-assembled into a liquid crystalline colloidal array (CCA) with deionized (DI) water as the dispersion media (cf. Figure 4.1,
(a) stilbene/PS-pPA). The stilbene/PS-pPA liquid CCA can be photopolymerized into a hydrogel; upon x-ray irradiation, the hydrogel will emit blue light due to the presence of stilbene (cf.
Figure 4.1, (b) emitter series no 1). As the nanoparticles have free alkynes on their surface (due
to propargyl acrylate and its higher solubility in water when compared to styrene) the hydrogel
can be infiltrated with an azide modified fluorophore(s), such as 2-(3-azidopropyl)-6-(piperidin-1yl)-1H -benzo[de]isoquinoline-1,3(2H )-dione (AzNap), and appropriate catalyst and reducing agent,
such as copper(II) sulfate and sodium ascorbate, which yields a hydrogel with dye covalently attached to the surface of the nanoparticles through a copper(I) catalyzed azide/alkyne cycloaddition
(CuCAAC) reaction. The AzNap fluorophore forms a Förster Resonance Energy Transfer (FRET)
pair with stilbene, so the hydrogel as a whole emits green light upon x-ray irradiation (cf. Figure
4.1,(c) emitter series no 2). Furthermore, covalently attaching both AzNap and N -(9-(2-((2-(2-(2azidoethoxy)ethoxy)ethoxy)carbonyl)phenyl)-6-(diethylamino)9,9a-dihydro-3H -xanthen-3-ylidene-N ethylethanaminium (AzRhod) through CuCAAC reactions shifts the x-ray stimulated emission to
orange as AzRhod is a FRET pair with AzNap (cf. Figure 4.1, (d) emitter series no 3).
Stilbene in its polycrystalline form has two main peaks and two observable shoulders in
its x-ray radioluminescence spectra: the main peak occurs at ca. 461 nm with the secondary peak
occurring at ca. 406 nm and two shoulders appearing at ca. 484 nm and 502 nm (cf. Figure 4.2a).
However, the luminescence of the stilbene/PS-pPA system could be manipulated by moving the
rejection wavelength by adding DI-water to the liquid array. Presented in Figure 4.2b are optical
photographs of the liquid stilbene/PS-pPA CCA under white light (left) and x-ray irradiation (right).
The x-ray emission from stilbene gives the droplet a blue color with the CCA appearing white under
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Figure 4.1: Crystalline colloidal array (CCA) composed of electrostatically assembled polystyreneco-poly(propargyl acrylate) with stilbene encapsulated inside the particle in (a) liquid form and
(b) encapsulated in a methacrylate based hydrogel that emits blue light upon x-ray stimulation
(emitter series no 1). (c) Methacrylate based hydrogel composed of polystyrene-co-poly(propargyl
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white light. However, when approximately half of the CCA was diluted and photographed under
white light and x-ray irradiation as presented in Figure 4.2c, the opalescent edge of the diluted CCA
can clearly be seen under white light (left), while the CCA under x-ray stimulation (right) appears
the same color blue to the left of the opalescent edge (i.e. where the additional deionized (DI) water
did not infiltrate the original CCA), while to the right of the opalescent edge of the CCA (i.e. where
the added DI-water changed the spacing between the nanoparticles) the resulting color is dark blue
because the rejection wavelength has been red shifted such that it inhibits a portion of the x-ray
stimulated emission. As the rejection wavelength moves through the x-ray stimulated emission of
the stilbene, there is a dramatic decrease in the spontaneous emission (cf. Figure 4.2d.1-d.4) at
the corresponding pseudo-band gap, which can be observed spectroscopically[198, 199, 216]. At a
rejection wavelength of 423 nm, the x-ray luminescence of stilbene exhibits a main peak occurring
at 388 nm with a broad peak ranging from ca. 430 nm to 517 nm resulting from the decrease of the
emission around the 423 nm rejection wavelength (cf. Figure 4.2d.1). The dominant wavelength,
calculated using the 1931 International Commission on Illumination (CIE) chromaticity diagram,
was 487 nm, which corresponded to a light blue color. The primary colors (red, green, and blue)
define the 1931 CIE chromaticity space accessible by the additive color approach. The dominant
wavelength for any given color is defined as the wavelength corresponding to a line drawn through
the color point (CIE (x,y) color coordinates), which connects both the color point and the white
point to the edge of the chromaticity diagram. Upon further dilution to yield a rejection wavelength
at 470 nm, the x-ray radioluminescence energy profile of the stilbene/PS-pPA CCA shifts to have a
maximum emission peak at 395 nm with a broad peak centered at ca. 502 nm (cf. Figure 4.2d.2); a
similar x-ray radioluminescence spectrum was obtained with a rejection wavelength of 480 nm with
a 10 nm shift where the decrease of the spontaneous emission occurs (cf. Figure 4.2d.3). However,
once the stop band has moved through the main emission of stilbene, the majority of the x-ray
emission profile of stilbene could be recovered though the emission is still suppressed in the pseudoband gap at 530 nm resulting in a non-Gaussian peak with a peak maximum at 397 nm (cf. Figure
4.2d.4)[195, 196]. The dominant wavelength, of the x-ray radioluminescence spectrum with rejection
wavelength at 530 nm, is 454 nm, which corresponds to a dark blue color. The varying shapes of
the x-ray radioluminescence spectra exhibiting varying pseudo-stop bands and the corresponding
dominant wavelengths confirm the observations from the optical photographs in Figure 4.2b,c.
While the pseudo-stop band, and thus the x-ray radioluminescence spectrum, could easily
79

3500

6000

2500

3000

1

reﬂection

0.8
radioluminescence

1500

4000

500
0
3500
3000

400

500
wavelength (nm)

600

700

0.2
1

(d.2)

2500

0.8

2000

0.6

1500

0.4

1000
500
0
3500

3000

0.2

1

(d.3)

2500

0.8

2000

0.6

1500

0.4

1000
500

0.2

0

(c)

3500
3000

1

(d.4)

2500

0.8

2000

0.6

1500

0.4

1000
500
0
300

0.2
400

500

600

wavelength (nm)

700

Figure 4.2: (a) X-ray radioluminescence spectrum of stilbene in its crystalline powder form. (b) Optical photographs
of stilbene/PS-pPA liquid CCA illuminated under white light (left) and under x-ray irradiation (right). Under x-ray
excitation, the droplet appears a bright blue color while the droplet appears white under white light illumination. (c)
Optical photographs of stilbene/PS-pPA liquid CCA illuminated under white light (left) and under x-ray stimulation
(right). The droplet has been diluted on the right side, and an opalescent line can clearly be seen in the white light
image (left), while the diluted portion of the CCA results in a dark blue color, and the undiluted portion results
in a bright blue color under x-ray irradiation (right). X-ray radioluminescence (blue) and reflection (red) spectra of
stilbene/PS-pPA liquid CCA with rejection wavelength at (d.1) 423 nm, (d.2) 470 nm, (d.3) 480 nm, and (d.4) 530
nm. X-ray irradiation performed with an AmpTek Mini-X x-ray unit equipped with a tungsten target operating at
50 kV and 70 µA.
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be manipulated in liquid form, the liquid CCA is not mechanically stable and the crystal is easily
destroyed without the ability to recover. These sensitivities can be assuaged by polymerizing the liquid CCA into a hydrogel. The liquid stilbene/PS-pPA CCAs were mixed with poly(ethylene glycol)
methacrylate (PEGMA, monomer), poly(ethylene glycol) dimethacrylate (PEGDMA, crosslinker),
and 2,2-diethoxyacetophenone (DEAP, photo-initiator) and were photopolymerized using ultraviolet
light[206]. This resulted in stable hydrogels, emitter series no 1, where the pseudo-stop band could
be tuned through a reversible dehydration/hydration process. Optical photographs revealed a pale,
translucent blue hydrogel under white light (cf. Figure 4.3a), while the hydrogel appears bright blue
under x-ray irradiation (cf. Figure 4.3b). In the x-ray radioluminescence spectra of emitter series
no 1, there is a large shoulder around 410 nm with a broad peak centered around ca. 505 nm, which
is reminiscent of the secondary peak in the liquid stilbene/PS-pPA CCAs. The expected peaks of
stilbene are present in the radioluminescence spectra; however, it appears that the peak at 505 nm
dominates and the 410 nm peak becomes the secondary peak. At a rejection wavelength of 583
nm, which is inside the emission of stilbene, the magnitude of x-ray radioluminescence of emitter
series no 1 is at its minimum (cf. Figure 4.3c). At an intermediate rejection wavelength of 510 nm,
the magnitude of the x-ray luminescence of the hydrogel is greater than that associated with the
483 nm rejection wavelength but less than that associated with the pseudo-band gap at 530 nm (cf.
Figure 4.3d), while the maximum in x-ray radioluminescence for emitter series no 1 is observed at
a rejection wavelength of 530 nm, which is outside the majority of the emission from stilbene (cf.
Figure 4.3e). The coupling of the rejection wavelength to the maximum x-ray induced emission of
the stilbene nanoparticle results in a decrease in the overall x-ray radioluminescence but does not
result in a divot in the spectrum like the liquid CCA because multiple crystals that are slightly
offset from each other are being sampled in the hydrogel while a single crystal is being sampled in
the liquid CCA. While the dominant wavelength varies from only 491 to 495 nm, the color purity
ranges from 0.394 to 0.451 to 0.554 as the rejection wavelength passes through the x-ray stimulated
emission of stilbene[217]. Color purity, under the 1931 CIE chromaticity space, is defined as the
ratio of the distance between (1) the white point (1/3, 1/3) and the color point (i.e. CIE (x,y) color
coordinates) and (2) the dominant wavelength and white point. Colors with high color purities (i.e.
the value approaches 1) appear saturated and monochromatic, while colors with low color purities
(i.e. the value approaches 0) appear pale.
While polymerizing the stilbene/PS-pPA methacrylate-based CCAs mechanically stabilizes
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Figure 4.3: Optical photographs of stilbene/PS-pPA methacrylate-based hydrogels (emitter series no 1) under (a)
white light and (b) x-ray irradiation. X-ray radioluminescence (blue) and reflection (red) spectra of emitter series
no 1 corresponding to reflection wavelength at (c) 483 nm, (d) 510 nm, and (e) 530 nm. X-ray irradiation performed
with an AmpTek Mini-X x-ray unit equipped with a tungsten target operating at 50 kV and 70 µA.
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the CCA, the luminescence of emitter series no 1 is poor. Many organic scintillators emit blue light
poorly, but this potential downfall can be utilized in a FRET system where the chosen fluorophore(s)
is a bright emitter, to not only increase the light output, but to also change the color emitted. To
increase the overall luminescence and manipulate the emitted color, emitter series no 1 was utilized
in CuCAAC reactions. Emitter series no 1 was swollen with AzNap, copper(II) sulfate, and sodium
ascorbate solutions. The CuCAAC reaction occurred in the swollen hydrogel between the free alkyne
functional groups on the surface of the PS-pPA nanoparticles and the azide group on AzNap[218].
After reaction completion, the catalysts and unreacted fluorophores were removed, and emitter series
no 2 appeared a bright yellow color (cf. Figure 4.4a); once emitter series no 2 was bombarded with
x-ray radiation, the hydrogels emit green light (cf. Figure 4.4b). Considering the maximum integral
of the x-ray radioluminescence spectra, which is proportional to power, the luminescence of emitter
series no 2 increases by 92% by adding the AzNap and exploiting FRET when compared to emitter
series no 1. By employing CuCAAC reactions and FRET, the x-ray excited optical luminescence of
a poor emitting hydrogel can be manipulated to become a much brighter system overall by coupling
a poor emitting x-ray excited probe to an x-ray inactive fluorophore.
Additionally, the maximum emission peak of emitter series no 2 has shifted to 534 nm and
540 nm when the pseudo-stop band is at 478 nm and 541 nm, respectively (cf. Figure 4.4c,d). As the
photoluminescence of AzNap occurs at 520 nm (monomeric peak) and at ca. 535 nm (J-aggregate
peak), the maximum emission peak for emitter series no 2 is attributed to the AzNap[219, 220, 221].
FRET, a dipole-dipole energy transfer mechanism, occurs between the stilbene and AzNap since
the emission of stilbene overlaps well with the absorbance of AzNap and the two molecules are
in close proximity. The Förster distance, i.e. the distance at which FRET is 50% efficient, is ca.
2.30 nm. When the rejection wavelength overlaps with the maximum emission of the AzNap (i.e.
530 nm), the x-ray luminescence decreases by 22% as calculated by comparing the integral of the
luminescence curve at each rejection wavelength.[197] It should be noted that AzNap shows far
less emission when excited through x-rays than stilbene, so all x-ray luminescence is attributed to
FRET between stilbene and AzNap. Clearly, the rejection wavelength plays a crucial role in the
amount of light allowed to escape the hydrogel. To obviate the possibility of inter-particle FRET, the
inter-planar spacing (dhkl ) and nearest neighbor spacing (a) was calculated using Bragg diffraction
theory: λ=2dhkl nc sinθ where λ is rejection wavelength, θ is diffraction angle, which is equal to 90o
since the particles arrange in a face centered cubic (FCC) crystal lattice and rejection wavelength
83

35000

(a)

30000

(c)

radioluminescence 1

reﬂection

0.8

20000

0.6

15000

0.4

10000

0.2

5000
0
35000
30000

0
1

(d)

0.8

25000
20000

0.6

15000

0.4

10000

0.2

5000
0
300

reflection (a.u.)

(b)

radioluminescence (counts)

25000

400

500

wavelength (nm)

600

0
700

Figure 4.4: Optical photographs of stilbene/PS-pPA methacrylate-based hydrogels functionalized with AzNap
(emitter series no 2) through a CuAAC reaction in the hydrogel under (a) white light and (b) x-ray irradiation. X-ray
radioluminescence (blue) and reflection (red) spectra of emitter series no 2 at rejection wavelength corresponding to (c)
478 nm and (d) 541 nm. X-ray irradiation performed with an AmpTek Mini-X x-ray unit equipped with a tungsten
target operating at 50 kV and 70 µA.

was sampled normal to the CCA, the plane of interest is (111), and nc , the refractive index of the
composite, is 1.363[206]. Given those parameters, the d111 spacing ranges from 174.7 nm to 193.7
p
nm, while the nearest neighbor spacing (a= 3/2dhkl ) ranges from 214.0 nm to 237.2 nm, which is
clearly more than the Förster distance (2.30 nm).
To further manipulate the color emitted, emitter series no 1 was modified with both AzNap
and AzRhod through CuCAAC reactions in the hydrogel (emitter series no 3). Due to the broadness
of the x-ray radioluminescence spectrum of stilbene, AzRhod does form a FRET pair with stilbene,
but the Förster distance is small, 2.07 nm, which indicates that AzRhod and stilbene do not form
as strong of a FRET pair as AzRhod and AzNap as the Förster distance between these fluorophores
is 3.62 nm, which indicates that most of the FRET arises from the AzNap/AzRhod transition.
Similarly to AzNap, AzRhod also shows almost no x-ray induced luminescence. In this way, all
emission is due to the x-ray stimulation of stilbene which transfers a small amount of energy directly
to AzRhod with most of its energy being transferred to AzNap, which, in turn, transfers its energy to
AzRhod (cf. Figure 4.1, (d) emitter series no 3). While emitter series no 3 is red under white light (cf.
Figure 4.5a), the hydrogel emits orange light upon x-ray irradiation (cf. Figure 4.5b). As observed
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with both emitter series no 1 and no 2, as the rejection wavelength approaches the emission of the
main emitter, the x-ray radioluminescence is significantly decreased. At a pseudo-stop band of 490
nm, the total emission is 74% greater than when the rejection wavelength is at 532 nm[197]. At a
rejection wavelength of 490 nm only a small portion of the x-ray emission of stilbene is suppressed;
therefore most of the energy of stilbene is still transferred to the AzNap and the AzRhod (cf. Figure
4.5c), yielding a maximum peak of 605 nm, which is indicative of the aggregate peak of AzRhod,
while the monomeric peak occurs at 585 nm[222, 223, 224]. While the 532 nm rejection wavelength is
mostly outside of the emission of AzRhod, the pseudo-band gap covers the majority of the emission
of AzNap. By suppressing the emission of AzNap, the energy transferred to the AzNap by the
stilbene is quenched due to the smaller local density of optical states; thus, the emission from
AzRhod is not fully activated (cf. Figure 4.5d), resulting in an overall decrease in emitted light[205]
though the exact mechanism of multiple FRETs in a photonic crystal remains a highly debated
question[200, 201, 202, 203, 204]. Emitter series no 3 emits orange with dominant wavelengths at 606
and 601 nm for rejection wavelengths of 532 nm and 490 nm, respectively with a high color purity
of 0.97 or greater as calculated using the 1931 CIE color space. As observed with emitter series
no 2, the possibility of inter-particle FRET does not exist for emitter series no 3 as the d111 spacing
ranges from 179.1 nm to 194.4 nm, and the nearest neighbor spacing ranges from 219.3 nm to 238.1
nm. Nonetheless, when comparing the integrals of the x-ray radioluminescence spectra at their
maximum, emitter series no 3 is 90% more luminescent than emitter series no 1, which demonstrates
that the x-ray radioluminescence can be greatly increased from emitter series no 1 even with multiple
FRETs. By utilizing stilbene as the x-ray active “pump” source and coupling it to a variety of
fluorophore combinations, CCA hydrogels could be made to emit blue light (emitter series no 1),
green light (emitter series no 2), and orange light (emitter series no 3).

4.4

Conclusion
X-ray imaging is becoming increasingly used as a diagnostic and treatment tool for a variety

of diseases as x-ray radiation more easily penetrates tissues when compared to visible or ultraviolet
light. The current effort presents fully organic, emission tunable hydrogels composed of water
dispersed electrostatically self-assembled polystyrene-co-poly(propargyl acrylate) nanoparticles in
which stilbene, an organic scintillator, has been encapsulated. Due to the alkyne groups on the
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Figure 4.5: Optical photographs of stilbene/PS-pPA methacrylate-based hydrogels functionalized with AzNap and
AzRhod (emitter series no 3) through CuAAC reactions in the hydrogel under (a) white light and (b) x-ray irradiation.
X-ray radioluminescence (blue) and reflection (red) spectra of emitter series no 3 corresponding to rejection wavelength
at (c) 490 nm and (d) 532 nm. X-ray irradiation performed with an AmpTek Mini-X x-ray unit equipped with a
tungsten target operating at 50 kV and 70 µA.

surface of the nanoparticle, the methacrylate based hydrogels can be swollen with a single or multiple
azide modified fluorophores and appropriate CuCAAC catalyst and reducing agent to covalently
attach the fluorophore(s) to the nanoparticle while already assembled into a hydrogel. Stilbene
serves to absorb x-ray radiation, which it converts to visible blue light. However, the amount of
light and the color of light can be manipulated through fluorophore(s) that FRET with one another.
In this way, the emission of the hydrogel can be heavily tuned and used in x-ray based imaging
technologies without the need for traditional toxic, heavy metal based imaging agents.

4.5
4.5.1

Experimental
Reagents and solvents
All reagents were purchased from commercial suppliers, such as Aldrich or Alfa Aesar. All

solvents used for reactions were distilled under nitrogen after drying over an appropriate drying
reagent. All other commercial reagents were used without further purification unless otherwise
stated. Deionized water was obtained from a Nanopure System and exhibited a resistivity of ca.
1018 Ohm−1 cm−1 . Analytical thin-layer chromatography was performed on glass plates coated with
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0.25-mm 230-400 mesh silica gel containing a fluorescent indicator. Column chromatography was
performed using silica gel (spherical neutral, particle size 63-210 µm). All monomers used in the
synthesis of hydrogels were mixed with mixed bed ion exchange resin (IER, BioRad Laboratories,
AG 501-X8 Resin, 20-50 mesh) for at least 24 hours prior to use.

4.5.2

Preparation of glass cells
Glass slides (Corning, 3 in x 1 in x 0.039 in) were cut in half, washed with soap and DI-

water, and dried under nitrogen. The dried, cut glass was cleaned using freshly made Piranha
solution (concentrated sulfuric acid:hydrogen peroxide, 3:1 by volume) for 24 hours. Then the
glass slides were washed with DI-water and dried under nitrogen and set aside. A solution of
octadecyltrichlorosilane (OTS) in toluene (30% by volume) was prepared in the nitrogen glove box.
The solution was taken from the glove box and the glass slides were coated with it to change the
surface of the glass from hydrophilic to hydrophobic. The coated slides were allowed to completely
dry. The white film that coated the slides was removed by friction. All glass slides were exposed
to nitrogen prior to use. Spacers were made by cutting a 2 x 1 cm section, using a die, from 2
adhered sheets of Parafilm R for a total film thickness of 250 µm. Spacers were stored in DI-water
with excess IER until needed. Glass cells were assembled by pressing the spacer onto one glass slide.
The CCA (60 µL) mixed with all monomers and initiator was placed in the center of the glass slide.
Another glass slide was slowly placed on top of the glass slide with spacer.

4.5.3

Chemical characterization methods
1

H NMR spectra were recorded on a JEOL ECX300 spectrometer. Chemical shifts for

protons are reported in parts per million downfield from tetramethylsilane and are referenced to
residual protium in the NMR solvent (CDCl3 : δ 7.26 ppm).

4.5.4

Syntheses

Synthesis of 6-(piperidin-1-yl)-1H -benzo[de]isoquinoline-1,3(2H )- dione (1)

6-(piperidin-

1-yl)-1H -benzo[de]isoquinoline-1,3(2H )-dione was synthesized according to a previously reported
method[220].
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Figure 4.6: Synthetic scheme to yield 2-(3-azidopropyl)-6-(piperidin-1-yl)-1H -benzo[de]isoquinoline-1,3(2H )-dione
(AzNap).

Synthesis of 1-azido-3-iodopropane (2)

1-azido-3-iodopropane was synthesized according to

an established method[214].

2-(3-azidopropyl)-6-(piperidin-1-yl)-1H -benzo[de]isoquinoline-1,3(2H )- dione (AzNap)
6-(Piperidin-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (1) (0.3 g, 1.07 mmol), potassium carbonate (0.3 g, 2.17 mmol), and 1-azido-3-iodopropane (2) (0.249 g, 1.18 mmol) were mixed with dry
DMF (5 ml). The obtained mixture was stirred at 80o C for 4 hours. After cooling, the mixture was
quenched with deionized water and was left overnight for crystallization. The solid was decanted
and extracted with dichloromethane. The solution was dried with Na2 SO4 and filtered. The filtrate
was evaporated under reduced pressure, and the residue was re-crystallized from hexane (cf. Figure
4.6). Yield 0.25 g, 64%, m.p = 87 o C. 1 H (CDCl3 ): δ 1.73 (m, 2H, J = 5.5 Hz), 1.88 (m, 4H, J =
5.5 Hz), 2.04 (m, 2H, J = 6.9 Hz), 3.23 (t, 4H, J = 5.5 Hz), 3.42 (t, 2H, J = 6.9 Hz), 4.27 (t, 2H,
J = 6.9 Hz), 7.17 (d, 1H, J = 8.3 Hz), 7.67 (m, 1H, J = 7.2 Hz), 8.39 (m, 1H, J = 7.2 Hz, J = 1.4
Hz), 8.49 (d, 1H, J = 8.3 Hz), 8.56 (m, 1H, J = 7.2 Hz, J = 1.4 Hz).

Synthesis of N -(9-(2-(chlorocarbonyl)phenyl)-6-(diethylamino)-9,9a- dihydro-3H -xanthen3-ylidene)-N -ethylethanaminium (3)

N -(9-(2-(chlorocarbonyl)phenyl)-6-(diethylamino)-9,9a-

dihydro-3H -xanthen-3-ylidene)-N -ethylethanaminium was synthesized according to a previously reported method[225].
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Figure 4.7:

Synthetic scheme to yield N -(9-(2-((2-(2-(2-azidoethoxy)ethoxy)ethoxy)carbonyl)phenyl)-6(diethylamino)9,9a-dihydro-3H -xanthen-3-ylidene-N -ethylethanaminium (AzRhod).

Synthesis of 2-[2-(2-Azidoethoxy)ethoxy]ethanol) (4) 2-[2-(2-Azidoethoxy)ethoxy]ethanol)
was synthesized by the method described in literature[226].

Synthesis of N -(9-(2-((2-(2-(2-azidoethoxy)ethoxy)ethoxy)carbonyl) phenyl)-6-(diethylamino)9,9adihydro-3H -xanthen-3-ylidene-N - ethylethanaminium (AzRhod) Compound (3) (0.41g,
0.82 mmol) was dissolved in dry dichloromethane (10ml). Then compound 4 (0.173g, 0.99 mmol)
was added into solution. The obtained solution was stirred and cooled to 0 o C. Triethylamine (0.166g,
1.64 mmol) was added dropwise into solution. The mixture was stirred at room temperature for
24 hours. After 24 hours, the reaction was quenched with water. The organic layer was separated,
dried with Na2 SO4 , filtered, and evaporated under reduced pressure. The residue was dissolved in
dichloromethane (0.5ml), and the crude product was precipitated by the addition of diethyl ether
(10ml). The mixture was then separated by centrifuging. The product obtained was a deep red
oil and was purified by column chromatography on silica with an eluent of dichloromethane:acetone
(5:1) to wash out impurities followed by an eluent of dichloromethane:methanol (10:1) to recover
the desired product (cf. Figure 4.7). Rf =0.2. Yield 0.34g (69%), dark-red oil.

1

H NMR (CDCl3 )

δ 1.32 (t, 12H, J =7.2 Hz), 3.35 (m, 2H, J =4.8 Hz), 3.55-3.70 (m, 16H), 4.17 (m, 2H, J =4.5 Hz),
6.82 (d, 2H, J =2.4 Hz), 6.90 (d.d, 2H, J =9.3 Hz, J =2.4 Hz), 7.06 (d, 2H, J =9.3 Hz), 7.28 (m,
1H, J =7.6 Hz), 7.70-7.84 (m, 2H, J =7.6 Hz, J =1.4 Hz), 8.33 (m, 1H, J =7.6 Hz, J =1.4 Hz).

13

C

NMR (CDCl3 ) δ 12.74, 46.22, 50.75, 64.77, 68.86, 70.16, 70.57, 70.65, 96.41, 113.64, 114.27, 129.76,
130.28, 130.49, 131.43, 131.65, 133.29, 133.78, 155.62, 157.87, 165.03. ESI+ Mass (m/z): calc. for
C34 H42 N5 O5 , 600.3; found, 600.5.
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Synthesis of stilbene/polystyrene-co-poly(propargyl) acrylate nanoparticles

Polystyrene-

co-poly(propargyl acrylate) with stilbene doped inside the nanoparticles were synthesized using a
standard free radical emulsion polymerization[213]. Styrene monomer was purified from the inhibitor
by extracting with an aqueous KOH solution (10% by volume, 3×100 mL) followed by washing with
deionized water (DI-water, 3×100 mL). The styrene was dried over Na2 SO4 and distilled under vacuum. Stilbene (1.5 g, 8.32 mmol) was dissolved in purified styrene (30 mL, 261.83 mmol) with heat
and sonication. DI-water (120 mL) was added to 4 neck round bottom flask equipped with a mechanical stirrer and thermocouple. A nitrogen purge was started with the purge gas below the solution
level. Purified styrene (10 mL, 87.28 mmol) was injected into the reaction flask while stirring the
DI-water at 370 rpm. Propargyl acrylate (0.91 mL, 8.24 mmol), purified by passing through basic
alumina, was injected into the flask. After 5 minutes, sodium lauryl sulfate (0.35 mL, 29% by mass
in DI-water) was injected dropwise into the reaction vessel and was allowed to mix for 5 minutes.
Then divinylbenzene (0.25 mL, 1.76 mmol) was added to the flask dropwise. The reaction vessel
was heated to 65o C. Once the vessel reached temperature, a solution of sodium hydrogen phosphate
(0.35 g, 2.47 mmol, dissolved in 2 mL DI-water) and a solution of potassium persulfate (0.35 g, 1.29
mmol, dissolved in 8 mL of DI-water) were added dropwise to the reaction flask. The purge gas was
moved above the solution level to keep a blanket of nitrogen over the reaction. The temperature of
the reaction was increased to 70o C. Purified propargyl acrylate (2.75 mL, 24.9 mmol) was added to
the stilbene/polystyrene solution. Once the reaction reached temperature, the stilbene/propargyl
acrylate/styrene solution (16.375 mL) was added to the reaction vessel dropwise. Next, divinylbenzene (0.6 mL, 4.212 mmol) was injected into the vessel dropwise. The remaining stilbene/propargyl
acrylate/styrene solution (16.375 mL) was added to the 4-neck flask. The reaction was allowed to
proceed for 2.5 hours. After 2.5 hours, the reaction was allowed to cool to ca. 37o C, and the product
was gravity filtered. The filtrate was placed into dialysis bags (50,000 MWCO) and was dialyzed
against DI-water until the conductivity of the bath remained constant. The dialyzed product was
stored in Nalgene containers with IER. After two days of storage with IER, the zeta potential, as
measured with a ZetaPlus zeta potential analyzer (Brookhaven Instruments Corp.), of the colloid
was -74.22 mV. The particle size was 131.1 nm ± 9.90 nm as measured by dynamic light scattering
(DLS, Coulter N4Plus dynamic light scatter).
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Synthesis of emitter series no 1 To increase the solids concentration of stilbene/PS-pPA colloids,
the colloids (1.5 mL) were centrifuged at 21,100 g for 20 min three times. After each centrifuge,
a small layer of the supernatant (ca. 200 µL) that was no longer luminescent was removed. The
colloids (150µL) were mixed with poly(ethylene glycol) methacrylate (60 µL), poly(ethylene glycol)
dimethacrylate (6 µL), and IER; the mix was placed on a shaker table at ca. 116 motions/min for
approximately 24 hours. After 24 hours, the photo-initiator, 2,2-diethoxyacetophenone (4 µL), was
added to the mix, and the mix was shaken for an additional 15 min. Glass cells were made as
described above. After assembly, the glass cell was photopolymerized using an UV oven (ELC-500
Light Exposure System, Electro-Lite Corporation) for 1 min on each side of the cell, alternating
sides, for a total of 6 minutes. After photopolymerization, the glass cell was submerged in DI-water,
and the top glass slide was removed along with the spacer. The polymerized hydrogel (emitter series
no 1) was removed and stored in DI-water.
Synthesis of emitter series no 2 Emitter series no 2 was synthesized using CuAAC. Emitter
series no 1 was swollen with solutions of AzNap (12 mM), sodium ascorbate (58 mM), and copper(II)
sulfate (23.4 mM) in DI-water:tetrahydrofuran (2:1). The swollen gel in excess solution was shaken
at 49 motions/min using a shaker table for 2 hours. After 2 hours, the hydrogel was removed and
placed in a fresh solution of DI-water with 4% tetrahydrofuran (THF). The solution was changed
until no AzNap was in the supernatant as detected by UV/vis. At this point, the hydrogel was
considered cleaned of any non-covalently attached fluorophore.
Synthesis of emitter series no 3 Emitter series no 3 was synthesized using CuAAC. Emitter series
no 1 was swollen with solutions of AzNap (4.67 mM), AzRhod (2.83 mM), sodium ascorbate (36 mM),
and copper(II) sulfate (14 mM) in DI-water:tetrahydrofuran (2:1). The swollen gel in excess solution
was shaken at 49 motions/min using a shaker table for 2 hours. After 2 hours, the hydrogel was
removed and placed in a fresh solution of DI-water with 4% tetrahydrofuran (THF). The solution
was changed until no AzNap and AzRhod was in the supernatant as detected by UV/vis. At this
point, the hydrogel was considered cleaned of any non-covalently attached fluorophore.
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4.5.5

Optical and x-ray radioluminescence characterization methods.
Absorbance spectra were obtained using a Perkin Elmer Lambda 950 spectrophotometer.

X-ray radioluminescence spectra were collected by irradiating the sample with a mini X-ray tube
(Amptek Inc., MA, USA), equipped with a tungsten target operating at a tube voltage of 50 kV and
a tube current of 79 µA. The radioluminescence was collected with a fiber bundle (Oriel) coupled
to a MicroHR (Horiba Jobin Yvon) monochromator and a cooled CCD detector (Synapse, Horiba
Jobin Yvon). The signal was collected on a grating with 600 line mm−1 and a blaze of 500 nm. The
spectra was analyzed with SynerJY (Horiba Jobin Yvon) software. The exposure time varied from
20-60 sec based on the luminescence of the liquid CCA or hydrogel.
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Chapter 5

Organic fluorophore coated
polycrystalline ceramic LSO:Ce
scintillators for x-ray bioimaging
5.1

Attributions
Dr. Stephen Foulger pioneered the ideas presented in this chapter with his National Science

Foundation (OIA-1632881) grant. Dr. Yuriy Bandera synthesized and analyzed, through NMR,
all fluorophores described in the following chapter. Dr. Aundrea Bartley, Kelli Cannon, Dr. Mark
Bolding, and Dr. Lynn Dobrunz at University of Alabama Birmingham performed the TUNEL
assay, neuronal analyses with LSO/AlNap, and confocal imaging. Ashley Dickey and Isabell Foulger
performed MTS assays and cultured a variety of healthy (i.e. non-cancerous) human cells with
the supervision of Cassie Gregory. Dr. Jeremy Day and Nancy Gallus of University of Alabama
Birmingham cultured rat primary neuron cells. All other syntheses and analyses were performed
by Mary Kathryn Burdette. The results in this chapter are presented in the following publication:
reprinted with permission from M.K. Burdette, Y. Bandera, E. Zhang, A. Trofimov, A. Dickey,
I. Foulger, J. Kolis, K.E. Cannon, A.F. Bartley, L.E. Dobrunz, M.S. Bolding, L. McMahon, and
S.H. Foulger. “Organic fluorophore coated polycrystalline ceramic LSO:Ce scintillators for x-ray
bioimaging.” Langmuir, in review, 2018. Copyright 2018 American Chemical Society.
93

5.2

Introduction
X-ray radiation is able to penetrate deeper into tissues than ultraviolet/visible light, which

makes the use of x-rays for bio-imaging and theranostic applications attractive[160]. Traditional uses
of x-ray stimulation in bio-imaging include x-ray projection imaging and computed tomography[161,
169]. More recently x-ray radiation has been utilized in advanced x-ray fluorescence computed
tomography (XRCT)[171], which utilizes positive contrast imaging agents to produce elemental
maps of the tissue, and x-ray luminescence computed tomography (XLCT) that relies on the x-ray
excitation and subsequent optical detection of the imaging agent[89, 162, 163, 164]. These imaging
agents employ molecules containing high atomic number elements due to their ability to absorb x-rays
and downconvert the energy (i.e. scintillators). Once the scintillator is irradiated with high energy
photons (such as those that come from x-ray or γ-ray radiation), electrons are promoted from the
valence band to the conduction band, which leave behind holes in the valence band. The electron-hole
pairs either travel through the conduction band until they reach the luminescent center or they get
trapped in the conduction band by defects in the material. Trapped electron-hole pairs are omitted
from the scintillation process and do not generate any light. The electron-hole pairs that reach
the luminescent centers recombine and transfer their energy to the active center, which then emits
visible light[227, 83, 84, 85, 86] For example, successful nanoparticle x-ray imaging agents include
gadolinium containing compounds, such as gadolinium oxide[175], gadolinium oxysulfide doped with
europium or terbium[176], sodium gadolinium tungstate[177], and alkali metal gadolinium fluorides
doped with europium[163]. Additional imaging agents that have been recently utilized for x-ray
radiation induced bio-imaging include lanthanum oxysulfide doped with europium or terbium[176]
and alkali metal yttrium fluorides doped with both ytterbium and erbium[178] or gadolinium[179].
While changing the phosphor to suit various emission needs is an option, many scintillators
are hygroscopic, meaning that they lose their scintillation properties upon being in a water-rich
environment[228, 229, 230]. Therefore, these compounds are not suitable for use as bio-imaging
agents. While recent investigations into color-tuning of perovskite nanocrystals based on counter
ion type and concentration have shown promise, these materials may induce toxicity as there is no
shielding of these particles from their environment[174]. It would be desirable to use a bright, nonhygroscopic scintillating particle whose emission can be tuned by attaching an organic fluorophore,
or multiple fluorophores, with various emission characteristics; however, these materials systems have
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not been studied in depth[231, 232, 233]. To this end, we demostrate that a lutetium oxyorthosilicate
doped with cerium (Lu2 SiO5 :Ce, LSO:Ce) particle can be coated with a single fluorophore or multiple
fluorophores and generate an effective energy transfer between the dye and core when excited through
X-ray radiation. Furthermore, we show that the fluorophore coated LSO:Ce particles could be
directly imaged with x-rays after incubation with rat cortical neurons. The particles as bare LSO:Ce
or single fluorophore coated LSO:Ce were shown to be non-cytotoxic to normal human dermal
fibroblast cells and rat cortical neurons, respectively. These fluorophore coated LSO:Ce particulates
are promising candidates for applications as x-ray excited optical luminescence imaging agents.

5.3

Results & Discussion
In the current effort, ca. 800 nm commercial lutetium oxyorthosilicate doped with cerium

(LSO:Ce) phosphors containing 1-10 at% cerium, as specified by the manufacturer, were surface
modified through organometallic chemistry with a silane linker (cf. Figure 5.1a, emitter series
no 1) to enable subsequent copper (I) catalyzed azide/alkyne cycloaddition (CuAAC) reactions.
Through CuAAC reactions between emitter series no 1 and 6-piperidin-1-yl-2-prop-2-yn-1-yl-1H benzo[de]isoquinoline-1,3-(2H )-dione (cf. Figure 5.1b, emitter series no 2) and N -(6-diethylamino)9-{2-[(prop-2-yn-1-yloxy)carbonyl]phenyl}-3H -xanthen-3-ylidene)-N -ethylethanaminium (cf. Figure
5.1c, emitter series no 3), the x-ray radioluminescence of LSO:Ce could be transformed from its normal blue emission (cf. Figure 5.1d) to have elements of green (cf. Figure 5.1e, emitter series no 2)
and red (cf. Figure 5.1f, emitter series no 3) in the x-ray radioluminescence spectra through Förster
resonance energy transfer (FRET).

5.3.1

Surface modification of LSO:Ce
Polycrystalline ceramic LSO:Ce contains lutetium, silicon, oxygen, and a small percentage

of doped cerium atoms that occupy lutetium sites. The LSO:Ce particles are modified by attaching
an organometallic linker with an azide group on one end ((3-azidopropyl)(trimethoxy)silane) to
the particle via a base catalyzed hydrolysis reaction in the presence of ammonium hydroxide in
a methanol solution. Upon a basic aqueous environment the methoxy groups on the end of the
linker hydrolyze to alcohol groups, which readily react with the surface of the LSO:Ce particle by
forming Si-O-Si bonds (cf. Figure 5.1a, emitter series no 1)[234, 235]. At the completion of the
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Figure 5.1: (a) Lutetium oxyorthosilicate doped with cerium (LSO:Ce) particles of median size ca. 800 nm surface
modified with 3-azidopropyl)(trimethoxy)silane (emitter series no 1), which emit blue when excited with x-rays. (b)
Emitter series no 1 surface modified with 6-piperidin-1-yl-2-prop-2-yn-1-yl-1H -benzo[de]isoquinoline-1,3-(2H )-dione
(AlNap) with a CuAAC transformation (emitter series no 2); emitter series no 2 emits green upon x-ray irradiation. (c)
Emitter series no 1 surface modified with AlNap and N -(6-diethylamino)-9-{2-[(prop-2-yn-1-yloxy)carbonyl]phenyl}3H -xanthen-3-ylidene)-N -ethylethanaminium (AlRhod) with multiple CuAAC reactions; emitter series no 3 emits
elements of red, green, and blue upon X-ray irradiation. X-ray radioluminescence spectra of (d) emitter series no 1,
(e) emitter series no 2, and (f ) emitter series no 3. X-ray radioluminescence spectra obtained with an AmpTek Mini-X
equipped with a silver target operating at 50 kV and 79µA.
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reaction, the product was put through a vigorous washing (through centrifugation) purification
process with a good solvent for the silane linker to remove any unattached linker. While surfaces of
larger particles are less energetic, longer reaction times do result in modification; Fourier transform
infrared spectroscopy (FTIR) confirmed attachment of the azide linker as indicated by the peak
at 2100 cm−1 , which is related to the stretching of the N=N (cf. Appendix D). In this way, azide
modified LSO:Ce (azLSO:Ce) particles are able to undergo a variety of CuAAC reactions, where
a variety of fluorescent tags, proteins, and targeting moieties could be covalently attached to the
particles to enhance their utility in bioimaging or other therapies[236]. Therefore, non-hygroscopic
LSO:Ce can easily be surface modified via facile reactions to exhibit emissions that cover the visible
spectrum. In addition to the surface modifications described here, see Appendix E.

5.3.2

X-ray radioluminescence of fluorophore modified LSO:Ce
Upon x-ray irradiation, the cerium dopant in the LSO crystal structure causes LSO:Ce

to emit in the blue portion of the visible spectrum. X-ray radioluminescence spectrum of the as
received, commercial LSO:Ce particles (size 2-4 µm) were deconvoluted into three peaks at 396 nm
(3.13 eV), 428 nm (2.90 eV), and 498 nm (2.49 eV) (cf. Figure 5.2). Ce3+ resides in two distinct
crystallographic sites with the first site (Ce1 site) being the 6-oxygen-coordinated site and the second
site (Ce2 site) being the 7-oxygen-coordinated site, where the Ce1 site is the dominant site in xray radioluminescence[237]. Particles of 2-4 µm are too large to be successful bioimaging agents;
therefore, the as received particles were ball milled in ethanol to achieve a median particle size of
800 nm, which is a more viable size for bioimaging agents (cf. Figure 5.3). Three SEM micrographs
at varying magnifications are presented to show detail of the particles post-ball milling. The ball
milled ca. 800 nm LSO:Ce particles were used in all further processes.
In emitter series no 1, the deconvolution of the x-ray radioluminescence spectrum revealed 2
peaks at 397 nm (3.12 eV) and 428 nm (2.90 eV) resulting from the Ce1 site. In each crystallographic
site there are two 4f ground states (2 F5/2 (emission at higher energy) and 2 F7/2 (emission at lower
energy)) due to spin orbit coupling[238, 239, 240]. There is a shoulder at ca. 498 nm (2.48 eV)
resulting from the combination of both 4f states in the Ce2 site (cf. Figure 5.4a), which agrees
well with the energy profile for commercially available LSO:Ce polycrystalline ceramics. The slight
difference in the shape of the energy profile and shifted deconvoluted peaks, when compared to
commercial LSO:Ce, can be due to the surface modification of emitter series no 1 since the emission
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Figure 5.2: Deconvolution of the x-ray radioluminescence spectrum of commercial, as received LSO:Ce particles
(2-4 µm). Deconvolutions revealed peaks at 498 nm (pink, attributed to the Ce2 site), 428 nm, and 396 nm (green
and purple, respectively, both attributed to the Ce1 site). X-ray radioluminescence spectra obtained with an AmpTek
Mini-X equipped with a silver target operating at 50 kV and 79µA.

of Ce3+ is greatly influenced by its environment due to the unshielded 4f → 5d transition[241]. While
the Ce3+ on the inside of the particle would not be influenced by the silane linker on the surface, the
Ce3+ close to the surface of the particle may feel the effects of the ligand, leading to a slight shift in
the energy profile. Additionally, the overall size of emitter series no 1 is smaller when compared to
commercial LSO:Ce, which can influence the energy profile[242, 243] though clearly none of these
modifications had a great influence on the x-ray radioluminescent emission characteristics of LSO:Ce.
The emission of emitter series no 1 could be tuned via judicious choice of Förster Resonance Energy
Transfer (FRET) pairs. By utilizing LSO:Ce as the x-ray excited “pump” source for other non-xray
active fluorophores, the emission of the particles could be tuned to range the entire visible spectrum
on the basis of a blue emitter.
6-piperidin-1-yl-2-prop-2-yn-1-yl-1H -benzo[de]isoquinoline-1,3-(2H )-dione (AlNap), when covalently attached to the surface of emitter series no 1, forms a FRET pair with LSO:Ce (cf. Figure
5.1b, emitter series no 2), causing an x-ray emission shift from blue (dominate peak at ca. 420 nm)
to green (dominant peak at ca. 525 nm) (cf. Figure 5.1e). It is clear from the deconvoluted radio-

98

3.6

(a)

(b)

(c)

3 µm
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Figure 5.3: Scanning electron micrographs (SEM) of LSO:Ce particles (median size 800 nm) at a magnification of
(a) 9,000 (scale bar 3.00 µm), (b) 12,000 (scale bar 4.00 µm), and (c) 15,000 (scale bar 5.00 µm). Images were taken
at 15 kV and 10 µA.

luminescence spectrum of emitter series no 2 that a significant portion of the energy from LSO:Ce
has been transferred to AlNap as indicated by the appearance of the peaks at ca. 525 nm (2.36
eV) and 534 nm (2.32 eV), which are attributed to the monomeric and J-aggregate peaks, respectively, of AlNap as these peaks coincide well with the peaks observed in the photoluminescence
spectrum of AlNap[219, 220, 221]. The Förster distance (i.e. the distance at which FRET is 50%
efficient) between LSO:Ce and AlNap is ca. 2.98 nm when 0.30 is used as the quantum efficiency
of LSO:Ce[244]; it should be noted that energy contributing to FRET is only considered from the
surface of the LSO:Ce core. With this in mind, modeling AlNap as a sphere of diameter 1.4 nm,
which is the fully extended length of the dye, 0.405 nm3 are directly in contact with the surface of
the LSO:Ce particle, which is indicates FRET is a possibility. Furthermore, the volume of the sphere
representative of the dye is 1.44 nm3 , and, if we look at Förster distance as a volume, which is 9 nm3 ,
the Förster “volume” is 6.27 times larger than the volume of the fluorophore. While the existence of
photon emission and photon re-absorbance cannot be completely obviated, there is strong evidence
to suggest that FRET is a viable energy transfer mechanism. This type of behavior is expected for
all systems reported.
The deconvolution of emitter series no 2 revealed only one LSO:Ce peak at 413 nm (3.00
eV); this is likely a combination of the peaks at 397 nm (3.12 eV) and 428 nm (2.90 eV) found in the
spectrum of emitter series no 1 as 413 nm (3.00 eV) is the average of these two peaks (cf. Figure 5.4b)
as these two peaks could not be individually deconvoluted reliably. Additionally, the band relating
to the Ce2 site could not be deconvoluted as it overlaps heavily with the strong AlNap bands; efforts
to introduce additional peaks in the deconvolution of the spectrum in Figure 5.4b does not provide
changes in the fitting curve, as the fitting software attempted to minimize the influence of those
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peaks. This can indicate that some of the peaks present in Figure 5.4a could merge together or be
suppressed in Figure 5.4b due to the introduced energy transfers caused by AlNap. Based on the ratio
of the integral of the AlNap component of the x-ray radioluminescence spectrum to the total integral
of the spectrum the dye component is responsible for 78% of the total spectrum suggesting that
energy transfer is efficient. In emitter series no 3 (cf. Figure 5.1c), LSO:Ce and AlNap remain FRET
pairs with one another, but AlNap then transfers its energy to N -(6-diethylamino)-9-{2-[(prop2-yn-1-yloxy)carbonyl]phenyl}-3H -xanthen-3-ylidene)-N -ethylethanaminium (AlRhod) through an
additional FRET, resulting in a shift from a blue emission to a blue emission with a prominent green
and red component (cf. Figure 5.1f). The Förster distance between AlNap and AlRhod is ca. 3.62 nm.
When comparing the integral of the AlRhod component of the x-ray radioluminescence spectrum
to the total spectrum, the AlRhod component composes 10.5% of the total x-ray radioluminescence
spectrum.
The deconvolution of the radioluminescence spectra of emitter series no 3 revealed an AlRhod
peak at 633 nm (1.96 eV), which coincides well with the photoluminescence J-aggregate peak of
rhodamine B. There is also a peak at 541 nm (2.29 eV), which is likely a combination of a small
monomeric AlRhod peak, which should be at ca. 585 nm (2.12 eV) with a major contribution from
AlNap as this peak is slightly red shifted from the expected AlNap peak at ca. 525 nm (2.36 eV).
Clearly, the energy transfers that takes place with emitter series no 3 is not as good as emitter series
no 2 as two LSO:Ce bands could easily be deconvoluted; however, these bands are red shifted from
their expected peaks at 397 nm (3.12 eV) and 428 nm (2.90 eV) which suggests that the peak from
the Ce2 site is embedded in the two LSO:Ce peaks observed in Figure 5.4c. To maintain the fit, the
peak attributed to the Ce2 site could not be deconvoluted separately from the presented LSO:Ce
peaks. Both AlNap and AlRhod are stable against x-ray irradiation as the fluorophores were exposed
to several cycles of x-ray irradiation with photoluminescence of each fluorophore being obtained after
each radiation cycle. The photoluminescence spectra of AlNap and AlRhod did not change at any
time after exposure to x-ray radiation (data not shown), indicating that the molecular structure of
the fluorophores remained intact as photoluminescence of the molecules would change upon bond
destruction.
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The deconvolution of the radioluminescence spectrum of (a) emitter series no 1 revealed 3 peaks at
397 nm (3.12 eV), 428 nm (2.90 eV), and 500 nm (2.48 eV), which corresponds to Ce3+ 2 F5/2 and 2 F7/2 in the first
crystallographic site and a combination of the 4f states in the second crystallographic site, respectively; (b) Emitter
series no 2 showed AlNap an aggregate peak at 534 nm (2.32 eV) and a monomeric peak at 525 nm (2.36 eV) as well
as an LSO:Ce peak at 413 nm (3.00 eV), which is a combination of the 397 nm (3.12 eV) and 428 nm (2.90 eV) peak
observed in emitter series no 1. (c) Emitter series no 3 exhibited an aggregate AlRhod peak at 633 nm (1.96 eV), a
peak at 541 nm (2.29 eV) which is a combination of the monomeric AlRhod peak and AlNap peaks, and two LSO:Ce
peaks at 484 nm (2.56 eV) and 416 nm (2.98 eV), which are slightly blue shifted from the expected peaks. Total
fit for the deconvolutions is presented in black with the actual data presented in blue. All x-ray radioluminescence
spectra were obtained with an AmpTek Mini-X equipped with a silver target operating at 50 kV and 79µA.

Figure 5.4:
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(a)

(b)

(c)

(d)

Figure 5.5: Microscopy images of neurons with emitter series no 2 in culture. Neurons and particles imaged in (a)
brightfield, (b) under X-ray irradiation with background subtraction in darkfield, (c) under X-ray irradiation with
contrast enhancement under X-ray irradiation with background subtraction, and (d) under X-ray irradiation with
contrast enhancement under X-ray irradiation with background subtraction pseudo-colored green. All scale bars are
50 µm. X-ray irradiation performed with an AmpTek Mini-X equipped with a silver target operating at 40 kV and
99µA. Blue arrows indicate the soma of the neurons, while red arrows indicate emitter series no 2.
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5.3.3

Neuronal assessment with particulate systems
It is clear from the radioluminescence spectra of emitter series no 2 and no 3 that x-ray

radiation can induce FRET between an x-ray active pump source and non-x-ray active fluorophores.
Therefore, these particles have potential as imaging agents for deep tissue applications. In order to
evaluate their imaging ability, emitter series no 2 was incubated with cultured single-cell layer rat
cortical neurons and imaged (cf. Figure 5.5). Upon being in a water-rich, biological environment,
emitter series no 2, which was a mix of a non-active precursor compound and ca. 10% AlNap, was
imaged under x-ray irradiation using a standard photomicrography microscope. However, even with
AlNap in low yield, emitter series no 2 was still able to be imaged under physiological conditions.
This is a good indication that the particles are not degraded in an aqueous environment[88, 245].
Futhermore, control studies of neurons incubated with particles but without x-ray irradiation showed
only a black picture (data not shown). While the particles were able to be successfully imaged, we
needed to ensure that the particles did not induce any cytotoxicity. Because emitter series no 2 was
imaged with rat cortical neurons, the terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) toxicity assay was also performed with rat cortical neurons. Primary cortical neurons are
particularly sensitive to slight alterations in their culturing conditions, which can lead to their cell
death[246]. Cell death involves atrophy of the cell body, condensation of the nuclear chromatin,
DNA fragmentation, and neurite degeneration. A TUNEL assay was used to determine the number
of neurons that had undergone cell death for each condition (cf. Figure 5.6a). The presence of 1.01
×1011 particles/mL or 2.02 ×1011 particles/mL of emitter series no 2 did not decrease the number of
viable cells in culture at the various time points observed (cf. Figure 5.6b). Additionally, there was
no change in the neuronal density between the various conditions (cf. Figure 5.6c). While emitter
series no 2 did not exhibit any cytotoxicity, it needed to be ensured that unmodified LSO:Ce particles
did not induce cytotoxicity. Therefore, LSO:Ce particles were incubated with normal human dermal
fibroblasts for 24 hr, 48 hr, and 72 hr at particle concentrations of 3.6×107 , 3.6×108 , or 3.6×108
particles/mL. At all concentrations and at all time points, there was no observable cytotoxicity
as confirmed via a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium (MTS) assay statistically analyzed with the Tukey’s test (cf. Figure 5.6d). As the
particles do not induce cytotoxicity, these particles are potential viable bio-imaging agents.
It was noticed that acute application of nanoparticles resulted in the nanoparticles quickly
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Figure 5.6: Cultured cortical neurons were incubated for up to 24 hours with or without emitter series no 2. The
cells were then fixed, analyzed for TUNEL reactivity, and counterstained blue to visualize the neurons. (a) Images
of cortical neurons with and without emitter series no 2 after processing with the TUNEL assay. The black arrows
indicate examples of healthy neurons. Dead neurons were identified as cells that showed TUNEL reactivity through
the brown staining of the condensed chromatin. Scale bar 25 µm. (b) Group data shows no change in neuronal survival
at any of the incubations time points (0, 4, 14, and 24 hours) (ANOVA, F4,108 = 1.2, P =0.31, n=3,3,3,3,4). Six to
eight images from each coverslip were analyzed. (c) The overall neuronal density was unchanged. (ANOVA, F4,108 =
1.0, P =0.39, n=3,3,3,3,4) (d) MTS cytotoxicity assay of normal human dermal fibroblast (NHDF) cell incubated
without particles (control) or with 3.6×107 , 3.6×108 , or 3.6×108 particles/mL for 24 hrs (blue), 48 hrs (green), and
72 hrs (pink). No cytotoxicity was observed for any of the concentrations at any time point as analyzed by the Tukey’s
test.
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Figure 5.7: Cultured cortical neurons were incubated for 24 hours with nanoparticles. Each row is a z-stack image
separated by 2 µm. The white arrows indicate neurons with nanoparticles (small dark structures) sitting on top of
the neurons. The nanoparticles come into focus on a slightly different plane than the neuronal cell bodies. All scale
bars are 10 µm.

surrounding the cells. For applications involving proteins localized on the cellular membrane extracellularly, particle uptake by the cells can be undesirable[109, 247]. To assess the potential for
neurons to engulf the imaging probes, neurons were incubated for 24 hours with the nanoparticles
and then z-stack images were taken. Figure 5.7 shows that even after 24 hours the nanoparticles
are still sitting on the cell surface. Therefore, these particulate systems are suitable to extracellular
bioimaging.
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5.4

Conclusion
As x-ray bio-imaging and theranostics continue to become more clinically viable options,

the need for better, more versatile imaging agents will grow. Herein, we created a particulate
system based in LSO:Ce cores that have been surface modified with green emitting (AlNap) and
red emitting (AlRhod) to generate systems that are capable of emitting at a variety of colors when
the core is excited with x-ray radiation. These particles were successfully imaged in vitro with rat
cortical neurons. The particulate systems were tested for cytotoxicity with multiple assays and were
never shown to be cytotoxic at high particle concentrations for up to 72 hours. Additionally, due to
the ease of surface functionalization of the particles, the particles could be functionalized to target
various extracellular targets for robust bioimaging.

5.5

Experimental

5.6

Experimental Section

5.6.1

Reagents and solvents
All reagents were purchased from commercial suppliers, such as Aldrich or Alfa Aesar, and

were used without purification. All solvents used for reactions were distilled under nitrogen after
drying over an appropriate drying reagent. LSO:Ce phosphors (median particle size: 4 µm) were
purchased from Phosphor Technologies. To decrease the size of the phosphor particles, the particles
were ball milled and a final size of ca. 800 nm as measured by a Coulter N4 Plus DLS (dynamic light
scattering) was obtained. All other commercial reagents were used without further purification. All
solvents were dried according to standard methods. Deionized water was obtained from a Nanopure
System and exhibited a resistivity of ca. 1018 Ohm−1 cm−1 . Analytical thin-layer chromatography
was performed on glass plates coated with 0.25-mm 230-400 mesh silica gel containing a fluorescent
indicator. Column chromatography was performed using silica gel (spherical neutral, particle size
63-210 µm).
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Figure 5.8: Synthesis of 6-(piperidin-1-yl)-2-(prop-2-yn-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (AlNap).

5.6.2

Chemical characterization methods
1

H NMR spectra were recorded on a JEOL ECX300 spectrometer. Chemical shifts for

protons are reported in parts per million downfield from tetramethylsilane and are referenced to
residual protium in the NMR solvent (CDCl3 : δ 7.26 ppm).

5.6.3

Syntheses

6-(piperidin-1-yl)-2-(prop-2-yn-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (AlNap) 6(piperidin-1-yl)-2-(prop-2-yn-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione was synthesized according to a previously reported method[219] (cf. Figure 5.8).

1

H NMR (CDCl3 ) δ 1.73 (m, 2H), 1.89

(m, 4H, J =5.5 Hz), 2.17 (t, 1H, J =2.4 Hz), 3.24 (t, 4H, J =5.5 Hz), 4.95 (d, 2H, J =2.4 Hz), 7.18
(d, 1H, J =8.3 Hz), 7.68 (d.d, 1H, J =7.2 Hz), 8.40 (d.d, 1H, J =8.3 Hz, J =1.4 Hz), 8.53 (d, 1H,
J =8.3 Hz), 8.61 (d.d, 1H, J =7.2 Hz, J =1.4 Hz).

Mono(N-(6-(diethylamino)-1-(2-((prop-2-yn-1-yloxy)
carbonyl)phenyl)-3H-xanthen-3-ylidene)-N-ethylethanaminium) monocarbonate (AlRhod)
Mono(N-(6-(diethylamino)-1-(2-((prop-2-yn-1-yloxy)carbonyl)phenyl)-3H-xanthen-3-ylidene)-N-ethylethanaminium)
monocarbonate (AlRhod) was synthesized according to a previously reported method[248] (cf. Figure 5.9). 1 H NMR (CDCl3 ) δ 1.33 (t, 12H, J =7.2 Hz), 2.42 (t, 1H, J =2.4 Hz), 3.65 (m, 8H, J =7.2
Hz), 4.62 (d, 2H, J =2.4 Hz), 6.84 (d, 2H, J =2.4 Hz), 6.92 (m, 2H, J =9.3Hz, J =2.4 Hz), 7.05 (d,
2H, J =9.3 Hz), 7.34 (d, 1H, J =7.6 Hz), 7.75 (m, 1H, J =7.6 Hz), 7.85 (m, 1H, J =7.6 Hz), 8.31 (d,
1H, J =7.6 Hz).
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Figure 5.9:

Synthesis of mono(N-(6-(diethylamino)-1-(2-((prop-2-yn-1-yloxy)carbonyl)phenyl)-3H-xanthen-3ylidene)-N-ethylethanaminium) monocarbonate (AlRhod).

(3-azidopropyl)trimethoxysilane (1)

(3-Chloropropyl)trimethoxysilane (1 g, 5.03 mmol), and

sodium azide (0.684 g, 10.1 mmol) were mixed with dry dimethylformamide (3 ml), and the obtained
mixture was stirred at 90o C for 1h. After cooling, the mixture was diluted with dry dichloromethane
(10 ml) and filtered. The filtrate was collected and evaporated under vacuum to give a 25% solution
of product in DMF. This solution was used in the next step. 1 H NMR (CDCl3 ) δ 0.68 (t, 2H, J =8.3
Hz), 1.70 (m, 2H, J =6.9 Hz, J =8.3 Hz), 3.25 (t, 2H, J =6.9 Hz), 3.56 (s, 9H).
Synthesis of emitter series no 1 LSO:Ce particles (average size 800 nm) (2 g) was mixed with
methanol (15 ml), and the obtained suspension was sonicated for 15 minutes. Then the solution of 1
in DMF (1.4 ml) was added, and the mixture was stirred one minute. Finally, the aqueous solution
of ammonium hydroxide (29%, 1 ml) was added to the mixture and stirred for 24 hours; then the
reaction was refluxed for 2 hours. After cooling, the particles were separated by centrifugation,
washed with methanol three times, and dried under vacuum at room temperature. The product
afforded was azide modified LSO:Ce particles (cf. Figure 5.10a). Yield 2g.
Synthesis of emitter series no 2 The synthesis of emitter series no 2 was performed by utilizing
a standard 1,3 Huisgen azide-alkyne cycloaddition. Emitter series no 1 (300 mg) were dispersed in
THF (2 mL) and added to the reaction vessel. Then AlNap (40 mg, 0.126 mmol) in THF (1 mL) was
added to the reaction mixture. Finally, copper (II) sulfate (62.7 mg, 0.251 mmol) in DI-water (1 mL)
and sodium ascorbate (124.5 mg, 0.628 mmol) in DI-water (1 mL) were added to the reaction vessel.
Then the reaction vessel was placed in the J-KEM mini-reactor with stirring at 28o C in the dark
with a nitrogen purge. The reaction was allowed to proceed for 24 hrs. Upon reaction completion,
the product was washed with THF. Then the product was washed with a water/EDTA solution to
remove the copper catalyst. Finally, the product was washed six more times with THF. Washes
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were performed to remove any unattached dye from the particles. All washes were performed via
centrifugation at 27,216 G for 15 min (cf. Figure 5.10b). Once the supernatant of emitter series no 2
showed no peaks indicative of AlNap, emitter series no 2 was said to be free from any unattached
fluorophore. After the purification process, FTIR of AlNap was compared to that of emitter series
no 2 to ensure attachment (cf. Appendix D). The vigorous washing procedure and the subsequent
FTIR, which confirms the presence of AlNap, suggests that a successful CuCAAC reaction does take
place and that the AlNap is covalently attached to the LSO:Ce core.
Synthesis of emitter series no 3 The synthesis of emitter series no 3 was performed by utilizing a
standard 1,3 Huisgen azide-alkyne cycloaddition. Emitter series no 1 (300 mg) were dispersed in THF
(2 mL) and added to the reaction vessel. Then AlNap (5 mg, 0.016 mmol) in THF (1 mL) was added
to the reaction mixture. Finally, copper (II) sulfate (39.14 mg, 0.157 mmol) in DI-water (1 mL) and
sodium ascorbate (77.63 mg, 0.392 mmol) in DI-water (1 mL) were added to the reaction vessel.
Then the reaction vessel was placed in the J-KEM mini-reactor with stirring at 28o C in the dark
with a nitrogen purge. The reaction was allowed to proceed for 1 hour. Then AlRhod (35 mg, 0.073
mmol) in THF (2 mL) was added to the reaction vessel. The reaction was allowed to proceed for
an additional 24 hrs. Upon reaction completion, the product was washed with a 60:40 THF:water
solution to remove the copper catalyst. Finally, the product was washed seven more times with
THF. Washes were performed to remove any unattached dye from the particles. All washes were
performed via centrifugation at 27,216 G for 15 min (cf. Figure 5.10b). Once the supernatant of
emitter series no 3 showed no peaks indicative of either AlNap or AlRhod, emitter series no 3 was said
to be free from any unattached fluorophore. After the purification process, FTIR of AlRhod was
compared to that of emitter series no 3 as well as emitter series no 2 to ensure attachment of both
AlRhod and AlNap (cf. Appendix D). The vigorous washing procedure and the subsequent FTIR,
which confirms the presence of AlNap and AlRhod, suggests that a successful CuCAAC reaction
does take place and that the fluorophores is covalently attached to the LSO:Ce core.

5.6.4

Optical and x-ray radioluminescence characterization methods.
Absorbance spectra were taken using a Perkin Elmer Lambda 950 spectrophotometer. Pho-

toluminescence spectra were collected using a Jobin-Yvon Fluorolog 3-222 Tau spectrometer. X-ray
radioluminescence spectra were collected by irradiating the sample with a mini X-ray tube (Amptek
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(a) Synthetic scheme to yield azide modified LSO:Ce particles. (b) Subsequent CuAAC reactions
with either AlNap (1 dye) or AlNap and AlRhod (2 dyes).
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Inc., MA, USA), operating at a tube voltage of 50 kV and a tube current of 79 µA. The radioluminescence was collected with a fiber bundle (Oriel) coupled to a MicroHR (Horiba Jobin Yvon)
monochromator (spectral dispersion 5.25 nm/mm with spectral resolution of 0.25 nm) and a cooled
CCD detector (Synapse, Horiba Jobin Yvon). The signal was collected on a grating with 600 line
mm−1 and a blaze of 500 nm. The spectra was analyzed with SynerJY (Horiba Jobin Yvon) software. The exposure time varied from 1.2-20 sec based on sample size and relative luminescence.
Spectra were not corrected for the spectra sensitivity of the system.

5.6.5

Infrared spectroscopy
Fourier transform infrared spectroscopy (FTIR) spectra were obtained on a ThermoScientific

Nicolet 6700 FTIR with a diamond crystal equipped with an attenuated total reflectance (ATR)
attachment. Spectra were corrected for the ATR attachment and were baseline corrected prior to
analysis. Analyses were performed with Omnic software.

5.6.6

Microscope imaging
Microscope images were acquired on a Nikon Diaphot 300 inverted microscope with camera

using OpenLab 3.1.4 software. Neuronal cell cultures were imaged using a 40x objective. Particles
were added to the cell cultures using a pipette. Bright-field images were obtained of the cells and
particles in the absence of X-ray excitation. Dark-field images of the radioluminescing particles were
obtained by continually exciting the particles during a four-minute exposure with an Amptek mini-X
X-ray unit (tube voltage of 40 kV and a tube current of 99 µA) placed approximately 2 mm from
the cell culture in a dark room. Dark-field images of the ambient background light were obtained
the same as the radioluminescing particle images without any X-ray stimulation. Images were
processed using MATLAB R2014b. First, the ambient background image was subtracted from the
radioluminesing particle image to remove any light not derived from the radioluminesence. Next, the
background-subtracted radioluminescence image was contrast enhanced such that 1% of the data
was saturated at the high and low intensities of the image. This contrast-enhanced backgroundsubtracted radioluminesence image was tinted green to accentuate the radioluminescence. Finally,
the green-tinted image was overlaid on the bright-field image at 20% transparency.
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5.6.7

Cultured cortical neurons
Approval was obtained for all experimental protocols from the University of Alabama at

Birmingham Institutional Animal Care and Use Committee. All experiments were conducted in
accordance with the Guide for the Care and Use of Laboratory Animals adopted by the U.S. National
Institute of Health. Primary rat cortical neuronal cultures were obtained from embryonic day
18 rats as previously described.[249] Briefly, the cell culture coverslips were coated with poly-Llysine (50µg/ml) overnight at 37o C and then rinsed three times with autoclaved distilled water.
Dissected cortical tissue was incubated with papain for 20 minutes at 37o C. After rinsing in Hank’s
Balanced Salt Solution, a single-cell suspension of the tissue was re-suspended in Neurobasal media
(Invitrogen) by trituration through a series of large to small fire-polished Pasteur pipets. Primary
neuronal cells passed through a 70 µM cell strainer were plated on poly-lysine coated coverslips
in a 12 well plate. Cells were grown in Neurobasal media plus B-27 and L-glutamine supplement
(complete Neurobasal media) for 15-16 days in vitro in a humidified CO2 (5%) incubator at 37o C.
A 50% media change occurred weekly.

5.6.8

TUNEL assay
The cortical neurons were incubated up to 24 hours with ca. 800 nm azLSO/AlNap nanopar-

ticles (final concentration 0.2 to 0.4 mg/mL) to determine effects on cell health. The nanoparticles
were diluted in phosphate buffer saline (PBS) and a small volume (10 to 20 µL) was added to the
wells to prevent any changes in osmolarity. Cell death of primary cortical cultures was assessed using the TUNEL assay technique by the NeuroTACS in situ apoptosis detection kit (R&D Systems).
After a brief rinse with PBS, coverslips were treated with 4% paraformaldehyde for 45 minutes.
The rest of the procedure followed the recommended steps as indicated by the manufacturer to
detect DNA fragments using the terminal deoxynucleotidyl transferase enzyme (TdT) and revealed
through a horseradish peroxidase system. Positive and negative controls were performed. For the
positive control, coverslips were treated with TACS-Nuclease (R&D Systems) that generates DNA
breaks and showed a pale brown staining in the majority of the cells (> 95%). No labeling was
observed when TdT was not included in the reaction. Neuronal cells were counterstained with either DAPI (4’-6-diamidino-2-phenylindole) or Blue Counterstain (R&D Systems). Three to four
coverslips were used for each condition. Multiple images (6-8) were taken and analyzed from each
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coverslip on an Olympus BX53 (40x objective) microscope. Visibility of neurons was reduced at the
center of the application site due to the high concentration of nanoparticles, therefore images were
taken in slightly less dense areas to improve visualize of the neurons and determine their survival.
The cells were analyzed blind to the incubation period by two separate individuals and the results
were averaged together. All TUNEL analysis statistics were performed using Origin software (Origin
Lab Corporation, 2002) and statistical significance was P < 0.05. Data are presented as means ±
SE and sample number (n) refers to coverslips for TUNEL assay. Statistical comparisons were made
using one-way ANOVA followed by Tukey’s posthoc analysis.

5.6.9

Cultured normal human dermal fibroblast (NHDF) cells
Normal human dermal fibroblast (NHDF) cells were obtained from ATCC. The NHDF

cells were cultured in Dulbeccos modified Eagles media (DMEM) containing 2% fetal bovine serum
(FBS), 7.5 mM L-glutamine, 5 ng/mL rh FGF basic, 5 µg/mL rh Insulin, 1 µg/mL hydrocortisone,
50 µg/mL ascorbic acid. Cells were cultured at 37o C in a humidified atmosphere of 95% air / 5%
CO2 .

5.6.10

MTS assay
Normal human dermal fibroblast (NHDF) cells were plated in 96 well plates at a cell den-

sity of 7,000 cells per well. After the cells were plated for 24 hours, the cells were incubated
with ca. 800nm commercial LSO:Ce particulates in concentrations of 3.6×107 , 3.6×108 , or 3.6×109
particles/mL. At each concentration, the cells were incubated for 24, 48, or 72 hours. At the conclusion of each time point, the cell viability was measured using a [3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay (CellTiter 96 R
AQueous One Solution Cell Proliferation Assay, Promega, Fitchburg, WI) following the manufacturer’s protocol. Briefly, the media was removed and the plate was washed several times with
phosphate buffered saline (PBS) before adding a solution containing 200µL of DMEM media and
40µL of the MTS assay reagent. After 3 hours, the absorbance was measured using a plate reader
at OD=490nm.

113

5.6.11

Thermal characterization methods
Thermogravimetric analysis (TGA) was performed on a TA Instruments Hi-Res TGA 2950

Thermogravimetric Analyzer equipped with Universal Analysis software. All TGAs were performed
from room temperature to 1000o C at 10o C/min in a nitrogen atmosphere with a switch to air at
700o C. Before each TGA run, the sample was purged in the furnace with nitrogen for 15 min.
Thermogravitmetric analysis was performed on particulate systems to determine fluorophore or
silane ligand coverage of the particles.

5.6.12

Scanning Electron Microscopy
A Hitachi 4800 field emission scanning electron microscope (FE-SEM) was used to obtain size

distribution of azLSO:Ce. The samples were platinum coated at 15 mA for one minute under argon
conditions at 200 mtorr. Images of secondary electrons were taken with an accelerating voltage of 15
kV. Image analysis was performed using ImageJ software and dimensions were calibrated according
to the scale bar of each picture.
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Chapter 6

Concluding Remarks
6.1

Summary
The objective of the presented work was to develop nanoparticle systems, containing fluo-

rophores as well as scintillating molecules, capable of enhanced bioimaging by 1) utilizing activated
fluorescence and 2) x-ray radiation instead of more traditional visible and ultra-violet light stimulation. Additionally, some particulate systems that exhibit x-ray excited optical luminescence can
be self-assembled into colloidal crystalline arrays (CCAs) where the color of emitted light can be
manipulated by photonic means as well as through judicious choice in fluorophores that form FRET
pairs with each other as well as the scintillating molecule or particle. In this way, both activated
fluorescence and, the relatively unexplored phenomenon of x-ray excited optical luminescence as it
applies to imaging and tuning emission color is utilized to create next-generation particulate systems
capable of superior bioimaging.

Bovine serum albumin coated nanoparticles for in vitro activated fluorescence and photodynamic therapy applications

Silicon phthalocyanine (SiPc) and its derivatives are some of the

most promising candidates for next-generation photodynamic therapy (PDT) probes as SiPcs emit
in the far-red/near infrared region of the electromagnetic spectrum. However, the small molecule
fluorophore suffers from short in vivo circulation times and severe hydrophobicity, limiting its usefulness as a PDT photosensitizer. To this end, more water-soluble SiPc derivatives, capable of
undergoing copper(I) azide/alkyne cycloaddition (CuCAAC) catalyzed reactions, were synthesized
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and their photodynamic therapy efficacy was evaluated. When compared to the standard, Pc4, the
newly synthesized SiPc derivatives were comparable in the induced cell death after irradiation of the
phthalocyanine with a red laser. While the novel small molecule silicon phthalocyanine derivatives
showed promise as photosensitizers, they will still suffer from short circulation times. To mitigate this issue, the SiPcs were covalently attached to poly(propargyl acrylate) (pPA) sub-100nm
nanoparticles through CuCAAC reactions. However, the pPA/fluorophore conjugate did not show
any efficacy toward photodynamic therapy and the fluorescence emission was always in an “ON”
state upon irradiation, which yields a poor signal/noise ratio. Additionally, it was hypothesized
that a non-radiative energy transfer took place between the fluorophore and the nanoparticle with
the nanoparticle acting as an energy sink. To assuage this issue, a stimuli responsive link needed
to be placed between the fluorophore and the nanoparticle. To this end, bovine serum albumin
(BSA) was modified to have azide groups on its surface. Using a series of CuCAAC reactions, pPA
nanoparticles were coated with BSA that was functionalized with the fluorophore. This particulate
system was not fluorescent in its intact state; however, once the BSA was destroyed by digestive
enzymes the fluorescence of the SiPc dye was recovered. In an in vitro setting the particulate system
is more easily endocytosed by cancer cells where fluorescence is induced only upon endosomal or
lysosomal uptake where the BSA becomes digested and SiPc (conjugated to peptide chains of the
digested protein) becomes emissive.

Dynamic emission tuning of x-ray radioluminescent dye-doped crystalline colloidal arrays: coupling the optical stop band with sequential Förster resonance energy transfers
X-ray based imaging has advantages over traditional visible light or ultraviolet light imaging techniques because x-rays more easily penetrate the body. However, most x-ray based imaging techniques
require heavy metal imaging agents that pose potential toxicity issues. Therefore, it would be ideal
for versatile, x-ray imaging agents to be fully organic. To this end, polystyrene nanoparticles with encapsulated organic, x-ray active molecules that could be coupled to a variety of fluorophores through
FRET, were synthesized so that the x-ray induced radioluminescence could span the entire visible
spectrum. Furthermore, the exact color of the particulate system could be tuned through photonic
means. To this end three particulate systems with one (emitter series no 1), two (emitter series no 2),
or three emitters (emitter series no 3) were designed. All three particulate systems self assembled
into electrostatically stabilized CCAs with very good zeta potentials (less than -60 mV). Emitter
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series no 1 was synthesized with only anthracene. Upon x-ray irradiation, emitter series no 1 emits
blue light with relatively high color purity; however, as the rejection wavelength is moved through
the emission of anthracene (by diluting the CCA and increasing the d111 spacing), the shade of blue
could easily be manipulated with varying color purities. Polystyrene nanoparticles with both anthracene and a naphthalimide derivative (AzNap) encapsulated inside the particle were synthesized
with anthracene acting as the x-ray excitable “pump” (or donor) and AzNap (not x-ray active) as
the green-emitting acceptor. Emitter series no 3 contained anthracene, AlNap, and rhodamine B
(RhB) where anthracene and AlNap remain FRET pairs with one another, but AlNap also acts as
the donor to RhB (not x-ray active) to yield an overall emission color of red. The exact shade of
both green and red emitted for emitter series no 2 and no 3, respectively, was easily manipulated by
moving the stop band through the emission range. Additionally, mixing all emitter series resulted in
white light emission where the exact white hue could be manipulated by varying the ratios of each
emitter series.

X-ray radioluminescent, click capable, stilbene-based colloidal crystalline arrays self
assembled into hydrogels with tunable x-ray emission

Building upon the findings reported

in Chapter 3, polystyrene-co-poly(propargyl acrylate) (PS-co-pPA) based CCA hydrogels were synthesized because liquid based CCAs are easily disrupted by ionic contamination and mechanical
perturbations, making them non-ideal candidates for use in the human body. Additionally, the fluorophore encapsulation method described in Chapter 3 requires a new synthesis each time a new color
of emitted light is needed. To mitigate these obstacles, propargyl acrylate was incorporated into
the synthesis of the nanoparticles to yield particles that have free alkynes on the surface. Stilbene,
another organic scintillator more soluble in styrene, was doped into the emulsion of polystyrene
and poly(propargyl acrylate). These particles yielded blue-emitting CCAs, but the x-ray induced
luminescence of stilbene is inferior to that of anthracene. However, these CCAs could be encapsulated into methacrylate based hydrogels where the stop band could be tuned through a reversible
hydration/dehydration process. These stilbene/PS-co-pPA hydrogels are blue emitting, but they
emit light poorly upon upon x-ray irradiation. However, a CuCAAC reaction was utilized to covalently attach AzNap to the nanoparticle while being in hydrogel form. In this way, the hydrogel was
transformed from being a poor blue emitter to a good green emitter where the rejection wavelength
could still be easily manipulated. To create strongly red-emitting hydrogels, AzNap and an azide
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modified rhodamine B derivative (azRhod) were attached to the nanoparticles through a CuCAAC.
All hydrogels were able to be imaged with a simple optical camera, indicating that these hydrogels
may be well suited to bioimaging applications.

Organic fluorophore coated polycrystalline ceramic LSO:Ce scintillators for x-ray bioimaging

While organic x-ray imaging agents mitigate the toxicity issues of inorganic imaging agents,

inorganic scintillators remain orders of magnitude brighter than organic scintillators. To this end,
lutecium oxyorthosilicate doped with cerium (LSO:Ce) particles were surface modified with organic
fluorophores to shift the bright blue emission of LSO:Ce to have elements of green and red achieved
by first surface modifying LSO:Ce with an azide linker through a silane bond followed by subsequent
CuCAAC reactions with an alkyne modified naphthalimide derivative (AlNap) and an alkyne modified rhodamine B (AlRhod) derivative. The bioimaging efficacy of the LSO:Ce/AlNap system was
tested in vitro with rat cortical neurons where the particles were illuminated under x-ray irradiation
and imaged using a standard photomicrography microscope. Furthermore, neither the LSO:Ce nor
the LSO:Ce/AlNap particles were cytotoxic to normal human dermal fibroblast cells or rat cortical
neurons, respectively, at high particle concentrations for up to 72 hours.

6.2

Recommendations for Future Research
To continue to evaluate the photodynamic therapy benefit of the activated fluorescence SiPc

nanoparticles described in Chapter 2, additional in vitro PDT studies need to be performed followed
by long-term in vivo studies in a rodent model. Other photosensitizers should also be explored by
incorporating them into the pPA/BSA nanoparticle scaffold. Furthermore, x-ray sensitive photosensitizers should be sought and incorporated into a particulate system as one of the main obstacles
of PDT is that it cannot be used in deep tissue cancers because red/near infrared light cannot penetrate deeply into the body; this issue would be mitigate by utilizing an x-ray active photosensitizer
or a FRET system that could be excited first through x-ray irradiation followed by an emission at
the appropriate wavelength of light to generate singlet oxygen.
In order to advance x-ray active photonic crystals, better hydrogels with more narrow rejection wavelengths need to be synthesized and evaluated. Other fluorophores should be incorporated
into the system to generate near infrared and infrared emitting hydrogels that may be better suited
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to nanotheranostic applications. While the organic hydrogels are promising imaging agents, the
fact remains that inorganic scintillators emit much more light than organic scintillators due to the
stopping power of heavy metals. Therefore, more ways to make inorganic scintillators more biocompatible need to be investigated to combine the superior x-ray induced emission of inorganic
scintillators and the non-toxic behavior of fully organic systems.
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Appendix A

Characterization of SiPc novel
compounds
A.1

Characterization of compound 4a
1

H NMR characterization of 4a showed the shielding of the axial substituent protons by

the electron cloud of the SiPc ring. Well-separated, upfield shifted triplets, starting from -1.92 ppm,
show methylene protons. (cf. Figure A.1). The CH2 protons attached to the azide group are shifted
from the triplet from 3.37 ppm observed in 3a is shifted to 2.93 ppm in compound 4a. Aromatic
protons in the final SiPcs show two, well-separated downfield shifted multiplets.
13

C NMR characterization of 4a confirms the theorized number of carbons and confirms the

structure (cf. Figure A.2).
ESI mass analysis of 4a confirms the proposed mass of the compound (cf. Figure A.3).

A.2

Characterization of compound 4b
1

H NMR characterization of 4b showed the shielding of the axial substituent protons by

the electron cloud of the SiPc ring. The CH2 protons are represented by the triplet at 3.37 ppm
for compound 4b. Well-separated, upfield shifted triplets, starting from -1.92 ppm, show methylene
protons. Aromatic protons in the final SiPcs show two, well-separated downfield shifted multiplets
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Figure A.1: 1 H NMR spectra of compound 4a

(cf. Figure A.4).
13

C NMR characterization of 4b confirms the theorized number of carbons and confirms

the structure (cf. Figure A.5).
ESI mass analysis of 4b confirms the proposed mass of the compound, and the presence of
44 mass units [OCH2 CH2 ]+ starting from molecular ion M+ (cf. Figure A.6).
The presence of azide groups in PEGylated SiPc (4b) was also confirmed by FTIR analysis.
The azide groups on 4b have a strong absorption at 2098 cm−1 (cf. Figure A.7).
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NMR spectra of compound 4a

Characterization of compound 5a
The 1 H NMR spectrum of 5a shows the shielding of the axial substituent protons by the

electron cloud of the SiPc ring. Alkyne protons in modified triethylene glycol 1a show a triplet at
2.43 ppm, while, for 5a, the signal is shifted to 2.34 ppm. Well-separated, upfield shifted triplets,
starting from -1.92 ppm, show methylene protons. Aromatic protons in 5a show two, well-separated
downfield shifted multiplets (cf. Figure A.8).
13

C NMR characterization of 5a confirms the theorized number of carbons and confirms the

structure (cf. Figure A.9).
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Figure A.3: ESI mass analysis of compound 4a, positive ionization.

A.4

Characterization of compound 5b
The 1 H NMR spectrum of 5b shows the shielding of the axial substituent protons by the

electron cloud of the SiPc ring. Well-separated, upfield shifted triplets, starting from -1.92 ppm,
show methylene protons. Alkyne protons in modified PEG600 1b and 5b show a triplet at 2.43 ppm
(cf. Figure A.10).
13

C NMR characterization of 5b confirms the theorized number of carbons and confirms

the structure (cf. Figure A.11).
The presence of alkyne groups in PEGylated SiPc (5b) was also confirmed by FTIR analysis
(cf. Figure A.12).
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Figure A.6: ESI mass analysis of compound 4b, positive ionization.
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Figure A.10: 1 H NMR spectra of compound 5b
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Figure A.12: FTIR interferogram of compound 5b which confirms the presence of alkyne functionality.
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Appendix B

Characterization of anthracene
(Anth), azide modified
naphthalimide (Napth), and
rhodamine B (RhB)
B.1

Absorbance, molar extinction coefficient, and photoluminescence of emitters
Due to the presence of several vibrational bands, Anth dissolved in aniline (10 µg/mL) yields

three distinct absorbance peaks at ca. 345 nm, 363 nm, and 382 nm[250]. The molar extinction
coefficient of Anth at 363 nm in aniline was calculated to be 6990 M−1 cm−1 . Photoluminescence
(PL) was performed on solid anthracene crystals (ca. 10 mg); there was only one distinct peak at
405 nm . However, it appears that there are shoulders at 425 nm, 455 nm, and 470 nm, which
are also indicative of the various vibrational bands of Anth[251]. The solution of Napth (IUPAC
name 2-(3-azidopropyl)-6-piperidino-2-aza-2H-phenalene-1,3-dione) in aniline (5 µg/mL) showed one
absorbance peak at a maximum wavelength of 400 nm; similarly it showed one fluorescence maximum
peak at 520 nm[221, 252]. The molar extinction coefficient of Napth in aniline was calculated to
131

be 34963 M−1 cm−1 at 400 nm. The absorbance spectrum of RhB in aniline (5µg/mL) showed
a maximum peak at 554 nm with a shoulder at ca. 525 nm, which is the J-aggregate peak. The
photoluminescence spectrum also shows one maximum peak at 580 nm with a J-aggregate peak at
630 nm[222, 223, 224]. The corresponding molar extinction coefficient of RhB at 554 nm was 20651
M−1 cm−1 .

B.2

Emitter concentration
The Anth concentration in emitter series n◦ 1 is 2.47×10−15 mg/particle or 7.67×1017 Anth

molecules/1 mL of CCA. The Anth concentration and Napth concentration in emitter series n◦ 2
is 2.58×10−15 mg/particle which converts to 8.75×1017 molecules/mL and 9.35×10−17 mg/particle
which converts to 1.55×1016 , respectively. The Anth, Napth, and RhB concentrations in emitter series n◦ 3 are 7.33×10−15 mg/particle (4.122×1018 molecules/mL), 1.49×10−16 mg/particle
(4.14×1016 molecules/mL), and 2.65×10−15 mg/particle (5.56×1017 molecules/mL), respectively.
Aniline was chosen for the solvent of all dye solutions because aniline has a similar refractive index
to polystyrene. The index match and molar extinction coefficient calculations allowed for the determination of dye content per particle and per volume. All molar extinction coefficients described
were calculated from an average of three UV/vis scans at different known concentrations of the dye.

B.3

NMR of azide modified naphthalimide (Napth)
NMR spectrum of Napth (cf. Figure B.2) was performed in deuterated chloroform and

chemical shifts are reported downfield from tetramethylsilane (TMS).
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Appendix C

Characterization of AzRhod
C.1

Absorbance and emission of AzRhod
Absorbance and emission spectra of AzRhod closely matched that of native rhodamine B.

C.2

NMR of AzRhod
NMR spectrum of AzRhod performed in deuterated chloroform.
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Appendix D

Characterization of AlNap and
AlRhod
D.1

Absorbance and emission of fluorophores
6-piperidin-1-yl-2-prop-2-yn-1-yl-1H -benzo[de]isoquinoline-1,3-(2H )-dione (AlNap) has an

absorbance at 400 nm[253, 252]. The emission profile of AlNap exhibits a maximum emission
at ca. 515 nm[219, 220, 221]. The maximum absorbance of N -(6-diethylamino)-9-{2-[(prop-2-yn1-yloxy)carbonyl]phenyl}-3H -xanthen-3-ylidene)-N -ethylethanaminium (AlRhod) was ca. 550 nm
with an aggregation peak at 515 nm, while the maximum emission for AlRhod was ca. 585 nm
when excited at 550 nm (cf. Figure D.1)[222, 223, 224]. No significant emission was detected for
the naphthalimide and rhodamine B derivatives when irradiated with x-rays (data not shown). It is
obvious that the emission of LSO:Ce overlaps well with AlNap, and the emission of AlNap overlaps
well with the absorbance of AlRhod.

D.2

NMR of AlNap and AlRhod
NMR spectra for AlNap (cf. Figure D.2) and AlRhod (cf. Figure D.3) performed in deuter-

ated chloroform. All chemical shifts are reported downfield from tetramethylsilane.
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Figure D.1: (a) Absorbance of 6-piperidin-1-yl-2-prop-2-yn-1-yl-1H -benzo[de]isoquinoline-1,3-(2H )-dione (AlNap),
optical emission of LSO:Ce (light green), optical emission of AlNap (dark green), absorbance of N -(6-diethylamino)-9{2-[(prop-2-yn-1-yloxy)carbonyl]phenyl}-3H -xanthen-3-ylidene)-N -ethylethanaminium (AlRhod) (pink), and optical
emission of AlRhod (purple). Shaded are the areas of emission/absorption overlap. Excitation of LSO:Ce, AlNap,
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LSO, which was measured in its solid form.

D.3

absorbance AlNap

FTIR of all emitter series
Figure D.4 presents the FTIR spectrum of emitter series no 1. The peak at 2100 cm−1 is

indicative of the N=N stretch in the azide linker. The range of peaks at ca. 922-901 cm−1 are those
of the LSO:Ce core.
The FTIR of AlNap clearly shows an alkyne peak at 3285 cm−1 while that peak has disappeared in the FTIR of emitter series no 2 because the alkyne has been consumed in the formation
of the triazole during the CuCAAC reaction. Additionally, in the FTIR of AlNap, the peaks at ca.
1696-1572 cm−1 , which are indicative of AlNap, are present in the FTIR of emitter series no 2 though
they have been slightly shifted and are now at ca. 1696-1586 cm−1 . The FTIR of emitter series no 2
also indicates the presence of LSO:Ce as indicated by the peaks at 922-900 cm−1 (cf. Figure D.5).
The broad peak at ca. 3363 cm−1 in the FTIR of emitter series no3 is indicative of AlRhod
when it is compared to the FTIR of AlRhod alone. Additionally, the peaks at 1582-1527 cm−1 in
the FTIR of emitter series no 3 represent overlapping peaks of both AlNap and AlRhod. The broad
peak centered at ca. 3363 cm−1 in emitter series no 3 is indicative of AlRhod and is also present in
the FTIR of AlRhod even though the peak has more solvable features in the FTIR of the spectrum
(cf. Figure D.6).
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Figure D.2: NMR spectrum of AlNap with integrals reported at the bottom of the spectrum.
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Figure D.3: NMR spectrum of AlRhod with integrals reported at the bottom of the spectrum.
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Figure D.4: FTIR spectrum of emitter series no 1.
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Figure D.5: FTIR spectrum of emitter series no 2 (red) overlaid with the FTIR spectrum of AlNap (blue).
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Figure D.6: FTIR spectrum of emitter series no 3 (red) overlaid with the FTIR spectrum of AlRhod (blue).
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Appendix E

Additional modification of silica
nanoparticles as proof of concept
of modification of LSO:Ce particles
O6 benzylguanine has been shown to bind selectively and irreversibly with the SNAP-tag,
a 182 residue peptide chain, which is a mutant of O6 -alkylguanine-DNA alkyltransferase, that can
be sequenced with almost any other protein of interest[254, 255] (cf. Figure E.1). In the case of
optogenetic applications, the SNAP-tag is co-expressed with the opsin extracellularly. Therefore,
the silica nanoparticles and radioluminescent particles are surface functionalized with a derivatized
O6 -benzylguanine, which serves to drag the particle closer to the opsin when it binds with the
SNAP-tag co-expressed with the opsin. This binding allows for a more effective energy transfer
between the radioluminescent particle and the particle.

E.1

Results & Discussion
Silica nanoparticles of diameter ca. 117 nm were surface modified with an azide modi-

fied silane linker. The silica nanoparticles were then modified with an alkyne derivative of O6 benzylguanine, fluorescein, and poly(ethylene glycol) with molecular weight 350 g/mol (PEG350).
PEG350 was covalently attached to the particles to increase colloidal stability. Silica particles were
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Figure E.1: Synthetic scheme of the commercially available O6 benzylguanine small molecule reacting with the
SNAP-tag peptide chain.

used as a substitute for silicate based radioluminescent particles to ensure that the particles could
be functionalized before much more expensive radioluminescent particles were used. By absorbance
spectroscopy, both the derivative O6 benzylguanine and fluorescein, which is used a fluorescence
reporting molecule, were attached to the particle as the alkyne modified O6 benzylguanine has a
maximum absorbance of ca. 290 nm, while alkyne modified fluorescein has a triplet peak at ca. 435
nm, 460 nm, and 490 nm (cf. Figure E.2). Additionally, the fluorescein remained luminescent after
attachment to the particle as shown with photoluminescence spectroscopy as evidenced by its peak
at ca. 540 nm. While the derivatized O6 benzylguanine is slightly different than the commercial O6
benzylguanine, it is hypothesized that the SNAP-tag will still bind with the newly synthesized O6
benzylguanine because the “reacting” bonds remain present in the new derivative.

E.2
E.2.1

Experimental
Reagents and solvents
All reagents were purchased from commercial suppliers, such as Aldrich or Alfa Aesar, and

were used without purification. All solvents used for reactions were distilled under nitrogen after
drying over an appropriate drying reagent. LSO:Ce phosphors (median particle size: 4 µm) were
purchased from Phosphor Technologies. To decrease the size of the phosphor particles, the particles
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Figure E.2:

Absorbance spectroscopy of silica nanoparticles surface functionalized with the alkyne derivative of
O6 -benzylguanine and alkyne modified fluorescein. Absorbance spectra were obtain in water/glycerol to match the
refractive index of silica.

were ball milled in ethanol with zirconia balls and a final size of ca. 800 nm as measured by a
Coulter N4 Plus DLS (dynamic light scattering) was obtained. All other commercial reagents were
used without further purification. All solvents were dried according to standard methods. Deionized
water was obtained from a Nanopure System and exhibited a resistivity of ca. 1018 Ohm−1 cm−1 .
Analytical thin-layer chromatography was performed on glass plates coated with 0.25-mm 230-400
mesh silica gel containing a fluorescent indicator. Column chromatography was performed using
silica gel (spherical neutral, particle size 63-210 µm).

E.2.2

Chemical characterization methods
1

H NMR spectra were recorded on a JEOL ECX300 (300 MHz for proton and 76 MHz for

carbon) spectrometer. Chemical shifts for protons are reported in parts per million downfield from
tetramethylsilane and are referenced to residual protium in the NMR solvent (CDCl3 : δ 7.26 ppm).
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Figure E.3: Photoluminescence spectroscopy of silica nanoparticles surface functionalized with the alkyne derivative
of O6 -benzylguanine and alkyne modified fluorescein. Photoluminescence spectra were obtain in water/glycerol with
an excitation of 460 nm.

E.2.3

Synthesis

Synthesis of 4-[2-Propynylmethoxy]benzyl alcohol (2) 4-[2-Propynylmethoxy]benzyl alcohol (2) was synthesized as described previously[256].
Synthesis of alkyne modified O6 -benzylguanine (3) 4-[2-Propynylmethoxy]benzyl alcohol
(2, 0.44 g, 2.5 mmol) was dissolved in dry dimethylformamide (4 mL). Then sodium hydride (0.065
g, 2.72 mmol) was added into the stirred solution under nitrogen. The obtained mixture was stirred
at room temperature for 10 minutes; then the solution of 4,6-dichloropyrimidin-2-amine (1, 0.37g,
2.26 mmol) in dimethylformamide (2 mL) was added into reaction. The mixture was stirred at
80 o C for 3 hours. At reaction completion, the reaction was cooled, diluted with DI-water, and
extracted with ethyl acetate. The organic solution was separated, washed with water, dried with
sodium sulfate, filtered, and evaporated under reduced pressure. The residue was purified by column
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chromatography with an eluent of dichloromethane:acetone (20:1), Rf =0.4 (cf. Figure E.4). Yield
0.46 g (67%). Clear solid, m.p=100 o C. 1 H NMR (CDCl3 ) δ 2.47 (t, 1H, J =2.4 Hz), 4.17 (d, 2H,
J =2.4 Hz), 4.61 (s, 2H), 5.31 (s, 2H), 6.15 (s, 1H), 7.37 (s, 4H);

13

C NMR (CDCl3 ) δ 57.26, 68.12,

71.26, 74.86, 79.66, 97.34, 128.30, 128.38, 135.82, 137.54, 161.01, 1362.36, 170.99.
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Figure E.4: Synthetic scheme yielding alkyne derivatized O6 -benzylguanine.

Prop-2-yn-1-yl 2-(3-oxo-6-(prop-2-yn-1-yloxy)-3H-xanthen-9-yl)benzoate (5)

Prop-2-yn-

1-yl 2-(3-oxo-6-(prop-2-yn-1-yloxy)-3H-xanthen-9-yl)benzoate (4) was synthesized according to a
previously reported method[257] (cf. Figure E.5).

1

H NMR (CDCl3 ) δ 2.31 (t, 1H, J = 2.4 Hz),

2.59 (t, 1H, J = 2.4 Hz), 4.59 (dd, 2H, J = 15.5 Hz, J = 2.4 Hz), 4.79 (d, 2H, J = 2.4 Hz), 6.47 (d,
1H), 6.56 (dd, 1H, J = 9.8, J = 2.0 Hz), 6.78 (dd, 1H, J = 9.0, J = 2.4 Hz), 6.84 (d, 1H, J = 9.8
Hz), 6.89(d, 1H, J = 9.0 Hz), 7.06(d, 1H, J = 2.4 Hz), 7.33 (dd, J = 7.6, J = 1.4 Hz), 7.66-7.69
(m, 2H, J = 7.6, J = 1.4 Hz), 7.26 (dd, 1H, J = 7.6, J = 1.4 Hz).
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Figure E.5: Synthetic scheme yielding alkyne modified fluorescein.
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Synthesis of methoxypolyethylene glycol 350 propargyl ester

Methoxypolyethylene glycol

350 (2 g, 5.7 mmol) was dissolved in dry THF (25 mL). Then sodium hydride (0.25 g, 6.3 mmol)
was added under nitrogen. The mixture was stirred for 10 minutes and propargyl bromide (0.75
g, 6.3 mmol) was added. The obtained mixture was stirred at room temperature for 18 hours. At
reaction completion, water was added to the reaction vessel, and the product was extracted with
dichloromethane. The organic solution was dried with sodium sulfate, filtered, and evaporated under
reduced pressure. The residue was washed with hexane; the hexane was decanted from the insoluble
and the produce was dried. Yield 2.1 g (95%), pale yellow oil. 1 H NMR (CDCl3 ) δ 2.43 (t, 1H, J
= 2.4 Hz), 3.37 (s, 3H), 3.54 (m, 2H), 3.65 (m, 28H), 4.19 (d, 2H, J = 2.4 Hz).

Synthesis of silica nanoparticles

Tetraethyl orthosilicate (TEOS) was dissolved in ethanol

(EtOH, 140 mL). Then deionized (DI) water (3 mL) was added to the reaction vessel followed by
the addition of ammonium hydroxide (29% in water, 2 mL). The solution was stirred vigorously for
approximately 22 hours. At reaction completion, the particles were centrifuged at 5000 rpm for 40
min. The nanoparticles were then re-dispersed in methanol (16 mL) using sonication; DI water (1
mL) was added to the dispersion to increase the dispersion rate. There were some aggregates in the
dispersion, so the dispersion was gravity filtered to yield a dispersion of ca. 117 nm particles. The
dispersion was used in the next step.

Synthesis of azide modified silica nanoparticles

The dispersion described above was placed

into a round bottom flask. (3-azidopropyl)trimethoxysilane (0.25 g) was added to the reaction vessel
as well as ammonium hydroxide (29% in water) and DI-water (0.75 mL). The solution was stirred
at room temperature for 21 hours followed by a reflux for 2 hours. After the solution cooled, the
nanoparticles were centrifuged at 4000 rpm for 40 min with re-dispersion in methanol (18 mL) three
times. The final product was redispersed in methanol (18 mL).
Synthesis of silica nanoparticles surface modified with alkyne modified O6 -benzylguanine
and alkyne modified fluorescein using CuAAC reaction

Alkyne modified fluorescein (2.5

mg), alkyne modified PEG350 (1 mg dissolved in 500 µL THF), and O6 -benzylguanine (5 mg) were
added to azide modified silica nanoparticles (200 mg) dispersed in tetrahydrofuran (THF, 2.85 mL).
Then a solution of copper sulfate (12.10 mg in 1 mL DI water) and sodium ascorbate (24.02 mg in 1
mL DI water) were added to the reaction vessel. The reaction was allowed to proceed for 24 hours in
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the dark at 28 o C in a nitrogen atmosphere. To remove unreacted moieties from the particle dispersion, the particles were washed with THF once followed by two washes with a solution of DI-water
and ethylenediaminetetraacetic acid (EDTA, 3 mL). Then the particles were washed with THF 10
more times until the supernatant showed no peaks indicative of O6 -benzylguanine and fluorescein.
All washes were performed in the centrifuge at 27,216 g for 15 minutes (cf. Figure E.6).
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Figure E.6: Synthetic scheme of the CuAAC reaction between azide modified silica nanoparticles, alkyne modified
O6 -benzylguanine, PEG350, and fluorescein.
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